| Organisation | Type | Fields of activity | Focus | is located in | Management | was founded in | Address | Homepage | Profile | Contacts | Number of employees | Certificates | BioChancePLUS | BioProfile | Scientific Advisory Board | Advisory Board | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3mach GmbH | Medtech | Medical Technology, Diagnostics | Hygiene solutions and products for the medical technology, diagnostics and medical sectors | Rangendingen | Dr. Robert Simmoteit (Managing Director) | 2003 | Ringstrasse 11 72414 Rangendingen Germany Phone: +49 (0)7471-984118 Fax: +49 (0)7471-984119 | www.3mach.de | 3mach GmbH is an innovative hygiene company operating in the medical technology, diagnostics and medical sectors. The company develops, produces and sells practical solutions and products for instrument preparation and also develops cost-effective diagnosis methods for straightforward analysis of medically relevant surface contamination. A further area of operation for 3mach is the development of innovative materials and products for medical applications e.g. for the regeneration of skin. Based on a tried-and-tested bio-compatible material concept, the aim is to offer cost-effective forms of treatment in a wide variety of areas. 3mach made a name for itself with its innovative highly flexible modular stand and component system for the hygiene technology sector. Highly flexible and secure mountings can be built using the components and assemblies. The extensive hygiene technology product range includes fixing elements, rotary rinsing lines, rinsing adapters, stand components and functional strainer baskets for instrument cleaning and logistics. | Dr. Robert Simmoteit (Robert.Simmoteit@3mach.de) | |||||||
| 4base lab GmbH | Biotech | Services | Service provider in the field of genomics and proteomics; GMP analyses | Reutlingen | Dr. Despina Tougianidou Dr. Thomas Maier Dr. Manfred Bayer | 1995 | Aspenhaustrasse 25 72770 Reutlingen Germany Tel.: +49 (0)7121-937557 Fax: +49 (0)7121-937558 Postal Adress: Postfach 4023 72771 Reutlingen Germany | info@4base-lab.de | www.4base-lab.de | 4base lab GmbH was founded in 1996 and provides services in the field of genome and proteome analysis. These include DNA sequencing, protein analysis (N-terminal sequencing, Edman degradation, MALDI-ToF analysis), the production of BAC and PAC clones, gene expression analysis, in vitro mutagenesis, mRNA 5’ mapping, polymerase chain reaction (PCR) analysis and cloning. In the R&D sector, 4base lab primarily focuses on the development of assays for detecting viral pathogens. Quality assurance is carried out based on ISO 9001 standards for medical products, foodstuffs and life science consumables. Drug testing involving DNA sequencing and real-time PCR is carried out in compliance with GMP standards. 4base lab GmbH has also developed the first CE-labelled test kit for the detection of all influenza A group viruses, which also includes the bird flu virus. | Birgit Blum (office@4base-lab.de) | 8 | The company holds the ISO 9001 certificate and is certified to carry out DNA sequencing and real-time PCR under GMP conditions. | Development of assays for the detection of viral pathogens | |||
| ABW GmbH | Medtech | Medical Technology | Manufacturing components and systems for optical 3D shape measurement | Frickenhausen | Dr. Henning Wolf | 1990 | Siemensstrasse 3 72636 Frickenhausen Tel.: +49 (0)7022-949292 Fax: +49 (0)7022-949294 | info@abw-3d.de | abw-3d.de | ABW manufactures components and systems for optical 3D shape measurement. As early as 1989, Dr. Wolf developed the first specialist LCD-based line projectors for 3D measuring using the stripe projection method. LCD projectors are robust and have no mechanically operated components. In addition, short switching times enable a measuring time of just 0.5 seconds to be achieved, making the projectors particularly suitable for the requirements of industry, e.g. for 100% monitoring of production and assembly processes. ABW - Automatisierung und Bildverarbeitung Dr. Wolf GmbH received the award for applied image processing at VISION '94 and VISION 2002, the 7th and 15th international trade fairs for image processing technology components, systems and applications, in Stuttgart, Germany, for its outstanding solutions. | |||||||
| ACES Ing.-GmbH | Medtech | Services, Medical Technology, Laboratory Techniques, Information Technology, Process Engineering | Finite Element Analysis (FEA) calculation, 3D-CAD design, product development | Filderstadt | Frank Thilo Trautwein (CEO) | Ludwigstr. 26 70794 Filderstadt Germany | info@acesgmbh.de | www.acesgmbh.de | Using calculations based on the Finite Elements Method (FEM), the properties and behaviour of materials when subjected to contact, friction, bending or bulging, non-linear material behaviour, the effects of temperature or oscillatory properties are mapped with high levels of accuracy. To carry out these services, the company has used NE/Nastran, a universal FEM code for solving structural analysis problems as its main analytical tool since 1998. 3D-CAD services are also offered for product development. 3D-CAD can be linked with CAE applications such as photo-realistic mapping, product animation, FEM calculation or rapid prototyping. ACES has experience in the fields of medical technology, electronics, software development and automation as well as vehicle technology. As a specialist in CAE applications, ACES advises on the possibilities and shortcomings of, and adaptation options for, the software being used. ACES also supports its customers in the implementation of CAE tools through software adaptations, interfaces, documentation and the programming of additional programs. | Frank Thilo Trautwein (CEO) | |||||||
| Agenolab GmbH & Co. KG | Biotech | Services, Development, Regenerative Biology | Speciality laboratory for bioanalytics and cell culture technology Provider of contract services and developments | Stuttgart | Dr. Andreas Greither | Kesselstrasse 17 70327 Stuttgart-Wangen Tel.: +49 (0)711-3513847 Fax: +49 (0)711-3513839 | info@agenolab.de | www.agenolab.de | Young, innovative biotechnology & life sciences company offering microbiology and molecular biology applications, tissue engineering, GMP production (§ 15 AMG), quality assurance, histology and oncology. Provider of contract services and developments using a laboratory with state-of-the-art equipment. | 10 | |||||||
| Agilent Technologies Deutschland GmbH | Biotech | Chemistry, Laboratory Techniques | Bioanalytical and electronic measuring technology for the life sciences, chemical analysis technology, communication and electronics. | Böblingen | Dr. Günter Nill (Chairman of the Management Board) Ulrich Bohn Siegfried Gross Alois Hauk | 1999 (spin-off from Hewlett-Packard) | Herrenberger Strasse 130 71034 Böblingen Germany Phone: +49 (0)7031-464-0 Fax: +49 (0)7031-464-2020 | www.agilent.com | Agilent Technologies Inc. (NYSE: A) is a world-leading technology company for bioanalytical and electronic measuring technology in the life sciences, chemical analysis technology, communication and electronics sectors. The company's approx. 19,000-strong workforce supports customers in more than 110 countries. In financial year 2005, Agilent generated turnover of US$ 5.1 billion. Agilent Technologies employs around 1,400 people in Germany, the majority of whom are based in Böblingen near Stuttgart and Waldbronn near Karlsruhe. The Life Sciences and Chemical Analysis Technology division, which has its German headquarters in Waldbronn, delivers all-in-one analytics solutions for the pharmaceuticals industry, in particular for disease research, research into new drugs, the development of new medications, and quality assurance in the pharmaceuticals manufacturing process. The 2100 Bioanalyzer was the first commercial device based on Lab-on-a-Chip technology to be launched on the global market. The successful combination of liquid chromatography (HPLC) with mass spectrometry (MS) in an HPLC-Chip/MS system represents a further milestone in the miniaturisation of analytical processes. Further information on Agilent Technologies can be found on the company's website. | ||||||||
| Albstadt-Sigmaringen University of Applied Sciences | Institute | Education | Courses in engineering, business and computer sciences, life sciences | Albstadt | Rector: Professor Dr. Günter Rexer Prorectors: Professor Dr. Markus Lehmann Professor Dr. Martin Rieger Bernadette Boden (Administrative Director) | Sigmaringen site Anton-Günther-Straße 51 72488 Sigmaringen Tel.: +49 (0)7571-7320 Fax: +49 (0)7571-732229 Postfach 1254 72481 Sigmaringen Albstadt site Jakobstraße 6 72458 Albstadt Tel.: +49 (0)7431-5790 Fax: +49 (0)7431-579129 | info@hs-albsig.de | www.hs-albsig.de | The Albstadt-Sigmaringen University of Applied Sciences was established in 1971 and has three faculties – Engineering, Business and Computer Science, Life Sciences. There are currently around 2500 students enrolled at Albstadt and Sigmaringen, with 50% at each of the two sites. Since its foundation in 1971, Albstadt-Sigmaringen University has concentrated on establishing and maintaining close contacts with local, regional and international companies. The 18 bachelor’s and master’s degree programmes are adapted to industry requirements; the students have a practical study semester integrated into the course and they also undertake a broad range of project work where they work in companies to acquire practical know-how. Albstadt-Sigmaringen was one of the first universities of applied sciences to adopt the new international bachelor’s and master’s courses. In the winter semester 2009/2010, the bachelor’s degree course in Textile Product Technology – Technical Textiles will be offered for the first time. The University offers the following 7-semester bachelor’s degree programmes: Clothing Technology, Textile Product Engineering – Technical Textiles, Communication and Software Engineering, Mechanical Engineering, Business Administration and Engineering, Business Administration, Business Informatics, Facility Management, Food/Nutrition/Hygiene, Pharmaceutical Technology. Building on the bachelor’s degree courses, the University of Albstadt-Sigmaringen offers master’s degree programmes (3 semesters) in Textile and Clothing Management, Systems Engineering, Mechanical Engineering – Computer-Aided Product Development and Manufacturing, Business Administration and Engineering – Production Management, particularly with regard to the automotive industry, Business Administration, Business Informatics, Biomedical Engineering as well as Facility Design and Management. | ||||||||
| Amedrix GmbH | Biotech | Regenerative Biology | Cell-free medical products based on collagen | Esslingen | Dr. Thomas Graeve | 2009 | Life Science Center Esslingen Schelztorstraße 54-56 73728 Esslingen Tel: +49 (0)711 933414-10 Fax: +49 (0)711 933414-11 | info@amedrix.de | www.amedrix.de | Amedrix GmbH develops medical products for the regeneration of soft tissue defects (e.g., the regeneration of skin defects) based on native collagen solutions. The matrices serve as three-dimensional cell carriers into which the patients’ cells can intrude, proliferate and regenerate defective tissue. This procedure does not require the removal of the patients’ own tissue prior to intervention. The Amedrix GmbH product range consists of collagen solutions, spumes, membranes, sponges and fleeces that vary in form, size and thickness to cater for a broad range of defect treatment. A proprietary method is used to isolate nucleic acid-free collagen. | |||||||
| AnDiaTec GmbH & Co. KG | Medtech | Development, Medicine, Medical Technology, Diagnostics | Innovative in vitro diagnostics for human and veterinary medicine, together with the food and environmental sector | Kornwestheim | Dr. Johannes Kehle (CEO) | 2003 | Leibnizstr. 11 70806 Kornwestheim Germany Tel.: +49 (0)7154-806 23-0 Fax: ++49 (0)7154-806 23-24 | info@andiatec.com | www.andiatec.com | AnDiaTec was founded by Dr. Johannes Kehle and Dr. Christoph Metzger-Boddien. AnDiaTec GmbH & Co. KG’s core activities focus on the development, manufacture and sale of in vitro diagnostic tools. The products marketed include ParaTub® and LactoScan®. ParaTub® is currently the only high-throughput detection method for Mycobacterium paratuberculosis (MAP), the pathogen responsible for incurable paratuberculosis in cattle. MAP causes major economic damage and is also linked to the inflammatory bowel condition called Crohn’s disease in humans. LactoScan® is a simple and rapid test for reliably detecting lactose intolerance in humans. It is likely that more than 10 million people in Germany are affected by lactose intolerance, a disease that, in the form of primary lactose intolerance, has genetic causes and can lead to under-supplies of lactase between the ages of 6 and 20 and subsequently lead to symptoms typical of the disease. AnDiaTec GmbH & Co. KG is also an adviser to the WHO in the context of a diagnostic project for enteroviruses in India. | The laboratory is accredited in accordance with DIN EN ISO IEC 17025 and 15189 | ||||||
| Andramed GmbH | Medtech | Medical Technology | Developing, manufacturing and marketing medical products for minimally invasive surgery | Reutlingen | Heinz Schade (CEO) | 2004 | Silvanerstrasse 8 72766 Reutlingen Germany Phone: +49 (0)7127-972290 Fax: +49 (0)7127-972291 | www.andramed.com | Andramed GmbH develops, produces and markets minimally invasive appliance technologies such as stents, microsnares and catheters. | EN ISO 9001:2000 | |||||||
| Anoxymer GmbH | Biotech | Development, Nutrigenomics | Health-giving plant substances for functional food and cosmeceuticals | Esslingen | Wolfgang Neldner (CEO) Dr. Karim Balan (CEO) Dr. Dietrich Paper (Director of R&D) | 2000 | Schelztorstrasse 54-56 D-73728 Esslingen Germany Tel.: +49 (0)711-90121090 Fax: +49 (0)711-90121099 | info@anoxymer.info | www.anoxymer.com | Anoxymer was founded at the end of 2000 and was headquartered at the Kompetenzzentrum für nachwachsende Rohstoffe (Competence Centre for Sustainable Raw Materials) in Straubing (Bavaria) until the end of 2005. Based in the Lifescience Center Esslingen since the start of 2006, the company specialises in research and development into new and innovative health ingredients from herbs, vegetables and fruits and uses these to produce standardised, highly water-soluble plant extracts with proven health benefits. Anoxymer markets these extracts as ingredients for foods (functional foods) and cosmetics (cosmeceuticals), and in the form of capsules/tablets as dietary supplements. Screening for bioactive substances that have a positive effect on health has already led to the discovery of new substance classes of oligosaccharides of plant origin exhibiting different types of physiological activity (Anoxymins®). In addition to their antioxidant character (radical scavenging activity), the health-giving properties of individual secondary plant substances lie in their immune-strengthening antiangiogenic and/or anti-inflammatory activity. In addition to the isolation of bioactive substances accompanying the biotest, and their biological and chemical standardisation, the company's proprietary and interlinked in-vitro and in-vivo test systems (CAM assays) not only enable Anoxymer to demonstrate the effectiveness of the substances, but also to identify potential toxicities and side-effects in good time. Health-giving extracts (Planox®) from various plants for anti-ageing and joint health have already been developed. The company has worked with cooperation partners from the foodstuffs and cosmetics industries to adapt these to their specific technological requirements for use in various foodstuffs or cosmetic products. Anoxymer also has further bioactive natural substances for digestion, diabetes and skincare in its product pipeline. Anoxymer enables its customers to explore new pricing and design opportunities through added-value products. The scientifically proven data relating to the functional and health properties of the standardised plant extracts and enriched foodstuffs is corroborated by test studies so that, in the future, there will be more concrete evidence on the health benefits, which can also be used for advertising purposes. | Wolfgang Neldner (wneldner@anoxymer.com) | ||||||
| Anseros GmbH | Medtech | Medical Technology | Development and manufacture in the ozone technology sector | Tübingen | Dipl. Ing. Klaus Nonnenmacher (CEO) | Dischingerweg 11 72070 Tübingen Phone: +49 (0)7071 7995-0 Fax: +49 (0)7071 7995-95 | info@anseros.de | www.anseros.de | Klaus Nonnenmacher, Managing Director of Anseros GmbH, took over the company from his father Erwin Nonnenmacher in 1985. After this, the company moved from Gärtringen to Tübingen. Anseros specialised in the manufacture and development of components and systems for the ozone technology sector. The products that followed from this are particularly environmentally friendly and are used in a wide range of applications including sterilisation, water purification and drinking water treatment. The portfolio includes ozone measuring equipment, ozone generators and compatible software solutions. Anseros GmbH also focuses on research, correct commissioning of the equipment and provision of customised services. | ||||||||
| AppliedSensor GmbH | Biotech | Development, Diagnostics, Laboratory Techniques, Process Engineering | Sensors and sensor systems, including sensors for CO, NO2, CH 4, H2 and volatile organic compounds | Reutlingen | Dr. Robert Straubinger (Managing Director, CEO) Henrik Kennås (CFO) Thomas D. Aiken (Manager Marketing and Sales) Per Holmberg (Manager Module Development) Jürgen Kappler (Manager Sensor Component Development) Heiko Ulmer (Manager Application Support MOS) | Gerhard Kindler Str. 8 72770 Reutlingen Germany Tel.: +49 (0)7121-514860 Fax: +49 (0)7121-5148629 | robert.straubinger@appliedsensor.com | www.appliedsensor.com | AppliedSensor was formed in 2000 from the merger of NST (Nordic Sensor Technologies, a spin-off of the University of Linköping in Sweden) and MoTech (a spin-off of the University of Tübingen). Collaboration between the Universities of Linköping and Tübingen in the field of sensor technologies had been ongoing since 1972. AppliedSensor currently has offices in Linköping (the headquarters in Sweden), New Jersey (USA) and Reutlingen. As the name suggests, the firm’s main area of focus lies in the development of sensors and sensor systems, gas detectors based on metal oxide semi-conductor systems (MOS), which are used particularly in the detection of carbon monoxide and nitrogen dioxide, field effect sensors for hydrogen and ammonia and QMB sensors for determining the presence of volatile organic compounds. | Dr. Robert Straubinger (robert.straubinger@appliedsensor.com) | |||||||
| ASID BONZ GmbH | Medtech | Medical Technology, Trade/Distribution | Trading and sale of medical products for urology, anaesthesia and surgery, together with general consumables | Herrenberg | Ingo Toljan (CEO) | 1811 | Hertzstrasse 3 71083 Herrenberg Germany Tel: +49 (0)7032-95620 Fax: +49 (0)7032-956258 | info@asid-bonz.de | www.asid-bonz.de | The firm was founded back in 1811 and, until 1931, was owned by Bonz family of chemists and pharmacists from Böblingen. The company grew to become one of the leading manufacturers of hydrochloric and nitric acids. Ernst Gottlieb Bonz and Richard Bonz are acknowledged as the pioneers of narcotic ethers used in operations. ASID BONZ GmbH is one of the leading providers of medical consumables in the fields of urology, anaesthesia and surgery. Its portfolio includes numerous disposable products such as catheters, gloves and bags. The firm also supplies products for wound care (e.g. Sofra-Tulle® SINE lubricated wound gauze) and for cleaning respiratory gases (e.g. Sodasorb® CO2 absorber). | ASID BONZ GmbH operates a DEKRA-certified quality assurance system in accordance with the applicable specifications of DIN EN ISO 9001:2000 in conjunction with EN 13488. The products comply with all the requirements of EC Directive 93/42/EEC passed by the Council on 14 June 1993 – Appendix V and are manufactured and sold in accordance with German Act on Medical Devices (MPG). | ||||||
| AUDAX Keck GmbH | Medtech | Medical Technology, Laboratory Techniques, Process Engineering | Industrial technology and medical engineering, oxygen-providing equipment for therapeutic and sporting applications | Calw | Günther Keck (Founder and CEO) Friedhelm Köhnen (Management Assistant) | 1982 | Weiherstrasse 10 75365 Calw Germany Tel.: +49 (0)7051-16250 Fax: +49 (0)7051-162550 | info@audax.de | www.audax.de | AUDAX-Keck GmbH was formed from AUDAX Bautenschutzsysteme, founded in 1982 by the current Managing Director Günther Keck. The company is represented by partner offices in a number of countries and focuses on industrial technology, medical technology, services and consulting. In the field of medical technology, the firm concentrates on oxygen-providing equipment for sports studies, physicians’ practices and vitality centres. The firm’s products include the Oxy-Mini, a small, portable device for oxygen inhalation, the O2-Vit, a small, refillable system for initial oxygen supplies in emergency situations and the Oxy-Genius 10. This is a variable combination device that can be used, for example, for emergency oxygen therapy and oxygen ionisation therapy. The Oxy-Genius 10 works according to the molecular filter principle: special precision filters (zeoliths) allow only oxygen molecules to pass through, holding back nitrogen and noble gas molecules, thereby significantly increasing the oxygen ratio. | Günther Keck (g.keck@audax.de) | Quality management system based on DIN EN ISO 9001: 2000 | |||||
| AXON’ KABEL GmbH | Medtech | Medical Technology, Laboratory Techniques, Process Engineering | Development and production of cables and connection systems, including for medical technology applications | Leonberg | Joseph Puzo (President and CEO of the Axon' Cable Group) | 1971 in Hanau, relocation to Leonberg in 1989 | Hertichstrasse 23 71229 Leonberg Germany Tel.: +49 (0)7152-979920 Fax: +49 (0)7152-979927 | sales@axon-cable.de | www.axon-cable.com | QS-9000 & ISO 9001 (AFAQ), VALEO 1000 (A+), AQAP (RAQ); the plant in France holds the ISO 9001 certificate and manufactures in accordance with the most important international standards. | |||||||
| B.E.S.T. Fluidsysteme GmbH | Biotech | Trade/Distribution, Laboratory Techniques | Semi-conductor technology for the biotechnology and pharmaceutical technology sectors, chemistry and the petrochemical/oil and gas industry, power station technology and instrumentation and analysis | Reutlingen | Reinhold Schuster (Managing Director) | 1947 in Ohio (parent company), 1980 (D) | Steigäckerstr. 13 72768 Reutlingen (Altenburg) Germany Tel.: +49 (0)7121-67000-0 Fax: +49 (0)7121-67000-55 | info@best-stg.de | www.swagelok.com | The Swagelok Company was founded in 1947 by Fred A. Lennon (1905 – 1998). Swagelok’s company headquarters are located in Ohio and B.E.S.T. Fluidsysteme GmbH (formerly B.E.S.T. Ventil + Fitting GmbH Stuttgart) in Reutlingen/Altenburg is one of Swagelok’s German offices. The company markets over 80 different designs of Swagelok® twin-ferrule tube fittings, quick connects and hoses, thread and weld fittings, screw fittings, valves, ballcocks and high-pressure components. | Reinhold Schuster (+49 (0)7127/9798-0; reinhold.schuster@best-stg.de) | ||||||
| Baden-Württemberg International | Service | Services | Agency for International Economic and Scientific Cooperation | Stuttgart | Dr. Michael Magenmeyer (CEO) Dr. Herbert Neuland (Managing Director) Ulrich Mack (Member of Board of Management) Herbert Bossinger (Member of Board of Management) | Haus der Wirtschaft Willi-Bleicher-Str. 19 D-70174 Stuttgart Tel.: +49(0)711-22787-0 Fax: +48(0)711-22787-22 | info@bw-i.de | www.bw-i.de, www.bw-invest.de | Baden-Württemberg International was established in 1984 as the ”Baden-Württemberg Export Foundation ”(Exportstiftung Baden-Württemberg) in order to provide support to small- and medium-sized enterprises for foreign market entry. In 2004, in addition to developing and working with international business contacts, setting up and dealing with international projects, marketing the region as a business hub, and encouraging companies to locate in the area, bw-i broadened its focus to include science, research and the arts at the same time as changing its name to Baden-Württemberg International. Baden-Württemberg International’s activities include initiating international cooperation through programmes aimed at penetrating key markets across the globe. bw-i also promotes Baden-Württemberg as a business, education, and research centre – both at home and abroad. In addition, bw-i offers advice and assistance to foreign companies wishing to invest in Baden-Württemberg and organises projects in selected countries. Baden-Württemberg International is also the central contact for companies in Germany and abroad. The mission of Baden-Württemberg International is to optimally position Baden-Württemberg in a globally competitive market as a location for business and research and to promote the opening of foreign markets for enterprises from within the state. | Ernst Pfister, MdL (Chairman of Supervisory Board, Baden-Württemberg Minister of Economics) | |||||||
| Baden-Württemberg: Connected e.V. | Biotech | Business initiative for the promotion of innovation and high-technology in Baden-Württemberg | Klaus Haasis | 1997 | Breitscheidstraße 4 D-70174 Stuttgart Tel: +49 (0)711-90715500 Fax: +49 (0)711-90715550 | info@bwcon.de | www.bwcon.de | Baden-Württemberg: Connected e.V. (bwcon) is a leading business initiative based in Stuttgart. It promotes Baden-Württemberg as a location for innovation and high-tech and is one of the most successful technology networks in Europe, with over 450 companies and research institutions among its members. More than 4,500 experts benefit from systematic networking via the bwcon platform. In the creative industries, healthcare, information and communication technologies and connecting technologies, bwcon provides a solid foundation for cross-sector technology application and interdisciplinary partnerships between suppliers, users and investors. The business initiative also provides an extensive range of consultation services for start-ups and expanding enterprises with its Coach & Connect programme. The added value of Baden-Württemberg: Connected lies in the possibilities generated by new cooperations and by networking. Members offer members first-hand information through talks, working groups and consultation. Current interest topics are dealt with in greater depth in numerous Special Interest Groups (SIG), seminars and expert forums. Baden-Württemberg’s most important technology prize, the annual CyberOne high-tech award, targets young and expanding companies with innovative business concepts that create new impulses and set new standards. The Federal Ministry of Economics and Technology (BMWi) in Berlin awarded first place to bwcon in its nationwide Competence Network 2008 competition in recognition of the network’s innovative service and added value for its members. | Oliver Zils, Head of Stuttgart bwcon office (zils@bwcon.de) | 7 | |||||||
| BECKER Dentale und Medizinische Geräte | Medtech | Medical Technology | Dental equipment, services and wholesale | Ebersbach an der Fils | Hans-Rainer Becker (Managing Director) | 1990 | Tiergartenweg 9 73061 Ebersbach Germany Phone: +49 (0)7163-53490-0 Fax: +49 (0)7163-53490-74 | info@becker-dental.de | www.becker-dental.de | BECKER Dentale und Medizinische Geräte markets around 50,000 products from all leading German manufacturers. | |||||||
| Beutter Präzisions-Komponenten GmbH & Co. KG | Medtech | Medical Technology | A partner for the supply and development of fine mechanical components, a specialist in manufacturing highly complex assemblies in small production runs. | Rosenfeld | Dr.-Ing. W.-D. Kiessling (Managing Director) | 1909 | Butzensteigleweg 4-6 72348 Rosenfeld Tel.: +49 (0) 74 28-9 33 0 Fax: +49 (0) 74 28-9 33 2 90 | www.beutter.de | Beutter is an international supplier of fine mechanical components and its main areas of activity include mechanical engineering, medical technology, aerospace, military engineering, hydraulics, optics, measuring technology and analysis technology. The company’s activities in the field of medical technology involve manufacturing individual components and assemblies for medical instruments and implants (surgical and dental technology). Manufacturing processes are based on design documentation and drawings supplied by customers. Beutter is keen to work with companies, universities and medical practitioners to help develop and design products and prepare them for production. The company’s quality management system is certified to DIN EN ISO 9001:2000, DIN EN ISO 13485 (medical products) and DIN EN 9100 (aerospace). | Dr.-Ing. W.-D. Kiessling | ~ 110 | ||||||
| Biametrics Marken and Rechte GmbH | Biotech | Laboratory Techniques | Innovative optical biosensor technologies for use in life science analytics | Tübingen | Dr. Günther Proll Florian Pröll | Auf der Morgenstelle 8 Geb. B D-72076 Tübingen Tel: +49 (0) 7071 29 73048 Fax: +49 (0) 7071 29 5490 | mail@biametrics.com | www.biametrics.com | The young company applies new technological methods used in the label-free detection of biomolecular interactions and fluorescence-based immunoassays for organic trace analytics. Applications range from diagnostics to process analytics, microarray technology to environmental and food analytics. Biametrics’ technology platform consists of several modules and is extremely flexible. This enables the company to react to current and future requirements in life science analytics in a client- and application-specific way. The company is a one-stop shop for technological solutions, e.g., decentralised diagnostics, screening using protein microarrays and fermentation monitoring. The company has extensive know-how in detection as well as in consumables and assay development, including technically mature surface chemistry. All these areas are covered by international intellectual property rights that are used exclusively by Biametrics Marken und Rechte GmbH. | ||||||||
| Biodegma GmbH Gesellschaft für umwelttechnische Anlagen und Verfahren mbH | Biotech | Services, Ecology/Environment, Laboratory Techniques | Mechanical and biological waste treatment, composting | Ludwigsburg | Reiner Glock Bernd Jörg Ralf Müller | Martin-Luther-Strasse 26 71636 Ludwigsburg Germany Tel.: +49 (0)7141-688880 Fax: +49 (0)7141-6888825 | info@biodegma.de | www.biodegma.de | Biodegma GmbH supplies products and services for the mechanical and biological treatment of waste, on-floor (hire system) ventilation and composting. | ||||||||
| BioLux GmbH | Biotech | Services, Trade/Distribution, Genomics | Genetic analysis and synthesis | Stuttgart | Dr. Klaus Höhnel (CEO) | Brommerstrasse 19 70563 Stuttgart Germany Phone: +49 (0)711-9018185 Fax: +49 (0)711-9018187 | info@biolux-biotech.com | www.biolux-biotech.com | Stuttgart-based BioLux GmbH operates a molecular biological laboratory. The company performs private paternity tests using DNA isolated from samples taken from the lining of the mouth. The BioLux service portfolio also includes DNA sequencing, Edman protein sequencing, peptide and artificial gene synthesis, and the production of polyclonal antibodies from rabbits and chicken eggs (contract immunisation). BioLux works closely with French company Genosphere Biotechnologies, based in Paris. BioLux also develops and markets the test systems of Slovakian company Dolfin for the detection of C. burnetii and Chlamydophila psittaci antibodies in biological samples. | ||||||||
| bioMérieux Deutschland GmbH | Biotech | Diagnostics, Trade/Distribution | Sale of in-vitro diagnostics | Nürtingen | Bernd Jung (Managing Director) | Weberstraße 8 D-72622 Nürtingen Tel.: +49 (0)7022-30070 Fax: +49 (0)7022-36110 | info.de@eu.biomerieux.com | www.biomerieux.de | Founded in 1976, bioMérieux Deutschland GmbH is part of the globally active bioMérieux Group. Based in the city of Nürtingen close to Stuttgart, the company sells bioMérieux systems and reagents to hospital laboratories, private medical specialists and companies in Germany. Its clients are served by a team of around 100 highly specialised staff who work in Nürtingen or directly on site at client companies. Continuous training and area-wide availability of its staff guarantee timely, high quality services for medical and industrial laboratories. The company’s growth has outpaced that of the German IVD (in vitro diagnostics) market as a whole and this will enable the company to make significant investments in the Nürtingen company site. With its high sales volume, the German subsidiary makes a major contribution to the company’s revenues. The company’s innovative product portfolio means that special effort has to be put into training the users. This accounts for the modern training centre that is used by more than 250 physicians and technical staff per year who come to participate in training courses lasting several days. | ||||||||
| BIOPRO Baden-Württemberg GmbH | Service | Services | State-wide service agency providing targeted support to research institutions and companies in the biotechnology and life sciences sectors. | Stuttgart | Dr. Ralf Kindervater (CEO) | Breitscheidstraße 10 D-70174 Stuttgart Tel.: +49 (0)711-21818500 Fax: +49 (0)711-21818502 | info@bio-pro.de | www.bio-pro.de | At the end of 2002, the Baden-Württemberg government established BIOPRO Baden-Württemberg GmbH as a wholly owned affiliate for the promotion of biotechnology in the state. The 10-person team under the leadership of Dr. Ralf Kindervater provides support to research institutions and companies in the biotechnology and life sciences sectors. As Baden-Württemberg’s central point of contact for business development issues in the biotechnology and life sciences sectors, it is the task of BIOPRO Baden-Württemberg GmbH to optimally position the strengths of this leading biotechnology location on a national and international level at the same time as developing the location to ensure future sustainability. Specific business promotion measures help to secure know-how and jobs in the state as well as transferring the huge potential of innovative research to industrial applications. BIOPRO Baden-Württemberg GmbH’s broad public relations work involves the dissemination of information about this highly innovative cross-sectional technology. | ||||||||
| biosyn Arzneimittel GmbH | Biotech | Development, Drug Development, Medicine, Nutrigenomics, Diagnostics | biosyn Arzneimittel GmbH was founded 1984 and is one of the first biotechnology companies. As a research oriented company biosyn focuses on oncology and intensiv care medicine. | Fellbach | Dr. Thomas Stiefel (Managing Director) Ortwin Kottwitz (Managing Director) | 1984 | Schorndorfer Strasse 32 70734 Fellbach Germany Tel: +49 (0)711-5753200 Fax: +49 (0)711-5753299 | info@biosyn.de | www.biosyn.de | biosyn Arzneimittel GmbH has specialised primarily in the fields of oncology and intensive care medicine biosyn currently offers around 30 drugs approved in 15 countries. biosyn's develpoment strategy is based on biologic molecules and trace elements that have proven efficacy with few side effects. Hemocanin based products like IMMUCOTHEL® or VACMUNE® are used in bladder cancer or as carriers for therapeutic vaccines. Selenium compounds like Sodiumselenite (selenase®) are used in sepsis patients to reduce mortality. In a double-blind, prospective study (SIC) study it could be demonstrated that high dose sodium selenite reduces the mortality rate for sepsis patients. The mortality rate among patients who were administered the drug was 42% as opposed to 57% for the control group. High dose selenium leads to a significant reduction (14,3%) in the mortality rate even in cases of severe sepsis such as septic shock. biosyn Vertriebs AG in Balzers, Liechtenstein and the biosyn Corporation in Carlsbad, California, USA, are subsidiaries of biosyn. biosyn also has a scientific office in Austria. | Approx. 80 | biosyn’s laboratories in Fellbach are GMP-certified | |||||
| biotask AG | Biotech | Services, Nutrigenomics | Analytical and consulting services for nutrition management, the animal feed industry and the agricultural/pharmaceutical industry | Esslingen | Prof. Bärbel Kniel (Director) Maximilian Moser (Director) | 2000 | Schelztortrasse 54-56 73728 Esslingen Germany Tel.: +49 (0)711-31059060 Fax: +49 (0)711-31059070 | max.moser@biotask.de | www.biotask.de | The key areas of the services provided by biotask AG include the analysis and interpretation of analysed results, together with appropriate consulting and customer support. This includes the conduction of sample analyses using chromatographic and molecular biology methods, customer-specific consulting involving quality assurance, development, purchasing and production, plus support for the procurement of raw materials, the setup and expansion of quality assurance systems and laboratory automation. | 8 | ||||||
| Biotechnologische Studenteninitiative (btS) e.V. | Service | Services | Student initiative with the aim of intensifying contacts between universities and industry | Stuttgart | Stuttgart: Philipp Peterburs Roland Stork Peter Kaiser | Stuttgart Office Ludwig-Pfau-Straße 15/1 D-70176 Stuttgart Tel.: +49 (0)176-23957792 | vorstand.stuttgart@bts-ev.de | www.bts-ev.de | The Biotechnologische Studenteninitiative (Biotechnological Student Initiative) was established in 1996 in Cologne with the aim of intensifying contacts between universities and industry. The btS now has offices in 13 university cities, including Stuttgart, and is managed by a national board consisting of 5 members. In addition, the btS has four working groups covering events, Internet, sponsorship and public relations. The majority of btS members are active students from all disciplines. Students hoping to have a career in the life sciences, doctoral students who are about to start their careers or former students who are already working, all participate in the activities offered by the btS. The btS also works with professors who actively support the initiative with materials, rooms and consultation. An important part of btS is its collaboration with industry representatives, who act as speakers, arrange company visits and provide advertising and sponsoring resources. In addition, the btS organises evening lectures under the theme “University meets Industry” and arranges company visits as well as organising workshops for its members, panel discussions on current-interest topics and the “ScieCon” partnering fair. The btS office in Stuttgart works in cooperation with BioRegio STERN (www.bioregio-stern.de) to promote the foundation of start-up companies (Science2Start) and was also actively involved in organising the 2009 BIOSTAR Congress on Regenerative Biology and Medicine. The btS meets every other Thursday in the “Unithekle”, a pub on the Vaihingen university campus. | ||||||||
| BioTeSys GmbH | Biotech | Services, Development, Drug Development, Diagnostics | Analysis of the biological function of active ingredients | Esslingen | Dr. Jürgen Bernhardt (CEO) Dr. Karin Engelhart (CSO) Consuelo Gallardo (COO) | 1999 | Schelztorstrasse 54-56 73728 Esslingen Germany Tel.: +49 (0)711-31057150 Fax: +49 (0)711-31057151 | bts@biotesys.de | www.biotesys.de | BioTeSys was founded in 1999 as a spin-off of the Institute of Biological Chemistry and Nutritional Science at the University of Hohenheim and has moved to the LSC (Life Science Centre) in Esslingen. BioTeSys has established and expanded three areas of expertise for its commercial activities. These include: Analysis, whose techniques are deployed either independently or in concert with others; Cell and Tissue Culture, complete with its associated testing options and Services for Clinical Trials (applications, monitoring, coordination etc.). The company’s own research focuses primarily on micronutrients and their enrichment for regenerating biological systems. BioTeSys uses nanoparticles as a new and smart means of transport for encapsulating active ingredients and addressing them so that they exert their effect directly on the target organ. This reduces the quantity of active ingredient in the body and avoids putting strain on the organism as a whole. Commissioned by Pascoe Pharmazeutische Präparate GmbH, BioTeSys developed a kit for determining micronutrients. This kit currently enables the presence of vitamin C, the E vitamins, ß-carotene and lycopene to be detected in swabs taken from oral mucosal tissue. | Dr. Jürgen Bernhardt (j.bernhardt@biotesys.de) | 14 | Nutritargeting: highly-selective enrichment strategies for the regeneration of biological systems | ||||
| Blessing Biotech GmbH | Biotech | Services, Nutrigenomics | Fermentation biotechnology services | Stuttgart | Jörg Groth (groth@blessing-biotech.de) Doris Scharf | 2005 | Leobener Strasse 71 70469 Stuttgart Tel.: +49 (0)711-8999-470 Fax.: +49 (0)711-8999-400 | info@blessing-biotech.de | The company began life in 1989 as BITEC, a production division of Gewürzmüller, in the form of a new plant for starter culture production. In 2005, the production division was hived off to form BLESSING Biotech GmbH and has since operated as an independent company. In October 2007, Frutarom Industries Ltd. (Israel) signed an agreement to acquire 100% of the share capital of the German companies Gewuerzmueller GmbH and Blessing Biotech GmbH in consideration for a cash payment of US$ 67 million (Euro 47.3 million). The company focuses in particular on manufacturing industrial-scale starter cultures (particularly lactic acid bacteria) for the foodstuffs and animal feeds industry, performing contract fermentation, and mixing and bottling biotech products. BLESSING Biotech has a comprehensive gene bank of lactic acid bacteria from which customers can assemble their products using their own formula. | 22 | |||||||
| Boppel Medical Engineering | Medtech | Medical Technology | Sale of products for sleep diagnostics | Weil der Stadt | Dipl.-Ing. Ralf Boppel (manager) | Stuttgarter Str. 4 71263 Weil der Stadt Post Box 1168 71255 Weil der Stadt Phone: 0800 0267735 Phone:+49 (0)700 26773563 Fax: +49 (0)700 32964792 | mail@boppel-med.de | www.boppel-med.de, www.boppel-med.eu, www.schlafdiagnose.eu | Boppel Medical Engineering develops and sells products for sleep diagnostics and is based in Weil der Stadt near Stuttgart. The company focuses in particular on sleep apnoea syndrome (SAS) where respiration typically stops during sleep for periods ranging from a matter of seconds to over a minute. The products are designed to ensure a reliable diagnosis and can be used for both clinical and outpatient applications. The portfolio of Boppel Medical Engineering is rounded off by complete recording systems, pneumotachographs for flow measurement and products for targeted build-up and endurance training of the respiratory musculature. The company also offers a high standard of customer support, particularly as regards processing of measurement data and adaptation to individual customer requirements. | ||||||||
| Bosch & Sohn GmbH & Co. KG | Medtech | Medical Technology, Trade/Distribution, Process Engineering | Development, production and worldwide sale of blood pressure monitoring equipment | Jungingen | Kurt Rädle (Managing Director) | 1965 | Bahnhofstrasse 64 72417 Jungingen Germany Tel.: +49 (0)7477-92750 Fax: +49 (0)7477-1021 | zentrale@boso.de | www.boso.de | The company’s product portfolio includes blood pressure monitoring equipment used in the professional sector as well as devices used for home measurement. Bosch + Sohn GmbH und Co. KG, boso for short, also markets pulse measuring equipment, thermometers and other medical appliances for the healthcare sector. boso products are available from specialist retailers, healthcare suppliers and pharmacies. The anaeroid devices for precisely measuring blood pressure feature are shock-protected. | Kurt Rädle, Oliver Wolf, Hans-Peter Haug | 60 | Medical products in accordance with EN 1060. The most important digital models also bear the quality seal of the German Hypertension Society. | ||||
| bosch engineering | Medtech | Medical Technology | Modern data acquisition, process visualisation, distant monitoring and remote control via the Internet | Balingen | Dr.-Ing. Gerhard Bosch | 2000 | Lortzingstr. 6 D-72336 Balingen Tel. +49(0)711-34169950 Fax +49(0)711-341699519 | bosch-eng@t-online.de | www.bosch-eng.de | Design, production and expansion of existing control systems for * continuous data acquisition * Automatic data storage on PC/server * Remote monitoring using Internet Explorer * Remote control using Internet Explorer * Realisation of individual control and process requirements | |||||||
| BOWA - electronic GmbH & Co. KG | Medtech | Medical Technology | Electrosurgery specialist (equipment & accessories) | Gomaringen | Dr. Thomas Kröber (CEO) | 1977 | Heinrich-Hertz-Strasse 4-10 72810 Gomaringen Germany Phone: +49 (0)7072-60020 Fax: +49 (0)7072-8719 | www.bowa.de | BOWA-electronic is an innovative medtech company specialising in the development and manufacture of electrosurgical equipment and accessories. BOWA is one of the few all-in-one solution providers and partners for everyday surgical application. The company's areas of activity include HF generators (BOWA ARC series), argon-plasma surgery (BOWA ARC PLUS series) and HF instruments for open, minimally invasive and ligation applications. Click the following link for more information on the red dot design award received by the company in 2006: TissueSeal BOWA-electronic is a partner of the University Hospital of University Hospital of Tübingen Experimental Operating Room and Ergonomics Lab. | 200 | ISO 13485 CE Certificate 9001 | ||||||
| Brillinger GmbH & Co. KG | Medtech | Medical Technology | Orthopaedic supplies, rehabilitation technology, orthopaedic shoe technology, home care, specialist medical equipment and silicon technology | Tübingen | Klaus Fischer (CEO) | 1902 | Handwerker-Park 25 72070 Tübingen Germany Phone: +49 (0)7071-41040 Fax: +49 (0)7071-4104500 Handwerker-Park 25 72070 Tübingen Tel.: +49 (0)7071-41040 Fax: +49 (0)7071-4104500 | info@brillinger.de | www.brillinger.de | Tübingen-based company Brillinger has been in existence for more than a century and has grown from a small medical products shop with a clinical workshop into an innovative health service centre. Klaus Fischer, who represents the third generation of the Brillinger family, took over management of the company in 1983. Since then, the company has continually raised the bar. The application of the latest technologies and products enables the company to provide first-rate orthopaedic technology solutions. Nonetheless, skilled craftsmanship remains at the heart of the company's production of high-tech prostheses, orthoses and other lifestyle aids. By actively sharing experiences with colleagues and institutions in Germany and abroad, and combining this with its own proprietary developments, Brillinger has optimised the products it supplies. External and internal training also ensures that the company's workforce is constantly kept up-to-date with the latest developments in the field. In addition to orthopaedic technology, Brillinger has also actively developed its rehabilitation technology, orthopaedic shoe technology, home care and specialist medical equipment sectors and a department for fitness and wellbeing. | 150 | ||||||
| c-a-i-r biosciences GmbH | Biotech | Development, Drug Development | Research and development of new agents for treating inflammatory processes | Tübingen | Dr. Wolfgang Albrecht (CEO) | TechnologiePark Tübingen/Reutlingen Paul-Ehrlich-Str. 15 72076 Tübingen Phone: +49 (0)7071–9652080 | info@cair-biosciences.de | www.cair-biosciences.de | c-a-i-r biosciences GmbH is a start-up company funded by the German Federal Ministry of Education and Research (BMBF) as part of the BioProfile programme. The world-renowned ratiopharm Group from Ulm is lead investor. This new company specialises in the research and development of new low-molecular, anti-inflammatory drugs for the treatment of diseases such as rheumatoid arthritis, chronic inflammatory intestinal diseases, asthma and psoriasis. The research focuses on protein kinases, which perform a key function in the regulation of pro-inflammatory signal molecules (TNF-alpha, interleukin-1beta), and on enzymes of the arachidonic acid cascade (cyclooxygenases, 5-lipoxygenase). The company was founded on the basis of developments and patents originating from long-term research collaboration between the ratiopharm Group and Professor Stefan A. Laufer from the Institute of Pharmacy at Tübingen University. As a result of the protein kinase inhibitor project, a drug candidate has already been pre-clinically developed and tested on humans in an initial study. c-a-i-r biosciences has now set its sights on developing further drug candidates for clinical testing. | ||||||||
| Cardio Bridge GmbH | Medtech | Medical Technology, Process Engineering | Development and marketing of the Reitan catheter pump | Hechingen | Thomas Radtke (Managing Director) | 2004 | Neue Rottenburger Strasse 50 72379 Hechingen Germany Tel.: +49 (0)7471-9881280 Fax: +49 (0)7471-9881284 | info@cardiobridge.com | www.cardiobridge.com | CardioBridge was founded in Hechingen in 2004, based on the takeover of patents and systems related to the Reitan catheter pump, a left ventricular cardiac support catheter for the minimally-invasive treatment of heart attacks. Pre-clinical trials confirm the pump’s excellent performance and haemodynamic properties. A 10F version of the pump is currently being developed. | |||||||
| Carestream Health Deutschland GmbH | Medtech | Medical Technology | Health imaging technology | Stuttgart | Hedelfinger Straße 60 D-70327 Stuttgart Tel: 0180/32 54 361 Fax: +49 (0)711-20707777 | de-csh-med-info@carestreamhealth.com | www.carestreamhealth.de | Carestream Health is a global leader in products, services and IT solutions for the medical and dental sectors. The company’s comprehensive product portfolio includes picture archiving and communication systems (PACS), radiology information systems (RIS), computed radiography (CR) imaging solutions, digital radiography systems (DR), laser printers, mammography systems, X-ray film systems for general X-ray diagnostics and dental imaging solutions. The company’s product portfolio also includes molecular imaging systems, X- ray films and radiography systems for non-destructive material testing. The company’s medical imaging and data processing products and services are used in 90 percent of all hospitals worldwide. Carestream RIS, PACS and IMS are used in more than 1,100 medical institutions, and with more than 50,000 laser imagers installed, Carestream Health is a leading supplier for digital imaging. Carestream Health employs around 8,000 people who look after tens of thousands of clients in more than 150 countries. | |||||||||
| Casualty Hospital Tübingen | Institute | Medicine, Regenerative Biology | Clinic and research focusing on trauma surgery | Tübingen | Prof. Dr. med. K. Weise (Medical Director) P. Mast (Financial Officer) Doris Dietmann (Director of Care) Responsible Body Verein für Berufsgenossenschaftliche Heilbehandlung Heidelberg e.V. Kurfürsten-Anlage 62 69115 Heidelberg Dr. E. Radek (Managing Director) | Schnarrenbergstr. 95 D-72076 Tübingen Tel.: +49 (0)7071-6060 | info@bgu-tuebingen.de | www.bgu-tuebingen.de | The Casualty Hospital in Tübingen is one of the best-known clinics in Germany for trauma and reconstructive surgery. It has a state-of-the-art centre for the surgical treatment of a broad range of injuries, including polytrauma and the treatment of severe burns. Besides trauma and reconstructive surgery, as well as plastic, hand and tumour surgery, the Casualty Hospital Tübingen specialises in the treatment of spinal cord injuries, knee and hip joint endoprostheses, orthopaedic rehabilitation, intensive care medicine and pain therapy. Since February 2006, the Clinic for Oral and Maxillofacial Surgery has also been part of the Casualty Hospital Tübingen. The clinic treats over 8,500 inpatients per year and around 25,000 outpatients. Its teams of surgeons carry out approximately 34,000 surgical interventions per year. The clinic is open to people who have suffered accidents at work as well as panel patients and private patients. The clinic is run by the “Verein für Berufsgenossenschaftliche Heilbehandlung Heidelberg e.V.“ association which is part of BG Chemie (Employers' Public Liability Insurance Association in Germany, Berufsgenossenschaft der chemischen Industrie) located in Heidelberg. The clinic works closely with the University of Tübingen and is in charge of activities related to trauma, hand, plastic and burn surgery in patient treatment, research and education. In the area of research, the Casualty Hospital Tübingen mainly focuses on autologous cartilage transplantation (ACT), and some of the insights gained have already been incorporated in clinical applications. In close cooperation with the NMI – Natural and Medical Sciences Institute at the University of Tübingen, the clinic is working on improving ACT, with the goal of being able to treat degenerative cartilage diseases. | ||||||||
| CeGaT GmbH | Biotech | Diagnostics, Genomics | DNA and RNA sequencing and diagnostics | Tübingen | Dr. Dr. Saskia Biskup Dr. Dirk Biskup | 2009 | Paul-Ehrlich-Str. 17 72076 Tübingen Tel.: +49 (0)172-3765180 | info@cegat.de | www.cegat.de | CeGaT GmbH, Centre for Genomics and Transcriptomics, was established in 2009. CeGaT’s service portfolio comprises the sequencing of DNA and RNA of humans, animals, plants and microorganisms. The sequencing involves the use of cutting-edge technologies, including the classical Sanger sequencing technology as well as modern high-throughput sequencing technologies such as ABI’s SOLiD technology. Depending on the scientific project, the company sequences individual DNA segments, genes, exomes, transcriptomes as well as whole genomes. If required, the results will also be analysed and interpreted. CeGaT is thus a point of contact and service provider to physicians, clinics, scientists and private individuals. The research and development activities focus on making high-throughput sequencing applicable for DNA diagnostics. Major focus is put on the establishment of diagnostic panels for various diseases, in particular for dementing and neurodegenerative diseases, metabolic diseases and eye diseases. | 7 | ||||||
| Center Systems Biology (CSB) | Institute | Development, Information Technology | Research and education in the field of systems biology | Stuttgart | Prof. Dr.-Ing. Dr.h.c. Matthias Reuss | Zentrum Systembiologie (CSB) Universität Stuttgart Allmandring 31 70569 Stuttgart Tel.: +49 (0)711-68569926 Fax: +49 (0)711-68565164 | witteler@zsb.uni-stuttgart.de | www.centersysbio.uni-stuttgart.de | The Center Systems Biology (CSB) is an interfaculty research institution at the University of Stuttgart. The CSB focuses on interfaculty and interdisciplinary research and education in the field of sys-tems biology. Its goal is to move on from the analysis of individual components of a biological system in order to reach a holistic understanding of the system as a whole and progress from a qualitative descriptive to a quantitative, theory-based and predictive biology. A particular feature of the systems biological activities of the University of Stuttgart within the CSB is the close co-operation between the biological, engineering and systems sciences. The interdisciplinary integration of the biological, systems and engineering sciences is the Uni-versity of Stuttgart’s Germany-wide unique selling point. The CSB’s board of directors is composed of members of the faculties involved. It is supported by a scientific advisory board composed of internationally renowned scientists in the field of sys-tems biology. The CSB’s activities are: • Initiation and coordination of research projects. • The joint acquisition and administration of funds for research projects. • The organisation of joint scientific events and providing information to professionals about research at the CSB. • The publication of research and progress reports. • The interfaculty coordination of measures for the appointment and replacement of profes-sors in the field of systems biology. • The establishment of junior research groups. • Involvement in the establishment of an international master’s “Systems Biology” course. Current research activities reflect the structure of the CSB and are divided into three areas: (1) Basic principles of systems biology, (2) applications in medicine and (3) applications in biotech-nology. A number of projects are also carried out in cooperation with the University of Tübingen and the University of Hohenheim, in which the systems biology activities of the partners are brought to-gether. The CSB commenced activities in 2007 with the financial support of the Baden-Württemberg Ministry of Science, Research and the Arts and the University of Stuttgart. The CSB has since initiated cooperative research projects that receive funding through the German Ministry of Edu-cation and Research (BMBF). | ||||||||
| Centre for Clinical Transfusion Medicine Tübingen gGmbH | Institute | Medicine, Diagnostics | Supply of patients with blood products and immunohaematological diagnostics | Tübingen | Prof. Dr. Hinnak Northoff (Medical Director) | Otfried-Müller-Str. 4/1 D-72076 Tübingen Tel.: +49(0)7071-2981616 | www.blutspendezentrale.de | The Centre for Clinical Transfusion Medicine Tübingen gGmbH (ZKT) is a joint venture of the Baden-Württemberg – Hesse DRK blood donation service and the University Hospital of Tübingen. The Centre for Clinical Transfusion Medicine supplies patients in all the clinics at Tübingen University Hospital and a number of other hospitals in the region with blood products. The vast majority of blood products required can be covered with donations obtained by the Blood Donation Centre in Tübingen. In addition, the ZKT is in charge of immunohaematological diagnostics. The ZKT has clean rooms where work is carried out according to international GMP (Good Manufacturing Practice) standards. | |||||||||
| Centre for Plant Molecular Biology | Institute | Development | Plant molecular biology | Tübingen | Managing Director (alternating) | c/o Silvia Röcker Auf der Morgenstelle 1 72076 Tübingen Tel.: +49 (0)7071-2978805 Fax: +49 (0)7071-293287 | silvia.roecker@zmbp.uni-tuebingen.de | www.zmbp.uni-tuebingen.de | Ever since its foundation in May 1999 as an interfaculty and interdisciplinary research priority within the Faculties of Biology, Chemistry and Pharmacy at the University of Tübingen, the Centre for Plant Molecular Biology has occupied a leading international position in the research and education of young scientists. This is evident from the large number of publications in leading scientific journals, comprehensive third-party funding, strong involvement in national and international research associations and the excellent evaluation by an independent scientific advisory board. In addition, over the last eight years, more than 20 ZMBP scientists have been appointed professors at German and international institutions. This is also clear evidence of the stimulating research environment at the ZMBP. Flat hierarchies, global budget, independent research and technological support from the ZMBP’s central service institutions provide junior researchers and group leaders optimal conditions to work and research in 16 independent groups of researchers. This modern structure, continuous technological development and quality control by the scientific advisory board ensure the international competitiveness and scientific excellence of the ZMBP. The latest recognition of the Centre’s capabilities was the German Council of Science and Humanities’ (Wissenschaftsrat) decision to grant the ZMBP a new research building. Further information can be found at http://www.zmbp.uni-tuebingen.de. Together with the Max Planck Institute for Developmental Biology and the University of Hohenheim, the ZMBP has initiated the “RegioPlantScience” research consortium with the goal of more effectively coordinating research and education in the field of plant sciences in the region. | ||||||||
| Centre for Regenerative Biology and Regenerative Medicine, ZRM | Institute | Services, Development, Regenerative Biology, Education | Support of regenerative biology and medicine projects | Tübingen | Managing Director: Prof. Dr. Thomas Skutella Deputy Managing Director: Prof. Dr. Wilhelm K. Aicher Coordinator/CEO: Prof. Dr. Konrad Kohler | Paul-Ehrlich-Straße 15 D-72076 Tübingen Tel.: +49 7071 29-85034 Fax: +49 7071 29-4553 | info@regmed.uni-tuebingen.de | www.regmed.uni-tuebingen.de | The Centre for Regenerative Biology and Medicine zrm is a joint facility of the University Hospital Tübingen and the School of Medicine of the Eberhard Karl University of Tübingen. The centre supports projects in the fields of regeneration biology and regenerative medicine from basic research to clinical application. Major foci are stem cell research, cell therapy and the development of molecular regenerative strategies and biomaterials. The zrm develops and coordinates courses and seminars and offers a wide spectrum of services to its partners in the Regenerative Medicine network, ranging from consulting and assistance with projects to access to human cell and tissue banks. While consulting and networking services are provided free of charge by the centre, services involving a greater investment in time and material are usually charged. The members of the zrm come from biology and medicine departments of the University of Tübingen and the University Hospital. Scientists and physicians cover the entire spectrum of expertise from basic research to clinical research all the way to therapeutic application. The zrm comprises the following institutions at the University of Tübingen: * Anatomical Institute, Department of Experimental Embryology and Tissue Engineering * University Hospital of Tübingen, Department of General, Visceral and Transplantation Surgery * University Hospital of Tübingen, Department of Dermatology * University Hospital of Tübingen, Internal Medicine I * University Hospital of Tübingen, Internal Medicine II * University Hospital of Tübingen, Internal Medicine III * University Children’s Hospital Tübingen, Department I (General Paediatrics, Haematology, Oncology) * Clinic for Neurology, Department for Neurodegenerative Disorders * University Hospital of Tübingen, Hospital of Neurosurgery * University Hospital of Tübingen, Orthopaedic Clinic * University Hospital of Tübingen, Hospital of Radiology, Division for Diagnostic Radiology * University Hospital of Tübingen, Department of Radiation Oncology * Institute of Clinical and Experimental Transfusion Medicine * University Hospital of Tübingen, Department of Thoracic, Cardiac and Vascular Surgery * University Hospital of Tübingen, Clinic for Urology * University Hospital of Tübingen, Centre of Dentistry, Oral Medicine and Maxillofacial Surgery * University Hospital of Tübingen, Institute of Medical Microbiology and Hygiene | ||||||||
| Centre of Competence Minimally Invasive Medicine & Technology Tübingen - Tuttlingen (MITT) | Service | Services | Consultation services for companies, physicians, inventors and research institutes | Tübingen | PD Dr. Ludger Schnieder (Managing Director, Tübingen Office) Dr. Theophil Rieger (Project Manager, Tuttlingen/Neuhausen Office) Members of the Board: Prof. Dr. med. Claus Claussen (Chairman) Dr.-Ing. Klaus M. Irion Prof. Dr.-Ing. Heinrich Planck Prof. Dr. med. Diethelm Wallwiener Dipl.-Ing. Egon Warfia Dieter Heiss Prof. Dr. med. Arnulf Stenzl | Tübingen office Hechinger Straße 262 D-72072 Tübingen Tel.: +49(0)7071-857893112 Tuttlingen office Gewerbepark Take-Off 3 D-78579 Neuhausen ob Eck Tel.: +49(0)7467-910785 | info@mittev.de | www.mittev.de | MITT offers both its members and non-members targeted consultation on issues in the medical technology area. MITT’s goal is to intensify the transfer of knowledge between small trades, industry and science, something that is highly important in the field of medical technology. The MITT competence centre offers its services to all medical device companies and research institutions. Important consultation topics are issues related to knowledge and technology transfer, education and training, as well as economic issues that typically arise in medical device companies. The service spectrum also includes the arrangement of contacts between parties interested in carrying out joint projects, research and analyses on medical technology issues, support for matters relating to product approval and patent applications, as well as project financing through the introduction of recipients to investors and through the acquisition of funding. At present around 70 companies, research institutes and private individuals are members of the association. | Prof. Dr. med. Dietrich Grönemeyer (Chairman) Paul Seiler Prof. Dr. med. Hans-Peter Bruch Sven Behrens Rüdiger Strehl Dr. Christopher Herrmann Uwe Petersen | |||||||
| CenTrial GmbH | Biotech | Services, Medicine | Contract research, CRO, services in clinical studies, training | Tübingen | Professor Christoph H. Gleiter (CEO) Dr. Armin Bauer (Project Manager) | 2000 | Otfried-Müller-Strasse 45 72076 Tübingen Germany Tel.: +49 (0)7071-2972262 Fax: +49 (0)7071-295158 | sekretariat.kks@kks-tu.de | www.kks-tu.de | CenTrial, a joint venture by the University Hospitals of Tübingen and Ulm, offers support in a CRO role in cooperation with study managers from the hospital, clinical practices, contract research institutes and industry in accordance with national and international standards. The studies are carried out to high levels of clinical, statistical methodological, technical and ethical quality, and are of high calibre with regard to health economics. CenTrial welcomes all studies and works with departments at the University Hospitals of Tübingen and Ulm, other study centres, affiliated physicians and industry partners. Through this network, CenTrial can provide a full spectrum of services, either individually or as all-in-one solutions. CenTrial was founded in December 2000 as an affiliated company of the University Hospital of Tübingen. Since 1 January 2006, CenTrial has been an affiliated company of the University Hospitals of Tübingen and Ulm. | Professor Christoph H. Gleiter | 40 | Quality management system/certification to DIN EN ISO 9001:2000 Quality assurance in accordance with ICH-GCP | ||||
| CeramTec AG | Medtech | Medical Technology | Ceramic for every area of living, working, and technology | Plochingen | Dr. Ulf-D. Zimmermann (Chairman of the Executive Board) Dr. Jürgen Huber Rolf-Michael Müller | 1996 Merger of Cerasiv GmbH and Hoechst CeramTec AG to form CeramTec AG | Fabrikstrasse 23-29 73207 Plochingen Germany Phone: +49 (0)7153-6110 Fax: +49 (0)7153-25421 | info@ceramtec.de | www.ceramtec.de | In 1996, Plochingen-based Cerasiv GmbH merged with Hoechst CeramTec AG of Marktredwitz to form CeramTec AG, part of the mg technologies ag Group. CeramTec AG has been part of Rockwood Specialties Group Ltd., based in Princeton, USA, since 2004. Key dates in the history of the company's founding include: 1903 Founding of Thomaswerke in Marktredwitz 1921 Founding of STEMAG Steatit Magnesia AG in Lauf 1951 Founding of SPK-Feldmühle, later renamed Cerasiv, in Plochingen CeramTec AG offers products for almost every area of living, working and technology and the companies within the CeramTec Group set the standard when it comes to high-performance ceramic. These products are tailor-made to meet the specific requirements of the automotive, electronics and medtech industries and the mechanical and appliance engineering sectors. The areas of application for CeramTec technical ceramic products range from ceramic seal and regulator discs for sanitary fittings, cutting plates for metal processing, substrates for electronic circuits, appliance and mechanical components, fuse components, protection components, piezoceramics as the key components of sensor technology products, and dipping formers for the manufacture of rubber globes right through to vacuum-sealed products for aerospace technology. BIOLOX® also offers products for the medtech sector including hip prosthesis components such as ball heads, inserts and revision ball heads, and components for knee prostheses. | |||||||
| Chemical and Veterinary Investigation Office Stuttgart | Institute | Services, Ecology/Environment | Investigation office focusing on food safety and animal health | Fellbach | Maria Roth | Schaflandstraße 3/ 2 und 3/ 3 D-70736 Fellbach P.O.1206 D-70702 Fellbach | Poststelle@cvuas.bwl.de | www.cvuas.de | The Chemical and Veterinary Investigation Office (CVUA) Stuttgart is one of four state investigation offices in Baden-Württemberg focusing on food safety and animal health. The CVUA in Stuttgart has 200 employees, including food chemists, veterinarians, biologists and technical staff who investigate approximately 24,000 products for harmful substances and around 117,000 animal samples for health risks/diseases per year. Besides the investigation of food and animals, the CVUA Stuttgart also offers consultation services to public authorities and state institutions relating to food monitoring and the control of animal diseases as well as organising additional training events and consulting services for producers and sellers of food or utensils. The CVUA Stuttgart has 7 departments that are housed in two buildings with 4,500 m2 of laboratory space and 1,700 m2 of office space. | ||||||||
| Consic Software Engineering | Biotech | Development, Information Technology | Software development | Kusterdingen | Managing Directors: Stefan Heymann Frank-P. Schänzlin | 2003 | Lustnauer Strasse 18 72127 Kusterdingen Germany Tel.: +49 (0)7071-689639 | info@consic.de | www.consic.de | Consic develops software designed to support quality management and production in the manufacturing, automotive and biotechnology industries. Consic software solutions can be tailored to the needs of individual customers or supplied as standard software products such as METER and PMM. METER software is used for the quality control of series parts and PMM has been developed for monitoring test instruments in quality management. As well as software, Consic also offers services such as customised add-ons, integration, training and support. | DIN/EN/ISO 9001:2000 | ||||||
| Crinotec GmbH | Biotech | Development, Laboratory Techniques, Process Engineering | Development of measurement processes in the field of biosensors and chemosensors | Tübingen | Andreas Fiedler (CEO) | Auf der Morgenstelle 28 72076 Tübingen Germany Tel.: +49 (0)7123-888422 Fax: +49 (0)7123-888455 | info@crinotec.de | www.crinotec.de | |||||||||
| CTV OPtimum Medizin- und Reinraumtechnik GmbH | Medtech | Medical Technology | IT system house for high-sensitivity rooms in the technical, scientific and medical sectors. | Ludwigsburg | Peter Nuß (CEO) p.nuss@ctv-optimum.de | 2003 | Oscar-Walcker-Str. 26b 71636 Ludwigsburg Germany Phone: +49 (0)7141-68899-83 Fax: +49 (0)7141-68899-70 | www.ctv-optimum.de | The strategic aim of CTV OPtimum Medizin- und Reinraumtechnik GmbH is to supply optimum and reliable innovative computer technology for high-sensitivity spaces, e.g. operating theatres, anaesthetics and intensive care wards. The company is constantly adding future-focused new and further developments to its portfolio. The company's main potential lies in its expertise and the reliability of all products, both in the medical and cleanroom sectors. The company has been the leading supplier of X-ray viewing equipment for operating theatres for 2 years, and is the leader in digital X-ray diagnostics in hospitals and specialist radiology practices. It can offer complete assembly of turnkey solutions with acceptance test records and commissioning in clinics and hospitals. The company has its own production and R&D facilities and can offer custom-made solutions to meet special customer requirements in house. | ||||||||
| Cumdente GmbH | Medtech | Medical Technology | Development of dental products | Tübingen | Dr. Frank Schynowski (CEO) PD Dr. Rainer Hahn (scientific director) | Konrad-Adenauer-Str. 9-11 72072 Tübingen Germany Tel.: +49 (0) 7071-9755721 Fax: +49 (0) 7071-9755722 | info@cumdente.de | www.cumdente.de | The desire to be “at the heart of dental practices” was the driving force behind the foundation of Tübingen-based dental manufacturing company Cumdente by dentist and scientist Dr. Rainer Hahn in 2002. For many years, Dr. Hahn was an innovative force in and advisor to the dental industry, and many of his patents were implemented in cooperative partnerships. With the foundation of Cumdente, he also became involved in production, logistics and sales. Many Cumdente products were created to meet the everyday needs of dental practices and are now relied upon by dentists throughout Germany, Austria and Switzerland. Due to the rapid developments in dentistry and the wide range of ideas gained through discussions, Cumdente’s product portfolio now encompasses almost every single specialist area – from endodontia and aesthetics to functional diagnostics and therapy. Since 2005, Cumdente has also been providing patients with exclusive prophylactic products from its Personal Care & Beauty division. | ||||||||
| Curetis AG | Medtech | Medical Technology | Novel, fast, cost-effective solutions for the efficient diagnosis of infectious diseases that can be applied anywhere and that enable reliable therapy suggestions to be made; products that support vaccine development in the pharmaceutical industry | Holzgerlingen | Andreas Boos (Director R&D, Managing Director) Johannes Bacher (Director Operations, Managing Director) Dr. Gerd Lüdke (Director Assay Development) Dr. Anne Thews (Director Marketing and Sales) | 2007 | Max-Eyth-Straße 42 D-71088 Holzgerlingen | Anne.Thews@curetis.com | www.curetis.com | In cooperation with leading academic centres and reference laboratories of the World Health Organisation, Curetis AG develops diagnostic solutions that enable the identification of infectious agents and pathogen resistances in only a few hours, in contrast to current methods that can take days or even weeks. The results are far more precise and more informative. The company’s diagnostic solution combines classical molecular biology methods in a compact instrument unit that is no larger than a laser printer and enables the simultaneous detection of up to one hundred parameters. The company’s diagnostic solutions reduce the time required for the simultaneous identification of tuberculosis pathogens and their resistances to less than four hours, with their simple and robust analytical devices that can easily be used in countries with high infection incidences (e.g., China, India, Southern Africa). Curetis AG envisages additional opportunities for its diagnostic solutions in another global infection threat – hospital-acquired infections. | Dr. Anne Thews (Anne.Thews@curetis.com) | ||||||
| CureVac GmbH | Biotech | Development, Drug Development, Medicine, Trade/Distribution | CureVac GmbH specialises in RNA molecules synthesised by chemical and enzymatic means. CureVac also carries out its own research in the field of tumour therapy. | Tübingen | Dr. Ingmar Hörr (CEO) Dr. Thomas Lander (CMO) Dr. Florian von der Mülbe (COO) Dr. Wolfgang Klein (CFO) Dr. Jochen Probst (CSO) | 2000 | Paul-Ehrlich-Str. 15 72076 Tübingen Germany Tel: +49 (0)7071- 920530 Fax: +49 (0)7071-9205311 | info@curevac.com | www.curevac.com | CureVac GmbH was founded as a spin-off of the University of Tübingen and has very quickly become established as one of the leading manufacturers of nucleic acids for use as active ingredients in pharmaceutical and therapeutic applications. CureVac GmbH’s portfolio primarily includes three products. 1) Modified and non-modified short (oligo-) RNA molecules are synthesised chemically in accordance with customers’ wishes. 2) The firm also offers RNActive™, an ultra-pure and stabilised form of mRNA that enables tissue and cells to be transfixed effectively. 3) In accordance with customers’ wishes, CureVac can create cDNA libraries in copyright-protected RNActive™ vectors. | Dr. Ingmar Hoerr (ih@curevac.de) | 48 | CureVac has cGMP production facilities compliant with FDA and EMEA standards | New approach to in vivo tissue generation through RNA technology, with skin tissue as an example | |||
| CyBio Robotics GmbH | Biotech | Lab automation systems and software solutions tailored to customer requirements | Martin Winter Harald Maier Frank Greiner | 1998 | Lustnauer Strasse 78 72127 Kusterdingen Germany Tel.: +49 (0)7071-36699-0 Fax: +49 (0)7071-36699-50 | info@cybio-ag.com | www.cybio-ag.com | CyBio Robotics GmbH - formerly accelab GmbH - not only specialises in synthesis, purification and packaging, sample preparation, screening, analytics and process optimisation but also offers a whole host of other solutions for different applications. The company was founded by chemist Martin Winter, electronics engineer Harald Maier and automation engineer Frank Greiner. In cooperation with other scientists at the University of Tübingen, the three founders won 1st place for their business plan in the "StartUp 97" regional competition in 1997. The company has now made a name for itself in the international arena and, in 2005, launched the LiquiSense product group which is based on a standardised robotic pipetting platform and can be utilised for liquid-liquid extraction and turbidimetry. In July 2006, CyBio AG, Jena (German Stock Exchange: General Standard, ISIN-Number DE0005412308) acquired about 78 % shares of CyBio Robotics GmbH. The remaining shares are held by executive management and leading employees. | |||||||||
| DATAPEC GmbH | Medtech | Medical Technology | Solution provider for innovative documentation systems | Pliezhausen | Hans-Hermann Schaber, Joachim Schweizer (Managing Partners) | Wilhelm-Schickard-Str. 7 72124 Pliezhausen Germany Phone: +49 (0)7127-970020 Fax: +49 (0)7127-970433 | www.datapec.de | DATAPEC GmbH views itself as a solution provider for innovative documentation systems. The company's countless years' experience and know-how in medical software development is channelled into meeting customer requirements exactly. Particular attention is paid to content, e.g. precise documentation, improved workflows, more efficient information processes and quality assurance including statistical analyses for medical and business-management purposes. | |||||||||
| DataPhysics Instruments GmbH | Biotech | Development, Chemistry, Laboratory Techniques | Innovations for surface chemistry | Filderstadt | Torsten Holz Horst Rau | 1997 | Raiffeisenstrasse 34 70794 Filderstadt Germany Tel: +49 (0)711-7705560 Fax: +49 (0)711-77055699 | info@dataphysics.com | www.dataphysics.de | DataPhysics Instruments GmbH’s customers primarily include scientific institutions and research organisations. The company develops new measuring instruments and systems for the measurement of surface chemistry properties. DataPhysics products are designed to offer a long service life, precise engineering and maximum measuring accuracy. DataPhysics processes samples for the research and development of applications in its customers’ fields of activity. The firm develops solution proposals for complex, application technology problems. DataPhysics also offers training courses and workshops. Topics include the theoretical principles of surface chemistry, application-specific information on the use of measuring instruments and interpretation of measuring results, how to use the instruments, customer training and equipment training for users. | Torsten Holz (t.holz@dataphysics.de) | ||||||
| Deutsches Erwachsenen Bildungswerk e. V. (DEB) | Service | Services | Adult education | Fellbach | Adolf Erben (Chairman) Jacqueline Erben-Schmittfull (Managing Director) | Auberlenstr.13 70736 Fellbach Tel.: +49 (0)711-610610 Fax: +49 (0)711-6152119 | berufskolleg@deb.de | www.deb.de | The non-profit DEB Group works in the field of adult education. DEB has educational and vocational institutions in around 50 cities in eight German states. The private vocational college in Fellbach (near Stuttgart) trains chemical technicians (CTA), pharmaceutical technicians (PTA) and biotechnological technicians (BioTA). The courses last from 2 to 2.5 years. If there is sufficient interest in the required modules, the Fellbach college will also run courses that qualify students to apply to universities of applied sciences. The college in Fellbach currently has around 180 students in eight classes, who have theory and practical classes in traditional classrooms as well as in four large chemistry laboratories, a galenics and botany laboratory. A computer room is also at the students’ disposition. | Gabriele Ring-Preising | |||||||
| Diagnostika GmbH Stuttgart | Medtech | Medical Technology | Manufacture and sale of medical products | Nürtingen | Dr. Volker Pfaffenholz (Managing Director) | Im Vorderen Feld 28 72622 Nürtingen Germany Tel.: +49 (0)7022-65708 Fax: +49 (0)7022-64886 | info@diagnostica-stuttgart.de | www.diagnostica-stuttgart.de | Diagnostika GmbH Stuttgart focuses on the manufacture and sale of medical products, in particular simple-to-perform testing methods such as serological antibody and antigen detectors (including pregnancy testing strips) and agglutination detectors. Other testing methods are used for the culture, detection and identification of urogenital mycoplasmas. | Dr. Volker Pfaffenholz | |||||||
| Dormed Vertriebsgesellschaft für medizinische Systeme mbH Stuttgart | Medtech | Medical Technology, Trade/Distribution | Sale of second-hand ultrasound equipment | Leinfelden-Echterdingen | Joachim Otten (CEO, Manager) Thomas Stücker-Everding (CEO) | Stettener Hauptstrasse 66 70771 Leinfelden-Echterdingen Germany Tel.: +49 (0)7157-880536 Fax.: +49 (0)7157-880537 | www.dormed.de | The company specialises in the sale of second-hand medical equipment, primarily used for ultrasound investigations. Dormed’s equipment includes models from various manufacturers such as Philips, Siemens and Toshiba. The firm also provides technical support. Since 1992, the company also sells new equipment within Germany with various ultrasound head configurations for all applications. Dormed Vertriebsgesellschaft, in addition to its office in Leinfelden-Echterdingen, also has branches in Holzwickede and Buchholz i.d.N. | |||||||||
| Dr. Carl GmbH – the medical people | Service | Medical education, further training and information. Dr. Carl GmbH, based in Stuttgart, produces and offers medical and scientific information, media and software for medical education, information and training of physicians, patients and healthcare staff. | Stuttgart | Dr. med. Ingo Carl | Von Pistoriusstr. 6a 70188 Stuttgart Tel.: +49 (0)711-2229040 Fax: +49 (0)711-22290499 | office@dr-carl.com | www.dr-carl.com | Dr. Carl GmbH has been developing content, media and software for medical education, information and training since 1994. We are primarily focused on the generation of medical and scientific content, and its presentation and dissemination with interactive and multimedia software. Our products are targeted at patients, physicians and other medical professionals. Our product portfolio includes software for Internet-based product communication, microsites, eDetails, lecturer tools and documents, CME-certified further training modules, case-based communication concepts and programmes for congress interaction and information. Our services comprise medical writing, visualisation using graphics, animation and video, as well as the programming of interactive multimedia applications and databases for the Internet and CD ROM. Dr. Carl GmbH works with renowned pharmaceutical and medical device companies. The company employs 11 people, including four physicians, and has a broad network of freelance (medical writing, graphics, animation and video) collaborators. | |||||||||
| Dr. Fenyves und Gut Deutschland GmbH | Medtech | Development, Medical Technology, Diagnostics, Process Engineering | The development of diagnostic systems and data recording equipment; sleep diagnostics and sleep screening | Hechingen | Andreas Faulhaber (CEO) | 1973 | Lotzenäcker 9 72379 Hechingen Germany Tel.: +49 (0)7471-9374 0 Fax: +49 (0)7471-9374 30 | info@fg-deutschland.de | www.fg-deutschland.de | This company, founded over 30 years ago, develops and produces diagnostic systems for use in the fields of lung function analysis and sleep medicine. Its portfolio of products includes sleep screening systems for the diagnosis of sleep-related respiratory problems, endurance training equipment for the respiratory musculature (Spirotiger) and biosignal simulators. The company markets pneumotachographs (laminar flow elements, after Prof. Fleisch) which capture precise flow signals in the measurement of gas flows. One further area of focus includes stationary and portable data recording equipment (data loggers) for use in technical applications. | Andreas Faulhaber (CEO) | 5 | ISO 9003 | ||||
| DR. PETRY genmedics GMBH | Biotech | Development, Medicine, Nutrigenomics | Staphylococcus research | Reutlingen | Justus Dehnen (CEO) Dr. Jörg Petry (CFO) Dr. Bernhard Krismer (CSO) Dr. Günther Thumm (COO) | Ferdinand-Lassalle-Strasse 57 72770 Reutlingen Germany Tel.: +49 (0)7121-95890 Fax: +49 (0)7121-958933 | info@genmedics.com | www.genmedics.com | DR. PETRY genmedics GmbH focuses on research into the Staphylococcus organism. The biotechnology firm, which has bases in Reutlingen and Tübingen, is not only seeking to combat the disease pathogen but also use it as a carrier agent for various active agents. The pathogen Staphylococcus epidermidis is capable of forming a biofilm on a range of surfaces. Thanks to its high levels of resistance to a wide range of antibiotics, pathogenic Staphylococci are becoming a major hazard in the field of medicine in the context of biofilm-related, foreign-body infections. It is for this area of activity that DR. PETRY genmedics offers an evaluation of materials for biofilm formation. As a result, new medical materials such as foreign-body implants can be checked for their biofilm formation properties. In addition to working with pathogenic Staphylococci, the firm also focuses on the expression of therapeutically-effective proteins in the food-grade bacterium S. carnosus. | Dr. Jörg Petry | Optimisation of the expression and purification of two staphylolytic active agents | Associated project NAPRAS; Development of new agents against biofilm formation on regenerative and synthetic tissue implants; Subproject 2: Assay development, screening, verification | Prof. Friedrich Götz Prof. Günther Jung P Prof. Joachim-Volker Höltje Prof. Rolf G. Werner | ||||
| Dürr Dental GmbH & Co. KG | Medtech | Medical Technology | Dental products | Bietigheim-Bissingen | Walter Dürr (CEO, Partner) Martin Dürrstein (CEO, Partner) | Höpfigheimer Strasse 17 74321 Bietigheim-Bissingen Germany Phone: +49 (0)7142-7050 Fax: +49 (0)7142-705500 | info@duerr.de | www.duerr.de | The name Dürr Dental has been synonymous with technical progress and innovation in dental medicine, both in Germany and across the globe, for more than six decades. Research and development play a central role in company investment. Dürr Dental's comprehensive product portfolio contains products for dental care, compressors, suction machines, automatic separators, amalgam separators, combination separators, suction units and also X-ray film developers and hygiene products, e.g. disinfectants. | EN ISO 9001 / 12.2000 certificate EN ISO 13485 / 07.2003 certificate | |||||||
| ebm-papst Mulfingen GmbH & Co. KG | Medtech | Medical Technology | Motor technology, fluid mechanics and electronics | Mulfingen | Gerhard Sturm Thomas Philippiak Thomas Borst Thomas Wagner | 1963 | Bachmühle 2 74673 Mulfingen Germany Phone: +49 (0)7938-810 Fax: +49 (0)7938-81110 | www.ebmpapst.com | Formed from ebm, PAPST and mvl, three companies steeped in tradition, the ebm-papst Group today offers a unique product portfolio of motors and fans that makes the company the world leader in its class. The company's product portfolio comprises approx. 14,500 different products, which are marketed worldwide. Examples of the company's products for the medical and lab technology sector include diagnostic equipment, incubators, centrifuges and drive units for operating tables and chairs. | More than 8,600 employees worldwide, 2,207 in Mulfingen | |||||||
| EDI GmbH | Biotech | Services | Commissioned research for the pharmaceutical, cosmetic and chemical industry. The effects of substances are checked on the human immune systems under in vitro conditions similar to those in vivo. | Reutlingen | Dr. Manfred Schmolz (Edigmbh@aol.com) | 1996 | Aspenhaustr. 25 72770 Reutlingen Germany Tel.: +49 (0)7121-434103 Fax: +49 (0)7121-491074 | info@edigmbh.de | www.edigmbh.de | EDI GmbH, acquired by Rules Based Medicine Rules, Inc. (RBM), a leading multiplexed biomarker testing laboratory for the life sciences industry in October 2007, offers commissioned research in the field of immunopharmacology, immunotoxicology and cell biology, together with commissioned development work and the validation of customised cell culture systems, but also immunoassays of all kinds. One key area of focus in the field of pharmacological assays is substance screening and the profiling (= characterisation) of active agents on a testing platform involving human, organotypical test cultures (HOT Screening and HOT Profiling). These permit a very complete picture of the main and side effects of active agents to be built up in vitro in a way that has never before been possible. This means that, from a series of comparable leads or drug candidates, the active compounds that demonstrate the most advantageous spectrum of effectiveness and the lowest probability of unwanted side effects can be specifically selected for further development or the clinical testing phase. For clinical trials, EDI GmbH has also developed a patented method that enables functional tests on the human immune system to be carried out at very low cost with hitherto unparalleled levels of reliability and sensitivity. The firm’s portfolio of services also includes the drafting of development plans, testing outlines and plans for clinical trials compliant with the German Drug Law (AMG), GCP etc., the creation of pharmacological-toxicological expert reports, medical writing, consulting in the context of immunological research and the coordination of accompanying experiments. The cellular tests carried out by EDI GmbH can be designed for use in pharmacological, toxicological or compatibility investigations. | Dr. Manfred Schmolz | < 10 | EN ISO 13485:2003 | ||||
| Edmund Bühler GmbH | Biotech | Chemistry, Ecology/Environment, Trade/Distribution, Laboratory Techniques | Manufacture and trading of conventional lab and R&D equipment in the field of materials research | Tübingen | Johanna Bühler-Otto (CEO) | 1880 | Edmund Bühler GmbH Jakobsgasse 14/1 72070 Tübingen Germany and Am Ettenbach 6 72379 Hechingen Germany Tel.: +49 (0)7471-9864-0 Fax: +49 (0)7471-9864-75 | info@edmund-buehler.de | www.edmund-buehler.de | The company was founded in 1880 by Edmund Bühler who, together with Professor Robert Bunsen (1811-1899), invented the Bunsen burner. Edmund Bühler GmbH develops and produces instruments for materials, lab and environmental technology at its Hechingen site and now exports its products to countries on all five continents. In the field of metallurgy, the company specialises in creating metals with new properties e.g. aluminium that is as strong as steel. When it comes to environmental technology, the company is currently developing investigative methods to detect water contamination through trace toxins such as pharmaceuticals, antibiotics and hormones. | |||||||
| E-Flox GmbH | Biotech | Development, Ecology/Environment, Process Engineering | Development and marketing of a burner for energy conversion processes based on the principle of flameless oxidation (FLOX) | Stuttgart | Dr. Roland Berger | 2005 | P.O. Box 1109 71264 Renningen Street address: Dornierstr. 14 71272 Renningen Tel.: +49 (0)7159 930895 Fax: +49 (0)7159 930896 Germany | berger@e-flox.de | www.e-flox.de | E-Flox GmbH was founded on 17 November 2005 with the aim of developing and marketing a burner for energy conversion processes based on the principle of flameless oxidation (FLOX). The company founders from the IVD (Institute of Process Engineering and Power Plant Technology) have joined forces with WS Wärmeprozesstechnik GmbH from Renningen, which has been manufacturing and selling ‘conventional’ FLOX burners for some time. The ‘new’ type of burner will increasingly be used in biomass applications. | |||||||
| EHS Medizintechnik GmbH & Co. KG | Medtech | Medical Technology, Trade/Distribution | Medical products for hospitals and physicians’ practices | Stuttgart | Volker Seebach (CEO) | Heilbronner Str. 3 70771 Leinfelden-Echterdingen Germany Tel.: +49 (0)711-72650 Fax: +49 (0)711-7265199 | info@ehs-med.de | www.ehs-med.de | EHS Medizintechnik provides comprehensive support to hospitals, university clinics and physicians’ practices in Baden-Württemberg, supplying a full range of medical technology. In addition to consulting, training and instruction, the firm also offers a wide portfolio of medical equipment and specialises in the disciplines of endoscopy/MIC, HF surgery, anaesthesia/ respiratory medicine/paediatrics, ultrasound, cardiology and physician’s practice equipment. EHS Medizintechnik GmbH & Co. KG also operates a health products shop that specialises in sleep apnoea, oxygen, medical and rehabilitation technology, and wound care. | EN ISO 13488:2000 and ISP 9001:2000 certified | |||||||
| EICH-COLON Medizinische Apparate | Medtech | Medical Technology | Developing, manufacturing and marketing medical instruments | Pfullingen | Helmut Eich (CEO) | Kunstmühlestrasse 12 72793 Pfullingen Germany Phone: +49 (0)7121-72441 Fax: +49 (0)7121-790786 | www.eichcolon.de | Eichcolon offers therapeutic equipment for simple, reliable colon hydrotherapy, the gentle infusion of fine-filtered water into the bowel. In addition, the company offers the Eichotherm radiation unit for light orange UV therapy to boost circulation (cardiovascular system), discharge/excretion (kidneys, bowel, skin) and bodily regulation (nervous system, adenoids). | |||||||||
| ELPRO Messtechnik GmbH | Biotech | Medical Technology, Laboratory Techniques, Process Engineering | Sensors for pharmaceutical and laboratory applications in deep-freeze units, incubators, clean rooms, autoclaves, muffle furnaces, for laboratory measurements and in cryostats. | Schorndorf | Lothar Poloczek (Managing Director) | Baumwasenstrasse 20/1 73614 Schorndorf Germany Tel.: +49 (0)7181-979480 Fax: +49 (0)7181-979485 | brd@elpro.com | www.elpro.com, www.elprogmbh.de | Elpro has many years of experience in the field of data loggers, which are important in qualified environments where various processes need to be monitored and documented. Elpro offers a complete system and associated services, including temperature mapping and factory and DKD calibration for use in (bio)pharmaceutical facilities, the foodstuffs industry, hospitals and medical institutions. | Alois Bischof (CEO) in Switzerland (Tel: ++41/(0)81-7500311 Fax: ++41/(0)81-7500317) | |||||||
| ELU GmbH | Biotech | Laboratory Techniques | Electrical air-conditioning and climate equipment – development, manufacturing, sales | Leinfelden-Echterdingen | Jürgen Schenk | 1948 | Bohnackerstrasse 4 70771 Leinfelden-Echterdingen Germany Tel: +49 (0)711-7977070 Fax: +49 (0)711-796880 Postal address: Postfach 200126 70750 Leinfelden-Echterdingen Germany | eluklima@aol.com | www.eluklima.de | The company was founded in 1948 as a firm specialising in the drying, heating and dehumidification of buildings. As technology evolved, air-conditioning equipment and air purification systems were added. Today, the company focuses on UV-C-radiation-based air curtains and air cleaning systems. Since 1997, the firm has also focused on the subject of “scent marketing” i.e. the manufacture and marketing of room aroma systems for areas up to 20,000 m3. These systems are used in the fields of scent marketing, the fragrancing of events, trade fair scenting and the introduction of aromas to sales areas. The company is one of the market leaders in this particular sector. | Jürgen Schenk | 24 | ISO 9002 | ||||
| EMC microcollections GmbH | Biotech | Services, Chemistry, Laboratory Techniques | Contract synthesis for the pharmaceuticals industry and molecular tools for biotechnology | Tübingen | Professor Karl-Heinz Wiesmüller (CEO and shareholder) Professor Günther Jung (CSO and shareholder) Dr. Friedrich Stracke (CFO and shareholder) | 1996 | Sindelfinger Str. 3 72070 Tübingen Germany Tel.: +49 (0)7071-40740 Fax: +49 (0)7071-407422 | emc@microcollections.de | www.microcollections.de | EMC microcollections GmbH was founded in 1996 and incorporated in January 2000. The company currently employs approx. 22 staff. The core areas of expertise for EMC microcollections lie in bioorganic synthesis and immunochemistry. In addition, EMC is well-renowned for establishing new strategies for pharmaceuticals development, including e.g. lead structure optimisation and analysis of organic chemical compounds. | Professor Wiesmüller | ||||||
| epikurion GmbH & Co. KG | Biotech | Drug Development | Production of natural cosmetics | Stuttgart | Dr.-Ing. Dierk-Oliver Kiehne Prof. Dipl.-Ing. Andreas Zagos | Sigmaringer Str. 35 D-70567 Stuttgart Tel.: 0711 /797328-12 Fax: 0711/797328-29 | info@epikurion.de | www.epikurion.de | epikurion® products are based on ancient formulations using natural materials from wild plants. In cooperation with renowned scientific institutions such as the Fraunhofer Institute, epikurion GmbH carries out experiments to identify the effect of wild plants. The active herbal ingredients are then isolated, leading to a combination of several active substances that have a joint mechanism of action. The numerous ingredients contained in epikurion® products are effectively combined to offer the maximum of care. All products conform to BDIH, IAHF and Ökotest standards. | ||||||||
| ERBE Elektromedizin GmbH | Medtech | Development, Medicine, Medical Technology, Trade/Distribution, Process Engineering | Development, manufacturing and sale of systems for electrosurgery, cryosurgery and physiotherapy. | Tübingen | Christian O. Erbe (CEO) Reiner Thede (CEO) | 1847 | Waldhörnlestrasse 17 72072 Tübingen Germany Tel.: +49 (0)7071-7550 Fax: +49 (0)7071-755179 | sales@erbe-med.de | www.erbe-med.de | ERBE Elektromedizin GmbH was formed from the workshop founded by Christian Heinrich Erbe in Tübingen 1847. ERBE develops and produces systems for electro-, cryo- and ophthalmological surgery and physiotherapy. It also markets a water jet-based surgery system. Its portfolio is geared towards surgical installations in all manner of disciplines within hospitals and specialist physicians’ practices both within Germany and abroad. The company has subsidiaries across Europe and in the USA, representatives in China and Russia and trade agencies worldwide. | 500 (worldwide), 400 (Germany), 350 (Tübingen) | QM system: ISO 9001, ISO 13485 Appendix II of Guideline 93/42/EEC; Licences: Conformity assessments and permits as decreed by EC guideline 93/42/EEC | |||||
| Esslingen Technical Academy (TAE) | Service | Services | Professional training and education | Ostfildern | Dipl.-Ing. Hans-Joachim Mesenholl | An der Akademie 5 D-73760 Ostfildern Tel.: +49(0)711-340080 | info@tae.de | www.tae.de | The Esslingen Technical Academy (TAE) offers professional training and education for companies and their specialists and executives. With more than 2,000 speakers from the realms of business and science, TAE organises about 1,000 events per year. The quality of the professional qualification offered by the TAE is certified according to DIN EN ISO 9001. The TAE offers education and training in the following eight business areas: mechanical engineering, automotive and tribology, mechatronics and automation technology, electrical engineering and electronics, information technology, medical technology, construction engineering as well as business administration and individual work skills. The practical relevance and the concrete benefit for participants and companies are the most important aspect of the events organised. | ||||||||
| Esslingen University of Applied Sciences | Biotech | University of applied Sciences with the faculties Natural Sciences, Management, Automotive Engineering, Information Technology, Mechanical Engineering, Mechatronics and Electrical Engineering, Social Work, Health and Nursing, Building Services, Energy and Environmental Engineering | Prof. Dr.-Ing. Bernhard Schwarz | Kanalstraße 33 73728 Esslingen Tel.: +49 (0)711-39749 Fax: +49 (0)711-3973100 Flandernstraße 101 73732 Esslingen Deutschland Tel.: +49 (0)711-39749 Fax: +49 (0)711-3974092 Robert-Bosch-Straße 1 73037 Göppingen Deutschland Tel.: +49 (0)7161-6790 Fax: +49 (0)7161-6792177 | info@hs-esslingen.de | www.hs-esslingen.de | The Esslingen University of Applied Sciences was established as a result of the merger between the two universities of applied sciences in Esslingen - the University of Applied Sciences - Technology (FHTE) and the University of Applied Sciences - Social Sciences (HfS). With around 5,200 students, Esslingen University is the third largest university of applied sciences in Baden-Württemberg. It has 11 faculties, 22 bachelor’s degree programmes and 12 master’s degree programmes. Esslingen University of Applied Sciences occupies three different sites. The faculties of applied sciences, basic sciences, automotive engineering, mechanical engineering, supply engineering and environmental engineering are located in the centre of Esslingen. The faculties of business management, information technology and social work, healthcare and nursing are located on Flandernstraße, which is also home to the international master’s degree courses coordinated by the University’s Graduate School. The faculties of mechatronics, electrotechnology and industrial engineering are located in Göppingen. The Faculty of Applied Sciences at Esslingen University offers a seven-semester biotechnology bachelor’s course, including a practical course in an industrial company. It confers basic chemical and physical knowledge and a well-founded theoretical and practical training in the areas of biochemical engineering, molecular, micro- and cell biology, biochemistry, analytics and diagnostics, quality assurance and project management. Compulsory optional subjects focus on bioprocess and systems engineering and molecular biotechnology. The “Chemical Engineering/Colour and Coatings” bachelor’s course has a technical and scientific orientation and focuses on chemistry, varnish technology, coating technology, corrosion and building protection as well as on environmental protection. The master’s courses “Applied Surface and Material Science” and “Environmental Protection” build on the bachelor’s courses. A ‘Master of Science’ can be obtained after three semesters. In 1998, the Esslingen University of Applied Sciences offered the first master’s degree course in English, which led to the establishment of the Graduate School faculty that combines three English-language postgraduate courses (Master of Business Administration and Master of Engineering). | ||||||||||
| EST! Medizintechnik AG | Medtech | Medical Technology, Trade/Distribution | Sale of diagnostic systems and manufacture of innovative products for ENT and neurology. | Reutlingen | Director with representative authority: Sven Hohmuth | 1999 | Gotlandstrasse 2 72768 Reutlingen Germany Tel.: +49 (0)7121-909000 Fax: +49 (0)7121-9090019 | info@est-med.com | www.est-med.com | As a manufacturer, EST! Medizintechnik AG provides diagnostic equipment and integrated, all-in-one solutions for ENT and neurology. The company also sells diagnostic technology from the firms Interacoustics, Otodynamics and Pilot Blankenfelde. Its portfolio of products includes audiometers, OAE measuring systems, various systems for balance investigation and vestibular diagnostics, rhinomanometers, tympanometers and the patient information system iPATIS. In addition to the service headquarters in Reutlingen, the firm has other service offices throughout Germany. | QM system: ISO 9001:2000 | ||||||
| ETC Elektrophorese-Technik GmbH | Medtech | Medical Technology, Ecology/Environment, Trade/Distribution, Laboratory Techniques | Systems, gels, buffers for horizontal gel electrophoresis | Kirchentellinsfurt | Dr. Hanspeter Schickle Wolfgang Gstrein | Gewerbepark Carl Schirm Bahnhofstrasse 26 72138 Kirchentellinsfurt Germany Tel.: +49 (0)7121-60253 Fax: +49 (0)7121-60252 | infoetc@etcelpho.com | www.etcelpho.com | ETC Elektrophorese-Technik GmbH sells electrophoresis systems, buffers and gels for use in areas such as biomedicine. | ||||||||
| euroderm GmbH | Biotech | The treatment of chronic wounds and human in vitro skin models | Dr. Andreas Emmendörffer Dr. Sabine Krüger | 2002 | Company headquearters: Weissenfelser Strasse 67 04229 Leipzig Germany Tel: +49 (0)341-492920 Fax: +49 (0)341-4929270 Production: c/o Fraunhofer-Institut für Grenzflächen- und Bioverfahrenstechnik (IGB) Nobelstrasse 12 70569 Stuttgart Germany | info@euroderm-biotech.de | www.euroderm-biotech.com | Euroderm was founded in 2002 as a start-up company in Leipzig and focuses on two areas of commercial activity. The first involves the development of various preparations for the treatment of chronic wounds, such as eurokinin® which, when applied daily to wounds, accelerates healing. Euroderm also develops human epidermis for trials in the chemical, pharmaceutical and cosmetic industry. eurokinin® is comprised of the patient’s own thrombocyte growth factors (PDGF, TGF-ß, b-FGF, EGF, PF-4) which are known to support wound healing. EpiDex™ is another product for the treatment of wounds which is cultivated from the patient’s own cells from the outer root shaft (ORS) of the hair. The autologous epidermis equivalent, EpiDex™, facilitates non-invasive treatment on an out-patient basis that is free from rejection reactions. euroskin, a product generated in cell culture, demonstrates the properties of normal skin, which can replace animal experiments for testing purposes. In May 2005, as part of the Central Germany IQ innovation prize, euroderm GmbH won the special prize from the Leipzig Chamber of Industry and Commerce for “Top Technology with a Future” in recognition of its eurograft product. | Dr. Wolfgang Richter | ||||||||
| ExploSys | Biotech | Services, Development, Information Technology | Simulation of biological systems | Leinfelden-Echterdingen | PD Dr. Martin Eichner Dr. Hans-Peter Duerr Dr. Markus Schwehm | 2005 | Westbahnhofstrasse 55 72070 Tübingen Germany Tel.: +49 (0)7071-2978250 Fax: +49 (0)7071-295383 | info@explosys.de | www.explosys.de | The three Explosys scientists work on the basis that even seemingly simple problems in public health are caused by complex, interacting factors and thus require customised solutions. Using mathematical models and computer simulations, they aim to create innovative and flexible solutions for precisely such problems. Of course, such models are also intended to advance fundamental research into epidemiological modelling. Realistically-simulated infection outbreaks are intended to train physicians and people in positions of responsibility in how to bring potential epidemics under control through fast and efficient intervention. “InterSim” is a computer model that can authentically simulate the progress of a spreading infection. It enables recommendations to be derived for decision-makers, for example, those in public health roles. InterSim has since received multiple awards, including the “Special Prize for Open Source Software” in October 2004 from the Business Initiative Baden-Württemberg: connected (bwcon). A simulator, based on InterSim, was developed following a commission from the BGMS (German Federal Ministry of Health and Social Security) and is currently being used by the Robert Koch Institute to develop efficient interventional strategies for epidemics. The "Influenza-Pandemic-Planning-Simulator" InfluSim enables the prediction of the temporal course of an influenza pandemic. The software can be downloaded from http://www.uni-tuebingen.de/modeling/Mod_Pub_Software_de.html. | Dr. Markus Schwehm (Markus.Schwehm@explosys.de) | K. Auranen K. Dietz G. Sallet A. Spielman | |||||
| EXZET Stuttgart - Centre for Company Foundation and Business Development | Service | Services | Process-oriented start-up consulting | Stuttgart | Oliver Förster Rolf Dingethal | Standort Stuttgart: Heilbronner Straße 67 70191 Stuttgart Tel.: +49 (0)711-28446698 Fax: +49 (0)711-28446697 Standort Reutlingen: Tübinger Straße 61 (entrance through no. 63) 72762 Reutlingen Tel.: 07121-3843277 Fax: 07121-3843554 | office@exzet.de, Reutlingen@exzet.de | www.exzet.de | EXZET, Zentrum für Existenzgründung und Unternehmensentwicklung (Centre for Company Foundation and Business Development), has a team of experienced, self-employed consultants who prepare start-up companies and established companies in different industrial sectors for the potential activities and requirements in all economic and sociopsychological issues related to company establishment and development. EXZET offers individual consulting, special seminars and workshops. In close cooperation with different partners, EXZET works towards improved conditions for company founders in Germany. EXZET is accredited according to the quality standards for target-group-specific consulting set by the Deutsches Gründerinnen Forum (German Founder Forum). EXZET’s service spectrum includes all phases of company development. The company’s key competence is the development and provision of full service packages consisting of know-how, small loans and networking. EXZET’s modern network structure enables economic and sociopolitical interests to be seamlessly linked. Besides its partners, EXZET has a management board that is responsible for the management and organisation of the company. It is synonymous with lively vision, state-of-the-art leadership and management principles and efficient work- and project structures. | ||||||||
| Festo AG & Co. KG | Biotech | Automation Solutions | Pneumatic and electromechanical components and systems for greater automation; training for industrial automation designers | Esslingen | Dr. Ekkehard Gericke (Order Fulfilment Management) Dipl.-Ing. Rudi Menrad (Sales Management) Dr. Thomas Rubbe (Knowledge and Information Management) Dr. Eberhard Veit (Spokesperson; Product- and Technology Management) Dr. Ulrich Walker (Finance Management) | Ruiter Straße 82 73734 Esslingen Tel.: +49 (0)711 - 347 - 0 Fax: +49 (0)711 - 347 - 21 44 | info_de@festo.com | www.festo.com | Festo is a global developer and supplier of automation solutions for applications in almost all industrial sectors. The family-owned company, which boasts sales in excess of 1.5 billion euros, has more than 12,000 employees in 56 national headquarters and over 200 branches, serving 300,000 customers in 176 countries. It offers standard electromechanical and pneumatic components, engineering and consulting services, customized manufacturing, assemblies and system solutions. Festo now also wants to extend the application of its products in the life science sector. This represents new territory for the company. The Biotech/Pharmaceuticals division, which was established in 2004, now defines, develops, produces and supplies components and system solutions used at decentralized control level for automating workflows in the production of active agents or in the (galenical) production of drugs. Festo’s newest division in the life science sector, MedLab, supports the development of active agents, quality control and analytics by designing new systems for controlling, handling and positioning in the field of laboratory automation. The company also leverages synergies from its automation solutions for installation in medical equipment and systems. This ultimately enables Festo to offer an extended product and service portfolio with a clear focus on the automation of fluid control, sample preparation and liquid handling systems and of instrumental analytics, diagnostics and therapeutic applications. Here, as in all its other sectors, Festo relies on close collaboration with leading mechanical engineering companies. Joint development projects using state-of-the-art technologies on both sides guarantee innovative and market-ready products. Customers, whether they be industrial or private end users, can therefore be confident they will receive highly efficient and dependable machines, equipment and systems. | DIN ISO 9001 since 1990 VDA 6.1 since 1999 VDA 6.4 since 2000 Best Factory Award 1997 ISO 14001 since 2000 | |||||||
| flyion GmbH | Biotech | Drug Development, Medicine, Trade/Distribution, Laboratory Techniques | Automated patch clamp technology | Tübingen | PD Dr. Albrecht Lepple-Wienhues (CEO) Dr. Dirck Lassen (Vice President of Commercial Operations) | 2001 | Waldhäuserstrasse 64 72076 Tübingen Germany Tel.: +49 (0)7071-688830 Fax: +49 (0)7071-6888399 | info@flyion.com | www.flyion.com | flyion GmbH was founded by Dr. Albrecht Lepple-Wienhues and Dr. Klaus Ferlinz in 2001 as a spin-off of the University of Tübingen (Institute of Physiology). The founders were supported by i.con.innovation. In 1991, Erwin Neher and Bert Sakmann won the Nobel Prize in Medicine for their groundbreaking study of ion channels. In its conventional form, the patch clamp process that they developed is extremely labour intensive and demands a high degree of manual dexterity in order to yield reliable results. flyion has simplified this procedure with its patented Flip-the-Tip™ technology, which is ideally suited for automation. The company offers a range of products based on this technology: · The Flyscreen® 8500 is a patch clamp robot that performs high-quality ion channel screenings automatically. Several compounds can be tested one after the other. · The PatchBox™ is a cost-effective plug&play workstation tool that can be combined with existing amplifiers, pullers and software. It is simple to operate and delivers a high success rate in the automatic formation of gigaseals and whole-cell configurations in a standard patch pipette. · The ChipTip™ recording tips for the Flyscreen® 8500 consist of a glass pipette in a plastic casing. They ensure high success rates and allow extremely fast solution exchange within the pipette while keeping volumes to an absolute minimum for the study of the fastest ligand-dependent ion channels. · The Feedback Microforge is a fully automatic micro glass pressure polishing system for the production of special glass pipette shapes in patch clamp technology. As a solutions provider, and to complement its product range, flyion also offers the following services that help ensure the company’s products are used efficiently: · hERG safety analysis of active substances · Ion channel screening to help discover new active substance candidates · Creation and characterisation of stably transfixed, inducible cell lines · Optimisation of assays for automated ion channel screenings | Ulrike Jakl for general queries (info@flyon.com) | ||||||
| Fr. Mollenkopf GmbH & Co. KG | Biotech | Laboratory Techniques | Optics, lab equipment, measurement and GPS navigation | Stuttgart | Dieter Mollenkopf (CEO) Hansjörg Mollenkopf (CEO) | 1847 | Hospitalstrasse 35 70174 Stuttgart Germany Phone: +49 (0)711-16279-0 Fax: +49 (0)711-16279-25 | info@mollenkopf-stuttgart.de | www.mollenkopf-stuttgart.de | This family business was founded in Stuttgart in 1847. The company sells and provides consulting services for spectacle frames and lenses, optical instruments, microscopes, lab glassware, lab equipment, lab material and measuring instruments for geodesy and construction. Mollenkopf also operates its own precision-mechanics and optical workshop where repairs can be carried out on microscopes, weather instruments and surveying instruments. | |||||||
| Fraunhofer-Institut für Grenzflächen- und Bioverfahrenstechnik IGB | Institute | Services, Development, Medicine, Chemistry, Process Engineering | The creation of solutions for business and public clients in the fields of health, the environment and technology | Stuttgart | Prof. Dr. Thomas Hirth (Institute Director) | 1952 | Nobelstrasse 12 70569 Stuttgart Germany Tel.: +49 (0)711-9704001 Fax: +49 (0)711-9704200 | info@igb.fraunhofer.de | www.igb.fraunhofer.de | IGB’s roots go back to 1952, the year in which the Institute of Surface Physics and Chemistry was founded. The Institute was taken over in 1962 by the Fraunhofer Society. The Institute was given its present name in 1976, coinciding with the creation of the research fields involving bioprocess technology and membrane technology. The Fraunhofer IGB is one of six Fraunhofer institutes in Stuttgart, the Fraunhofer Society’s largest location. The IGB’s main areas of expertise include surface technology, membrane technology, biotechnology, cell system technology and bioprocess technology. The IGB offers its clients full-service solutions, ranging from market analysis and research to ready-to-use development. The scientists working at the IGB focus on various disciplines – from physics, chemistry, biology and molecular biology to engineering-related sciences. Their goal is to translate biological and biochemical problems and challenges in product preparation and environmental technology into commercially-attractive and environmentally-friendly processes and products. The IGB’s core areas of research are handled in four divisions, each focusing on different areas of application or business. 1) The “Molecular Substances for Pharmaceuticals and Chemical Industries” division focuses primarily on the development of therapeutic proteins and target screening, diagnostic methods using biochips and diagnostic agents, biocatalysis and enzyme screening, fermentation, downstream processing and scale-up production. The second division focuses on the development of 3-dimensional, organoid cell structures as test systems, tissue engineering and manufacturing based on GMP guidelines. In the “Functional Surfaces and Membranes” division, the scientists primarily work on surface-dominated polymers, biomaterials and biomimetic surfaces, together with the design of new membranes. The Fraunhofer IGB’s fourth division is devoted to biotechnical environmental rehabilitation, the recycling of organic waste, waste water purification and water management and the regenerative production of materials using microalgae. In addition to this purely R&D-based activity, the Fraunhofer IGB also offers services in various sectors such as analysis, molecular biology, cell biology and commissioned research into cell therapy agents based on GMP. | Dr. Claudia Vorbeck (claudia.vorbeck@igb.fraunhofer.de) | 140 | Accreditation to DIN EN ISO/IEC 17025 for HPCL, IC, GPC, GC and GC/MS, ESCA; GMP unit and manufacturing permit for autologous chondrocyte transplants (others have been applied for). | ||||
| Friedrich Bosch Medizintechnik GmbH + Co. KG | Medtech | Development, Medical Technology, Process Engineering | Manufacture of blood pressure monitoring equipment and accessories | Bisingen | 1924 | Hohenlaienstrasse 30 72406 Bisingen Germany Tel.: +49 (0)7476-3554 Fax: +49 (0)7476-3556 | jb@fbosch.de | www.fbosch.de | Friedrich Bosch Medizintechnik GmbH + Co. KG manufactures medical equipment and accessories relating to blood pressure monitoring for hospitals and doctors worldwide. Its range of products include sphygmomanometers for doctors and for self-measurement, pulse meters, tourniquets and cuffs of various designs, together with other diagnostic equipment such as laryngoscopes and otoscopes. | CE certificate, i.e. certified according to DIN ISO 9001 and EN 46001 | |||||||
| Friedrich-Miescher Laboratory | Institute | Development | Biological research | Tübingen | Prof. Dr. Christiane Nüsslein-Volhard | Spemannstraße 39 D-72076 Tübingen, Germany Tel.: +49 (0)7071-601800 Fax: +49 (0)7071-601801 | www.fml.mpg.de | The Friedrich-Miescher Laboratory (FML) is a research institute belonging to the Max Planck Society, named after Friedrich Miescher, a renowned Swiss biologist who discovered DNA whilst carrying out research in Tübingen. The Institute was established in 1969 with the objective of giving outstanding young scientists the opportunity to carry out research within independent research groups. The projects all last five years. The FMO is on the Max Planck Campus in Tübingen, which also hosts the Max Planck Institutes for Developmental Biology and Biological Cybernetics. The FML consists of up to four independent research groups headed by junior group leaders who work on different aspects of biology. The Antonin lab deals with nuclear envelope dynamics, the Hauf lab with chromosomal segregation, the Ivanov lab with the cohesion of sister chromatids and the Rätsch lab with machine learning in biology. | |||||||||
| FRYKA Kältetechnik GmbH | Medtech | Medical Technology | Developing and manufacturing cooling and deep-freeze units for lab and analysis technology, research and industry. Series-produced products and custom-made solutions. | Esslingen | Ralph Kaiser (CEO / Sales, Marketing, Technology) (ralph.kaiser@fryka.de, Tel. ext. 11) Achim Kaiser(CEO/OrderFulfilment,Production) (achim.kaiser@fryka.de, Tel. ext. 12) | 1972 | Ohmstrasse 4 73730 Esslingen Germany Phone: +49 (0)711-310599-0 Fax: +49 (0)711-310599-29 | info@fryka.de | www.fryka.de | The company was founded 35 years ago by Rolf Kaiser and, since then, has been producing cooling and deep-freeze appliances for lab and analysis technology, research and industry. The company specialises in producing compressor-cooled refrigerators with cooling performances of 100 to 4000 Watt, focusing in particular on tailor-made solutions and proprietary OEM equipment. | |||||||
| G. Albert Storz | Medtech | Medical Technology | A specialist in ENT instruments, particularly those required for throat operations. | Rottenburg am Neckar | Ulrich Binder | 1889 | Schwalbenweg 1 78573 Wurmlingen Germany Phone: +49 (0) 7461-2251 Fax: +49 (0)7461-2152 | info@ga-storz.de | www.ga-storz.de | G. Albert Storz was founded by G. A. Storz in Tuttlingen in 1889. Now based in Wurmlingen near Tuttlingen, the company is managed by Ulrich Binder in its fourth generation. The company specializes in the production of ENT instruments, particularly those instruments required in throat operations, such as mouth gags, tonsillectomies, tourniquets or tongue spatulas. | |||||||
| G. Heinemann Ultraschall- und Labortechnik | Medtech | Medical Technology, Trade/Distribution, Process Engineering | Laboratory and wholesale ultrasound technology. | Schwäbisch Gmünd | Andreas P. Heinemann (Managing Director) | 1962 | Erwin-Rommel-Strasse 42 73525 Schwäbisch Gmünd Germany Phone: +49 (0)7171-61142 Fax: +49 (0)7171-38750 | info@gheinemann.de | www.gheinemann.de | For more than 40 years, G. Heinemann has sold and serviced ultrasonic cell disruptors, cleaning technology and measuring equipment, homogenizers, cooling equipment, bead mills and the full range of equipment required for ultrasonic liquid processing. G. Heinemann’s strength lies in its ability to provide one-to-one, application-oriented consulting. As a manufacturer-independent provider, the company’s top priority is always to recommend the best equipment for the customer’s particular application. It is a traditional family-run company with many years’ experience and close customer ties. Customers value its one-to-one, customized support. Its in-depth product and application know-how and close contact with manufacturers ensure that the customer receives extensive advice – even with complex, unfamiliar tasks. The company also provides its own repair service. | Andreas P. Heinemann | 3 | |||||
| Gambro Dialysatoren GmbH | Medtech | Development, Medicine, Medical Technology, Trade/Distribution | Dialysis technology | Hechingen | Dr. Heiko Zimmermann (CEO) | 1973 | Holger-Crafoord-Strasse 26 72379 Hechingen Tel.: +49 (0)7471-170 Fax: +49 (0)7471-171157 | info.germany@gambro.com | www.gambro.com | Gambro is a global group that specialises in dialysis technology, blood component technology and healthcare services. The joint-stock company, based in Sweden, is divided into Gambro Healthcare, Gambro Renal Products and Gambro BCT. It’s Hechingen office is one of the group’s production facilities operated by Gambro Renal Products, manufacturing dialysis machines, haemoperfusion cartridges, electrolyte concentrates and other medical items for single use. Hechingen is also home to the research and development centre for dialysis machines/membrane technology and the logistics and distribution centre for Germany, Switzerland, Austria and the Benelux countries. One of the branch offices of Gambro Dialysatoren GmbH, which is also located in Hechingen, solely produces catheters for use in dialysis. | Approx. 1500 | CE certificate as per EC guideline 93/42EEC, certificate compliant with ISO 13485, Certificate ISO 14001, basic certificate from the “Beruf + Familie” audit | New, molecularly-defined, MIF-based methods for extracorporal apheresis aimed at regenerating plasma in sepsis and SIRS. Antibacterial and biofunctional surfaces for extracorporal and cell therapy methods. | ||||
| gelcompany GmbH | Biotech | Laboratory Techniques, Proteomics | Systems, gels, fluorescent dyes, buffers for horizontal and vertical gel electrophoresis and analysis | Tübingen | James Walker Dipl. Ing. Wolfgang Gstrein Dr. Hanspeter Schickle Günter Thesseling | 1991 | Paul-Ehrlich-Str. 15 72076 Tübingen Tel.: +49 (0)7071-257030 Fax: +49 (0)7071-2570369 | www.gelcompany.com | gelcompany GmbH, known as ETC Elektrophorese-Technik GmbH up to 2008, has been producing ready-made gels for electrophoresis applications in protein, DNA and RNA analytics for around 20 years. The gels are bonded to a non-fluorescent plastic film and are easy to handle. The specific composition of the carrier film enables the sensitive and specific detection of proteins and nucleic acids with fluorescent dyes. The Australian company Fluorotechnics Pty Limited, which developed a highly sensitive fluorescent dye and an appropriate detection system and markets these throughout the world, realised the potential of the company’s products and acquired ETC GmbH in October 2007. The additional acquisition of San Francisco-based Gel Company, which led to the new company name, enabled Fluorotechnics to broaden its existing product portfolio in October 2008. | Günter Thesseling (guenter.thesseling@gelcompany.com) | |||||||
| German Centre for Biomaterials and Organ Replacement | Institute | Services, Development, Regenerative Biology, Process Engineering | Development of biomaterials and organ replacements | Denkendorf | Prof. Dr. Ing. H. Planck (Chairman) Prof. Dr. med. H.D. Becker (Vice Chairman) Prof. Dr. human. biol. Lutz Claes (Secretary) Prof. Dr. med. Karl-Klaus Dittel (Auditor) Dr.-Ing. Martin Dauner (Coordinator) | Körschtalstr. 26 D-73770 Denkendorf Tel: +49(0)711-93400 Fax:+49(0)711-9340297 | bmoz@itv-denkendorf.de | www.itv-denkendorf.de | The German Centre for Biomaterials and Organ Replacement Stuttgart-Tübingen (BMOZ) brings together the scientific and clinical institutions of the universities of Stuttgart and Tübingen and is being funded by the German Federal Ministry of Education and Research (BMBF) for a period of five years as part of the “Ma-Tech” programme. BMOZ has obtained additional financial support from the Baden-Württemberg Ministry of Science, Research and the Arts, the University of Tübingen and project-related industry funds. BMOZ’s main activity is the coordination of research projects funded by the BMBF and its industrial partners. The goal of the Centre is to give industry a basis for the concerted development of biomaterials and organ replacements. Besides basic research, the partners are therefore mainly focused on application-oriented developments in cooperation with pharmaceutical and medical device companies. The Centre’s activities are: * Design and development planning * Polymer synthesis and processing * Surface modification (plasma, wet, biochemistry) * Implants & instruments: development / production * Purification and sterilisation methods * Pharmacological studies * Tissue engineering * Testing (biomechanical, physical-chemical, biological) * In vivo animal studies * Clinical trials The laboratories of the research institutes that are part of BMOZ (ITV, IGB, NMI) along with the animal experiment institute at the University of Tübingen are all accredited by the Zentralstelle der Länder für die Gesundheit (ZLG) for the medical product area. | ||||||||
| Gerwing Medizinprodukte Gerd Riester e.K. | Medtech | Medical Technology | Development, production and distribution of hospital and care supplies. | Jungingen | Gerd Riester (proprietor) | 1985 | Killertalstrasse 18 72417 Jungingen Germany Phone: +49 (0)7477-1523855 Fax: +49 (0)7477-8036 | info@gerwing-riester.de | www.gerwing-riester.de | GERWING manufactures goods for the hospital wholesale sector. Its product range encompasses almost all aspects of patient fixation in OP surgery, intensive care or hospital beds. In addition, it manufactures universal holders for cannulae (e.g. tracheal cannulae) and tubes. The range of products also includes tourniquets and antidecubitus supports (ankle and elbow pads) made from high-quality Trevira hollow fibre fabric. | Gerd Riester | Gerd Riester | |||||
| GETEX LENZ Technische Textilien GmbH | Medtech | Medical Technology | Supplies complete textile solutions, semi-finished products and accessories for the orthopaedics, diagnostics, therapeutics and wellness sectors. | Göppingen | Hans Peitsch (Managing Director) | Hofhalde 13-15 73035 Göppingen Germany Phone: +49 (0)7161-1568910 Fax: +49 (0)7161-13719 | getex-lenz@getex-lenz.de | www.getex-lenz.de | Getex Lenz GmbH has been manufacturing, finishing and customizing technical textiles such as Velcro fasteners, medical cushions and woven and knitted fabrics for more than 30 years. The company uses techniques such as ultrasonic and high-frequency welding, sewing, punching, laminating and a variety of coating techniques to provide an enhanced finish to the bandages. Our products are inspected by accredited textiles institutes, comply with the Oeko-Tex Standard 100 and have been checked for biocompatibility. Getex Lenz GmbH provides everything you need from a single source – including expert consulting, development skills and made-to-measure solutions that meet the very highest quality standards. | ||||||||
| Gewürzmüller GmbH | Biotech | Nutrigenomics | Spice products, starter cultures and ingredients | Korntal-Münchingen | Thomas Rendlen (Owner and Managing Director) | 1896 | Siemensstr. 1 70825 Korntal-Münchingen Germany Tel.: +49 (0)7150-20900 Fax: +49 (0)7150-20907000 | info@gewuerzmueller.de | www.gewuerzmueller.com | Gewürzmüller GmbH was founded in 1896 and is based in Korntal-Münchingen. In October 2007, Frutarom Industries Ltd. (Israel) signed an agreement to acquire 100% of the share capital of Gewuerzmueller GmbH. With its comprehensive range of spices and pickle cultures, Gewürzmüller is a household name in the meat processing, hotel and catering industries. The company’s research and development know-how stems from its in-house “Sensorikum” for sensory training and testing and its cooperation with research institutes, including the University of Hohenheim’s Institute for Food Technology. Research focuses on developing both combinations of spices and starter cultures (e.g. ACTI-PRO with probiotic properties. The Lactobacillus paracasei bacteria this product contains regulate the balance of natural intestinal flora and help strengthen natural defensive mechanisms). | Approx. 200 | DIN EN ISO 9001 | |||||
| GlaxoSmithKline Consumer Healthcare GmbH & Co. KG | Biotech | Medicine, Nutrigenomics, Trade/Distribution | Oral care/dental health, pharmacy-only and freely available medicines/dietary supplements | Herrenberg | Managing Directors: Jürgen Reinhardt Adrian Bauer Klaus Seeger Herman van Barneveld Cornelis van Schagen | Headquarters: Bußmatten 1 77815 Bühl/Baden Germany Tel.: +49 (0)7223-76-0 Fax: + 49 (0)7223-76-4000 Production/R&D location: Benzstr. 25 71083 Herrenberg Germany Tel.: +49 (0)7032-9220 Fax: + 49 (0)7032-5221 | unternehmen@gsk-consumer.de | www.gsk-consumer.de | GlaxoSmithKline is one of the world’s leading healthcare companies. 100,000 people throughout the world work in the areas of pharmaceuticals (prescription medicines/vaccines) and consumer healthcare (products for oral and dental health and self medication). GlaxoSmithKline is represented in Germany by its Pharmaceuticals division based in Munich and its Consumer Healthcare division headquartered in Bühl. The Consumer Healthcare location in Bühl is responsible for business in Germany, Austria and Switzerland. The Herrenberg site is home to R&D for vitamin supplements and natural remedies, as well as being the production site for natural remedies and oral care products such as Odol® mouthwash. Odol®, Odol-med3®, Dr. Best®, Sensodyne®, Chlorhexamed® and Corega® are helping to improve dental health and are market leaders in the oral hygiene markets. Abtei is the largest brand in the freely available medicines/dietary supplements sector. The vitamin supplements Cetebe® and Eunova®, the plant-based urological product Granu Fink®, NiQuitin® (to help stop smoking), Zovirax® (to treat cold sores) and Formigran® (to treat migraines) represent key areas of expertise in the market for self-medication products available only from pharmacies (pharmacy-only products). With around 560 employees and innovative healthcare concepts represented by strong brands, GlaxoSmithKline Consumer Healthcare is one of the most successful companies in the sectors of oral care/dental health and both freely available and pharmacy-only medicines/dietary supplements. | Ms. Ulli Manz/Company Communication; Tel.: + 49 (0)7223-76-2221; Fax: + 49 (0)7223-76-3221 | |||||||
| Gottl. Kern & Sohn GmbH | Medtech | Medical Technology | Manufacture and distribution of precision balances and test weights. | Balingen | Martin Sauter (General Manager): t-straub@kern-sohn.com (Secretary) Ulrich Ulmer (Sales Manager): ulmer@kern-sohn.com Thomas Fimpel (Marketing Manager): fimpel@kern-sohn.com Elmar Hauschel (Factory Manager): hauschel@kern-sohn.com Marco Occhionero (IT Manager): occhionero@kern-sohn.com Joachim Hausmann (Purchasing): hausmann@kern-sohn.com Otto Grunenberg (Manager of DKD calibration laboratory, QM Manager): grunenberg@kern-sohn.com | 1844 | Ziegelei 1 72336 Balingen-Frommern Germany Phone: +49 (0)7433-9933-0 Fax: +49 (0)7433-9933-149 | info@kern-sohn.com | www.kern-sohn.com | This medium-sized, family-run company was founded by Gottlieb Kern in 1844 and manufactures high-precision balances, including laboratory balances, analytical balances, moisture analyzers, industrial balances, crane scales, counting balances, pallet scales and test weights in all OIML accuracy categories. One of its core areas of expertise is the DKD calibration of scales and weights. The calibration laboratory is in the vanguard of European technology and its high level of automation enables DKD calibrations 24 hours a day, 7 days a week. As well as scales, test weights and DKD calibrations, the company also offers a comprehensive service covering all aspects of weighing technology. The company is certified in accordance with the latest version of DIN ISO 9001:2000 and accredited to DIN EN ISO/IEC 17025. It is also represented by an extensive network of specialist retailers worldwide. | |||||||
| Graduate School of Cellular & Molecular Neuroscience | Institute | Medicine, Education | Graduate education in the neurosciences | Tübingen | Prof. Dr. Horst Herbert (Coordinator) | University of Tübingen Graduate Training Centre of Neuroscience Österbergstraße 3 D-72074 Tübingen Tel.: +49 (0)7071-2977179 Fax: +49 (0)7071-295089 | neuro.office@uni-tuebingen.de | www.neuroschool-tuebingen-molec.de | The Graduate School of Cellular & Molecular Neuroscience was established at the University of Tübingen in 2007 through the joint efforts of the Medical School, the School of Biology and the School of Biochemistry & Pharmacy. It is strongly supported by the Hertie Institute for Clinical Brain Research, the Tübingen Centre of Neurodegenerative Diseases, the Centre for Integrative Neurosciences and the NMI Natural and Medical Sciences Institute at the University of Tübingen. The programme gives students (master/PhD) an interdisciplinary education in the neurosciences, with particular focus on the practical and theoretical training in the molecular and cellular biology of neurodegenerative diseases, mechanistic aspects of neural plasticity and neuroregeneration, basic mechanisms of learning and memory and modern microscopy methods. International students receive financial support (grants) from the programme’s cooperation partners, the Hertie Foundation and the Helmholtz Society. The Graduate School of Cellular & Molecular Neuroscience works closely with the Graduate School of Neural & Behavioural Sciences. | ||||||||
| Graduate School of Neural & Behavioural Sciences - International Max Planck Research School | Institute | Medicine, Education | Graduate education in the neurosciences | Tübingen | Prof. Dr. Horst Herbert (Coordinator) | University of Tübingen Graduate Training Centre of Neuroscience Österbergstraße 3 D-72074 Tübingen Tel.: +49 (0)7071-2977179 Fax: +49 (0)7071-295089 | neuro.office@uni-tuebingen.de | www.neuroschool-tuebingen-cogni.de | The Graduate School of Neural & Behavioural Sciences – International Max Planck Research School was established at the University of Tübingen in 1999 through the joint efforts of the Medical School, the School of Biology and the Max Planck Institute for Biological Cybernetics. Additional training is provided by the Hertie Institute for Clinical Brain Research, the Centre for Integrative Neuroscience and the NMI Natural and Medical Sciences Institute at the University of Tübingen. Graduate students begin with a one-year interdisciplinary practical and theory-based training period, followed by a master’s and subsequently a doctoral thesis. The main training focus is sensory and motor systems neuroscience, neuropsychology, neurophysiology and specific brain imaging methods, both with regard to the healthy and the diseased brain. International students receive financial support from the Max Planck Society in the form of grants. The Graduate School of Neural & Behavioural Sciences works closely with the Graduate School of Cellular & Molecular Neuroscience. | ||||||||
| Greiner Bio-One GmbH | Biotech | Development, Laboratory Techniques | Development of laboratory products and synthetic consumables for the life sciences sector | Frickenhausen | Dr. Axel Greiner, Executive Director Boris Greiner MBA, Executive Director Heinz Schmid, Managing Director of Greiner Bio-One GmbH, Germany | 1868/1963 | Maybachstrasse 2 72636 Frickenhausen Germany Tel.: +49 (0)7022-9480 Fax: +49 (0)7022-948514 | info@de.gbo.com | www.gbo.com | Carl Albert Greiner founded the firm in 1868, which originally started out producing corks. Later, Greiner specialised in the processing of synthetics. Greiner Bio-One GmbH in Frickenhausen, which belongs to the BioScience division of the Greiner Bio-One International AG holding company, is responsible for the manufacture of the firm’s laboratory products. The portfolio includes diagnostic and analytical methods, HTS products (High-Throughput Screening) for the screening of pharmaceutical active agents, specialist vessels for tissue culture and products used in the context of biochip technology (PapilloCheck® for the early detection of cervical cancer, ParoCheck® for the detection of periodontal pathogens, CarnoCheck® for the detection of the DNA of eight animal species in food, CytoCheck® for the quality assurance in the biopharmaceutical industry). | Tobias Rigling (Marketing) | 6000 (worldwide), 1100 (BioScience + Preanalytics), 400 (BioScience) | DIN EN ISO 9001:2000 ISO 13485:2003 | ||||
| Gründler GmbH | Medtech | Medical Technology | Development and sale of systems for the humidification of medical gases | Freudenstadt | Markus Gründler Dr. med. Christoph Gründler | Carl-Benz-Straße 5 72250 Freudenstadt Tel.: +49 (0)7441-91460 Fax: +49 (0)7441-914677 | info@gruendler-medical.de | www.gruendler-medical.de | Located in the city of Freudenstadt, Gründler medical is a young company that develops, manufactures and sells innovative products for intensive care medicine. Gründler medical has developed an innovative system for the humidification of medical gases used for non-invasive and invasive ventilation therapy. The HumiCare® 200 system is superior to state-of-the-art humidifiers in many respects: the system is extremely versatile and can be used in combination with a broad range of ventilators and ventilation therapy devices. HumiCare® 200 consists of the H200 humidifier, a detachable humidification chamber and heatable respiratory tubing. | The company is certified according to DIN EN ISO 13485:2003 as well as Appendix II, Paragraph 3 of the European directive 93/42/EEC. | |||||||
| HAEBERLE GmbH & Co. KG | Medtech | Medical Technology | Multifunctional medical cart systems and more … | Stuttgart | Doris Geysel-Fuchs (Managing Director) | 1933 | Breitwiesenstrasse 13 70565 Stuttgart Germany Phone: +49 (0)711-78314-0 Fax: +49 (0)711-78314-77 | info@haeberle-med.de | www.haeberle-med.de | HAEBERLE’s range of products includes innovative and versatile cart and trolley systems and a wide range of tried and tested products, such as dispensing and disposal systems, X-ray viewers, medical examination lamps, linen and waste collection systems, and more… HAEBERLE now uses its decades of experience and innovative designs to specialize in the development of customized product solutions that meet customers’ individual requirements, all the while ensuring to use high-quality materials and contemporary colour schemes in product development. HAEBERLE’s particular specialty is made-to-measure OEM versions for industrial customers. | EN ISO 9001: 2000 and EN ISO 13485: 2003 | ||||||
| Hain Lifescience GmbH | Biotech | Development, Diagnostics, Trade/Distribution | Manufacturing diagnostic systems | Nehren | David Hain (CEO) Tobias Hain (CEO) Roman Tepperwien (Sales Manager) Michael Wirth (Marketing Manager) Dr. Stefan Kress (Production Manager) Dr. Vera Allerheiligen (R&D Manager) | 1986 | Hardwiesenstr. 1 72147 Nehren Germany Tel.: +49 (0)7473-94510 Fax: +49 (0)7473-945199 | info@hain-lifescience.de | www.hain-lifescience.de | The company started out as a partnership founded by brothers David and Tobias Hain that was initially limited to mail order. Following the development of new diagnostic tools, the company was restructured in 1989 to form Hain Diagnostika GmbH. In 2001, Hain Diagnostika GmbH merged with Advanced Diagnostic Systems GmbH (ADS) and was renamed Hain Lifescience GmbH in 2002. One of the base technologies established by Hain Lifescience is the DNA-STRIP® which, although comparable to DNA chips, is more cost-effective and accurate. The company also develops products for genotyping, dental, microbiological and molecular-biological diagnostic solutions, and swab and transport systems. | |||||||
| Haselmeier GmbH | Medtech | Medical Technology | Development, production and distribution of application tools for the pharmaceuticals sector. | Stuttgart | Matthias Meissner (Managing Director) | 1920 | Vaihinger Strasse 48 70567 Stuttgart Germany Phone: +49 (0)711-71979-0 Fax: +49 (0)711-717871 | info@haselmeier.com | www.haselmeier.com | Wilhelm Haselmeier founded Wilhelm Haselmeier GmbH & Co. in 1920 in the Degerloch district of Stuttgart and specialized in the development and production of glass syringes. Today, Haselmeier GmbH is one of the world’s leading suppliers of pen-injectors for the hypodermic injection of pharmaceuticals. The pen systems are used in intensified insulin therapy, thrombosis prophylaxis and treatment using growth hormones. The pen and auto-injection systems are usually fitted with a hidden needle. Haselmeier GmbH’s other main areas of expertise are custom design and the production of medical devices, as well as product and production planning in "simultaneous engineering" to optimize workflow processes. | Certified to ISO 13485:2003 Certificate number: Q1N 05 07 55003 003 93/42/EEC Directive Annex II, Point 3 Certificate number: G1 04 12 55003 001 | ||||||
| Hauswirtschaftlich-sozialpädagogische Schule (HWS) | Service | Services | School education | Albstadt | Wolfgang Wunder (Headmaster) Gerhard Schweizer (Deputy Headmaster) | Johannesstraße 6 72458 Albstadt Tel.: +49 (0)7431-121151 Fax: +49 (0)7431-121158 | info@hws-albstadt.de | www.hws-albstadt.de | The HWS in Albstadt is a vocational school in Baden-Württemberg that specialises in housekeeping and social pedagogy. The school was established in 2004 as a result of the merger between the Friederike-Rösler School in Balingen and the Hauswirtschaftliche Schule Albstadt (housekeeping school in Albstadt). The school has 700 students, 70 teachers and 32 classes. The HWS offers 12 varied and interesting school types, including five in social pedagogy, which have led to the establishment of a regional social pedagogy competence centre in Albstadt. The grammar schools specialising in nutrition and biotechnology offer stimulating science-oriented courses. In addition, the school offers the possibility of pursuing a two-year vocational training course (Fachschulreife) and of attending different one-year full-time schools as part of the compulsory education requirements. The HWS Albstadt is a so-called OES – operatively independent school – school that participates in the Baden-Württemberg school development process. | ||||||||
| heckel medizintechnik GmbH | Medtech | Medicine, Medical Technology, Trade/Distribution | Development, manufacture and sale of systems for full-body and local hyperthermia | Esslingen | Stefan Heckel-Reusser (Management) | 1994 | Blumenstrasse 18 73728 Esslingen Germany Tel.: +49 (0)711-9315891 Fax: +49 (0)711-9315893 | info@heckel-medizintechnik.de | www.heckel-medizintechnik.de | heckel medizintechnik gmbh was founded at the end of 1994 under the name “heckel – Therapeutic Infra-Red Systems”. The firm develops, produces and sells full-body hyperthermia systems that artificially raise the body temperature using infra-red radiation, thereby stimulating the body’s self-healing abilities in people with chronic illness. These systems, which feature a newly-developed, multi-functional reflection tent, are used to treat various conditions including degenerative diseases of the musculoskeletal system, chronic inflammatory diseases and cancer-related illnesses. The company sells equipment for local deep hyperthermia which is used in the treatment of tumours. | Stefan Heckel-Reusser | 3 | All products bear the CE mark and comply with the requirements of the European medical products guideline 93/42/EEC. Certified according to EN ISO 13485 and EN ISO 9001 by the TÜV Product Service, Munich. EC certificate for the quality assurance system in place in its hyperthermia equipment division and physiological monitoring systems (as per Appendix II, MDD 93/42/EEC). | ||||
| Heinz Kurz GmbH Medizintechnik | Medtech | Medical Technology | Development, manufacture and sale of implant systems for use in otorhinolaryngology | Dußlingen | Traute Kurz-Butzki (Managing Director) Uwe Steinhardt (Chief Technology Officer) Harry Braun (Chief Financial Officer) | Tübinger Str. 3 72144 Dusslingen Tel.: +49 (0)7072-91790 Fax: +49 (0)7072-917979 | info@kurzmed.de | www.kurzmed.de | Heinz Kurz GmbH Medizintechnik has been developing and producing implant systems for use in otorhinolaryngology since 1993, which it sells all over the world. The company’s product portfolio mainly consists of implants for middle ear reconstruction as well as implants for the stabilisation of the nose, vocal cord and trachea. The company has a subsidiary in Dallas/USA. | ||||||||
| Heinz Schade GmbH | Medtech | Medical Technology | Manufacturing of sensors for the semiconductor industry and equipment for medical technology. | Reutlingen | 1999 | Silvanerstrasse 8 72766 Reutlingen Germany Phone: +49 (0)7127-972290 Fax: +49 (0)7127-972291 | www.heinz-schade.de | Heinz Schade GmbH is primarily active in the development of equipment for the medical and process technology sectors. The company’s main focus is on sensors for process technology and semiconductor production, as well as devices for stent and catheter production, low-frequency current systems for therapeutic applications, and technical developments for quality management. | |||||||||
| Helmut Saur Laborbedarf | Medtech | Medical Technology | Distribution of laboratory supplies | Reutlingen | Helmut Saur (Managing Director) | Wannweiler Strasse 11 72770 Reutlingen Germany Phone: +49 (0)7121-54008 Fax: +49 (0)7121-54000 | info@h-saur.de | www.h-saur.de | Helmut Saur provides a comprehensive range of laboratory supplies, including oxygen measurement instruments, photosynthesis systems, chlorophyll and fluorescence systems, light sources and sensors, hybridization ovens, vacuum concentrators, rotators, micromanipulators, hot plates, light boxes or cell culture systems. | ||||||||
| Hertie Institute for Clinical Brain Research (HIH) | Institute | Medicine | Research into the brain and brain diseases (in particular Alzheimer’s, Parkinson’s) | Tübingen | Prof. Dr. Thomas Gasser Prof. Mathias Jucker Prof. Dr. Arthur Melms Prof. Hans-Peter Thier Wolfgang Pfaff (Managing Director) | Otfried-Müller-Str. 27 72076 Tübingen | www.hih-tuebingen.de | The Hertie Institute for Clinical Brain Research (HIH) was established in 2002 by the University of Tübingen and the non-profit Hertie Foundation in Frankfurt. The Institute combines neuroscientific research with the clinical treatment of brain disorders. The Institute is located in a research building on the Schnarrenberg campus in Tübingen. The HIH has four divisions: General Neurology (Interim Director: Prof. Arthur Melms) Cognitive Neurology (Director: Prof. Hans-Peter Thier) Neurodegenerative Diseases (Director: Prof. Thomas Gasser) Cell biology of neurological diseases (Director: Prof. Mathias Jucker) The HIH employs around 200 scientists under the leadership of 10 renowned professors, who investigate the information-theoretical and neuronal basics of important brain functions such as perception, memory and learning. These findings are used to prevent and treat brain diseases such as Alzheimer’s, Parkinson’s, stroke, tumours or multiple sclerosis. In addition, the scientists analyse brain-oriented applications for technological applications, for example traffic safety systems. The Hertie Institute for Clinical Brain Research has close structural connections with the Hospital for Neurology, both of which are part of the Centre of Neurology, a multifunctional institution which is able to offer clinical brain research, medical treatment and scientific education. | |||||||||
| Hezinger Algaetec GmbH | Biotech | Development, Trade/Distribution | Development, production and distribution of installations for the cultivation of microalgae on an industrial scale | Kornwestheim | Steffen Hezinger (CEO) Timo Enderle | 2007 | Max-Planck-Straße 1 70806 Kornwestheim Tel: +49 (0)7154 8208-80 Fax: +49 (0)7154 8208-88 | algaetec@hezinger.net | www.hezinger-algaetec.com | Hezinger Algaetec was founded in 2007 with the aim of developing and producing installations for the industrial cultivation of microalgae and distributing these worldwide. The company plans and supplies the entire production chain – from algae cultivation to biomass utilization – as a complete, customized system. The key components of the installations are the photobioreactors, which the company develops in-house. The premise of the procedure developed by Hezinger Algaetec is to utilize as little artificial energy (e.g. electricity) as possible in the system. The main source of energy for the bioreactors is natural sunlight, the use of which ensures that industrial algae cultivation is cost-effective, environmentally friendly and results in a positive energy balance. Hezinger Algaetec works closely with well-known biology, light engineering and planning specialists in order to ensure perfect results in the development and production of photobioreactors. | |||||||
| Hohenstein Institutes Bönnigheim | Institute | Services, Development, Education | Contract research, testing, certification and consulting | Bönnigheim | Dr. Stefan Mecheels (Management) | Castle of Hohenstein 74537 Bönnigheim Tel.: +49(0)7143-2710 Fax: +49(0)7143-27151 | info@hohenstein.de | www.hohenstein.de | The Hohenstein Institutes are internationally recognised research and service centres. Companies and businesses along the entire textile chain, and in numerous other associated areas, benefit from the skills of the Hohenstein experts in research, development, testing, consulting, certification and all types of training. The core competences of the Hohenheim Institute of Hygiene and Biotechnology include: * hygiene and microbiological investigations (hygiene management) * safety testing (skin compatibility) * activity testing (antimicrobial surfaces) * efficacy testing (transfer of cosmetically and medically active substances, wound dressings) | Dr. Dirk Höfer, Head of the Institute of Hygiene and Biotechnology (d.hoefer@hohenstein.de) | |||||||
| Hölle & Hüttner AG | Biotech | Services, Laboratory Techniques, Information Technology, Process Engineering | Information technology – optimisation of processes and products and subsequent improvement in companies’ ability to deliver quality | Tübingen | Dr. Steffen Hüttner Peter Beck | 1992 | Derendinger Strasse 40 72072 Tübingen Germany Tel.: +49 (0)7071-9761-1 Fax: +49 (0)7071-9761-90 | lifescience@h-net.com | www.h-net.com | Hölle & Hüttner AG specialises in the implementation of new technologies and complex issues in science and technology-related projects. Hölle & Hüttner’s portfolio embraces more than 300 projects in over 10 countries. Hölle & Hüttner AG is a pioneer in the combination of life sciences and information technology, aimed at automating workflows. Its areas of focus lie in laboratory information and production systems, control software, the operation of laboratory equipment, integration issues, archiving and document management based on established standards. Hölle & Hüttner AG’s headquarters are located in Tübingen, while the firm has branch offices in Munich, Cologne, Manchester (UK) and Houston (USA). | Dr. Steffen Hüttner | 26 | QM system compliant with ISO 9001ff | Effects of heat-shock proteins (HSP) on wound healing | |||
| HORO Dr. Hofmann GmbH | Medtech | Medical Technology, Trade/Distribution, Laboratory Techniques | Production of heating cabinets, heated chambers and laboratory burners | Ostfildern | Gerhard Bosch | 1945 | Rudolf-Diesel-Strasse 8 73760 Ostfildern Germany Tel.: +49 (0)711-3411059 Fax: +49 (0)711-3482708 Lortzingstr. 6 72336 Balingen | info@horo-dr-hofmann.de | www.horo-dr-hofmann.de | Manufacture and marketing of Electrical laboratory burners Heated cabinets/chambers Drying cabinets/chambers Ultra-dry cabinets Refrigerators and incubators Special constructions as per customers’ wishes | Gerhard Bosch | 20 | |||||
| Hutzel DrehTech GmbH | Medtech | Medical Technology | Production of precision turned parts | Steinenbronn | Jochen Gabriel (President) | 1948 | Gewerbestraße 5 71144 Steinenbronn Germany Phone: +49 (0)7157-5246-0 Telefax: +49 (0)7157/5246-33 | Info@hutzel.de | www.hutzel.de | The company was founded in 1948 by Gustav Hutzel. The present-day Hutzel group consists of five supplier companies: Hutzel DrehTech GmbH in Steinenbronn in Stuttgart, Hutzel-Seidewitztal GmbH in Liebstadt in Dresden, Hutz-EL s.r.o. in Klasterec n.O. in the Czech Republic, HandlingTech Automations-Systeme GmbH in Stuttgart, and Waldmann & Weigl GmbH in Stuttgart The company manufactures ready-to-assemble precision turned parts from 1-200 mm in diameter and up to approximately 1000 mm in length from all machinable materials, including titanium and zirconium. The turned parts are primarily used in the automotive industry, medical technology (dental medicine, orthopaedics, hearing implant technology, and medical instruments), the armaments industry and mechanical engineering. In addition, HandlingTech develops automation solutions. | 310 (across all branches) | ||||||
| ibt - immunological & biochemical testsystems GmbH | Biotech | Development, Diagnostics | Development and production of innovative immunoassays | Reutlingen | Aspenhaustrasse 25 72770 Reutlingen Germany Tel: +49 (0)7121-514634 Fax: +49 (0)7121-514635 | info@ibtsystems.de | www.ibtsystems.de | The company, founded as A.F. Schützdeller, Biochemicals (AFSBIO), developed, produced and sold poly- and monoclonal antibodies, proteins and antigens for research into infectious diseases, transcription research, cytokines and growth factors. Shifting its area of focus onto the development and production of innovative immunoassays based on non-radioactively-marked IGFs, the firm renamed itself ibt – immunological & biochemical testsystems GmbH. The firm’s scientific focus currently lies on the field of insulin-like growth factors (IGFs) and insulin-like growth factor binding proteins (IGFBPs). A special biotinylation technology, which ensures the binding of ligands to IGFBPs, IGF receptors and antibodies, is used in the manufacture of biotinylated IGFs and analogue substances. Areas of application for biotinylated IGFs and analogue substances include binding assays, immunoassays, Western ligand blots, immunohistochemistry, immunoprecipitation, flow cytometry and cross-linking experiments. | |||||||||
| IDENTXX GmbH | Biotech | Services, Development, Ecology/Environment | Early detection of infected seeds using DNA probe technology | Stuttgart | Frank Brändle (Managing Director) | IDENTXX GmbH Maybachstrasse 50 70469 Stuttgart Pflanzenschutz FON +49 (0)711 93343651 Herbologie FON +49 (0)711 93343653 Labor FON +49 (0)711 93343654 FAX +49 (0)711 93343659 | info@identxx.de | www.iden | With state-of-the-art biomolecular methods the young company IDENTXX meets the challenge to sustain and improve crop health. Only an exact and reliable identification of pathogens and resistances in seeds and plants can avoid crop damage and yield losses. IDENTXX develops tailor-made solutions in diagnostics for weed science and plant protection. Our services focus on the detection of plant pathogens and herbicide resistances, for which the latest biomolecular methods are applied. The methods are individually and continuously adapted to the problem at hand. The services of IDENTXX benefit clients in the sectors of agricultural production of arable and special crops as well as ornamentals. It may play a key role in improving seed production, plant breeding, development of plant protection products, and is targeting agricultural associations and public authorities. IDENTXX runs its own brand-new laboratory and greenhouses under the direction of experienced specialists. Hence, it enables the application of the latest biomolecular technologies in combination with classical greenhouse testing. | ||||||||
| IEG Industrie Engineering GmbH | Biotech | Ecology/Environment | Remediation of contaminated sites and environmental technology | Reutlingen | 1976 | Lilienthalstrasse 6 72770 Reutlingen Germany Tel.: +49 (0)7121-568150 Fax: +49 (0)7121-504824 | sales@ieg.org | www.ieg.org | Founded in 1976 as a general mechanical and systems engineering office, the firm’s focus gradually shifted to the field of contaminated site remediation and environmental technology. IEG performed pioneering work in the development of in situ circulation systems for remediating soil and groundwater, begun in 1986. In the field of mechanical engineering, IEG is the leading supplier of calculation programs and services in the engineering sector, in particular for gear systems. | ||||||||
| ifex – Initiative for Start-Ups and Business Transfer | Service | Services | Supporting company foundations and securing company successions | Stuttgart | Prof. Peter Schäfer (Director) | Theodor-Heuss-Str. 4 D-70174 Stuttgart Tel.: +49(0)711-1232786 | ifex@wm.bwl.de | www.newcome.de, www.wm.baden-wuerttemberg.de | The Baden-Württemberg government sees the promotion of company foundation and the securing of company successions as central issues in its small- and medium-sized businesses policy. In 2001, the Baden-Württemberg parliament decided on the permanent continuity of the Initiative for Start-Ups and Business Transfer (ifex) following the recommendation of the “Mittelstand” survey committee. ifex has been run by the Baden-Württemberg Ministry of Economic Affairs since 1st July 2004 and is part of the “Start-up and Business Transfer / ifex" division (no. 33). ifex has a network of approximately 1400 institutions, chambers, associations, business development organisations, universities, schools, authorities and representatives from private companies. These cooperation partners and their innovative ideas contribute to the new company foundation culture. ifex has developed diversified information, qualification and consultation services. ifex initiates state-wide campaigns and competitions, new ways of assistance and concerted actions. Projects and partners are coordinated on the regional as well as international levels. In addition, ifex also supports information, qualification, consultation, coaching and target-group specific model projects and regional projects being carried out by partner organisations. | ||||||||
| immatics biotechnologies GmbH | Biotech | Development, Drug Development, Medicine | Immune therapy, oncology | Tübingen | Paul G. Higham (CEO) Dr. Carsten Reinhardt (CMO) Dr. Harpreet Singh (CSO) | 2000 | Paul-Ehrlich-Strasse 15 72076 Tübingen Germany Tel. +49 (0)7071-5651250 Fax +49 (0)7071-56512599 | info@immatics.com | www.immatics.com | immatics is a biopharmaceutical company dedicated to the development of innova¬tive cancer immunotherapeutics. immatics' proprietary technology for the identification of tumor-associated pep¬tides (TUMAPs) enables the development of novel anti-cancer vaccines for multiple cancer indications. immatics is currently developing two multi-TUMAP products in clinical phase II studies – IMA901 for the treatment of renal cell carcinoma (RCC) and IMA910 for the treatment of colorectal carcinoma (CRC). Further product candi¬dates are currently in pre-clinical de¬velopment. With its unique proprietary XPRESIDENT™ discovery platform, immatics is constantly identifying very large numbers of naturally-presented tumor-associated peptides (TUMAPs) directly from primary tumor tissue. Since 2004 alone, the company has identified more than 50,000 TUMAP sequences and has secured the IP rights for those with high potential for use in cancer therapy. immatics identifies TUMAPs which occur as natural ligands of HLA class I and II-receptors. These TUMAPs can activate cyto¬toxic T cells and T helper cells, key players of the cellular immune response, which have the ability to eradicate cancer cells once they are primed effectively. TUMAPs are short peptides which are excellent drug candidates. They can be syn¬thesized and characterized by established, robust and fully scalable chemistry. | Dr. Harpreet Singh | 65 | “PROstat – regenerating micturition function in benign prostatic hyperplasia through immune therapy” Identification, selection and validation of tumour-related peptides in stomach carcinomas aimed at defining a therapeutic vaccine based on immunogenic peptide epitopes. | Prof. Hans-Georg Rammensee Prof. Cornelius Melief Prof. Christoph Huber Prof. Craig Slingluff | |||
| Improvision Deutschland | Biotech | Imaging, Trade/Distribution, Information Technology | Development and distribution of software and systems for scientific imaging applications | Tübingen | Vor dem Kreuzberg 17 72070 Tübingen Germany Tel.: +49 (0)7071-7936 990 Fax: +49 (0)7071-7936 992 | adminde@improvision.com | www.improvision.com | Improvision was founded in 1990 and is now part of PerkinElmer Inc., a global leader in healthcare research solutions. Based in the UK, Improvision develops cell imaging software systems in the field of microscopy including Volocity, the market-leading software system for 3D and 4D imaging of cell structure and functions. Improvision products are used by scientists all over the world to further our understanding of the causes, prevention and treatment of diseases such as cancer, Alzheimer’s disease, and Cystic Fibrosis. | |||||||||
| Inmedea GmbH | Biotech | Development, Medical Technology, Imaging, Information Technology | Development of a medical training programme | Reutlingen | Angelika Schäfer | 2006 | Gerhard-Kindler-Str. 6 72770 Reutlingen Tel: +49 (0) 7121-12706-0 Fax +49 (0) 7121-12706-20 | info@inmedea.com | www.inmedea.com, www.prometheus.uni-tuebingen.de | Inmedea GmbH is currently developing Prometheus, a teaching and training system that offers a realistic hospital simulation. The virtual hospital features various departments, each with typical patients, and a virtual multimedia library. The library includes a large collection of texts, tutorials, training programmes and reference works and offers a platform for acquiring theoretical knowledge, which is then applied in the virtual clinic and translated into expertise for use in real-life scenarios. The Prometheus project was funded up to 2003 as part of the German Federal Ministry of Education and Research (BMBF) "New Media in Education" initiative. The idea and concept behind the solution were developed by a working group from the Department of Neuroradiology at the University of Tübingen headed by Professor Voigt. | Angelika Schäfer, MD with responsibility for student learning; Franz Gerstheimer, MD with responsibility for CME | ||||||
| Insilico Biotechnology AG | Biotech | Development, Laboratory Techniques, Information Technology | System biological research | Stuttgart | Klaus Mauch | 2001 | Nobelstrasse 15 70569 Stuttgart Germany Tel.: +49 (0)711-674 2164 Fax: +49 (0)711-674 2166 | info@insilico-biotechnology.com | www.insilico-biotechnology.com | Insilico Biotechnology designs and optimizes biotech processes for the chemical, pharmaceutical, agricultural and food industries. Insilico boasts internationally recognized expertise and the world's only system biology platform combining proprietary databases, cell models and computer-controlled evaluation methods. By integrating and evaluating experimental data using genome-wide network models, Insilico offers new solutions for manufacturing biochemicals and biopharmaceuticals, validates active substances and reduces drug development periods. Founded as a spin-off of the University of Stuttgart in 2001, Insilico currently employs eight staff. The company, which was converted into a joint-stock company in July 2006, is headed by Klaus Mauch. Since 2005, Insilico Biotechnology AG as an industrial partner in the federal HepatoSys competence network has been performing computer-based mapping and testing of liver cell metabolism. Insilico is responsible in particular for determining kinetic parameters using supercomputers. The aim is to model a »virtual liver cell« to enable physiological cell processes – such as the breakdown of drugs and toxic substances – to be followed »in silico«. For the second project phase, Insilico will receive Euro 250,000 of funding over the next three years. | Klaus Mauch | 8 | Prof. Matthias Reuss Prof. Rolf D. Schmid Prof. Bernard Witholt Prof. Dr. Stefan Schuster | ||||
| Institut Dr. Lörcher | Biotech | Services, Chemistry, Ecology/Environment | Chemical and microbiological analytics | Ludwigsburg | Dr. Klaus-Peter Lörcher | 1979 | Martin-Luther-Str. 26 D-71636 Ludwigsburg Tel.: +49 (0)7141-975700 Fax: +49 (0)7141-9757070 | www.loercher.de | Dr. Klaus-Peter Lörcher established his institute in Ludwigsburg in 1979 with authorisation from the Stuttgart Region Chamber of Commerce and Industry for analytical chemistry, water, wastewater and waste chemistry. Dr. Lörcher’s institute specifically focuses on chemical analytics, organic trace analysis, dioxin and metal analysis, swimming pool, compost and solid matter analytics, microbiology, indirect discharger cadastre and compartment air analyses, landfill surveillance, quality control of sewage sludge, expert opinions on fire loss, house and commercial waste to name just a few of the analyses offered. In early 2008, Dr. Lörcher was accredited by DIN CERTCO Gesellschaft für Konformitätsbewertung mbH, which has enabled him to carry out assessments into the environmental effects of synthetic turf, plastic coating for outdoor sports grounds and the investigation of wood pellets made of unchanged natural wood for use in small fireplaces. | ||||||||
| Institut Pieldner GmbH | Biotech | Services, Chemistry, Genomics, Education | Services in the food chemistry and food micro/molecular biology sectors | Stuttgart | Horst U. Pieldner (proprietor) | Julius-Hölder-Str. 20 70597 Stuttgart Phone: +49 (0)711 722094-0 Fax: +49 (0)711 722094-15 | info@ipdp.de | www.ipdp.de | Based in Stuttgart-Degerloch, the Institut Prof. Dr. Pieldner has been an established name in the fields of chemical, microbiological and genetic food testing for 40 years. This accredited institute supports a wide range of companies involved in the manufacture and trading of foodstuffs, cosmetics and articles of daily use. The company focuses on customised support to ensure product hygiene and uses state-of-the-art testing procedures. In addition to its role as a testing laboratory, the Institut Prof. Dr. Pieldner also offers its customers a high standard of comprehensive advice and support. This enables precise checking of compliance with complex food-law requirements and identification of any further problem areas. As well as seminars and training courses to provide information about food law, hygiene and food safety, the company also offers comprehensive on-site monitoring of workplaces throughout Germany. | Horst U. Pieldner (state-certified food chemist); Tanja Pieldner (state-certified food chemist) | |||||||
| Institut Prof. Dr. Jäger | Biotech | Services, Chemistry, Ecology/Environment, Laboratory Techniques | Environmental analysis | Tübingen | Dr. Walter Jäger | 1977 | Ernst-Simon-Strasse 2-4 72072 Tübingen Germany Tel.: +49 (0)7071-70070 Fax: +49 (0)7071-700777 | Institut@institutdrjaeger.de | www.institutdrjaeger.de | The laboratory’s main area of focus lies on chromatographic analysis methods (GC, LC, HPLC) and in particular the determination of halogenated aliphats, aromates, phenolic compounds and so on as single substances (PCP, PCB, HCB, pesticides, etc.) and as sum parameters (AOX, EOX, AOS, TON, TOP, TOSI etc.), the taking of samples and the analysis of dioxins and furanes. The company is based in Tübingen, with field offices in Konstanz, Villingen-Schwenningen and Weimar. | Approx. 65 | All required quality assurance certificates | |||||
| Institute of Textile Technology and Process Engineering Denkendorf ITV | Institute | Development | Research and development in all areas of textile technology and textile machinery construction, biomedical technology, management research | Denkendorf | Prof. Heinrich Planck; Director of the Institute and Head of the Biomedical Technology Division | Körschtalstrasse 26 73770 Denkendorf Germany Postal address: Postfach 11 55 73766 Denkendorf Germany Tel.: +49 (0)711-9340–0 Fax: +49 (0)711-9340-297 | info@itv-denkendorf.de | www.itv-denkendorf.de | The ITV Denkendorf has its roots in Reutlingen where, in 1855, following an initiative from the industry sector, the City of Reutlingen and the Kingdom of Württemberg, a weaving school was founded from which a professional college for spinning, weaving and knitting was formed in 1891. In 1910, the college was extended to include a testing office, with a research institute being added in 1921. As part of its joint industrial research, the ITV Denkendorf supports small to medium-sized companies in their quest to tackle research and development problems. The firm’s divisions, which essentially encompass the entire domain of textile technology and associated specialities, also focus on this key mission. The ITV is part of the German Institutes of Textile and Fibre Research (DITF) in Denkendorf, a research centre that focuses comprehensively on the requirements of the textile industry. The ITV Denkendorf’s research and development work, along with its measuring, testing and certification activities, are carried out in the following areas and focus fields: Staple fibre technology/filament yarn finishing/knitting technology/fleece technology/weaving technology sustainable raw materials/plant fibres Technical textiles/surface technology/environmental technology, biomedical technology, including tissue engineering, medical products, implants, plus material and implant testing Process control/automation/measuring technology | Hendrik Hauss (Hendrik.Hauss@itv-denkendorf.de) | Associated project: liver reactor; subproject A | ||||||
| Interfaculty Institute for Biochemistry (IFIB) | Institute | Development, Chemistry | Interdisciplinary biochemical and biomedical research | Tübingen | Prof. Dr. Thilo Stehle (Institute Director) Dr. Klaus Möschel (Managing Director) | Hoppe-Seyler-Str. 4 72076 Tübingen Tel.: +49 (0)7071-2973341 | klaus.moeschel@uni-tuebingen.de | www.ifib.uni-tuebingen.de | The Interfaculty Institute for Biochemistry (IFIB) at the University of Tübingen was established in 2004 by the Faculty of Chemistry and Pharmacy and the Faculty of Medicine with the goal of carrying out interdisciplinary biochemical and biomedical research. In addition, the IFIB is closely linked with the Centre of Plant Molecular Biology (ZMBP) in Tübingen. Modern biochemical and biomedical research focuses on complex issues. Cooperation between different groups of researchers around the world is therefore absolutely necessary. The IFIB participates in many international collaborations and is part of numerous research networks. | ||||||||
| International Reference Centre DNA Viruses | Institute | Development, Medicine, Genomics | International reference centre for the genomics and diagnosis of viruses with small circular DNA | Stuttgart | Prof. Dr. Holger Jeske | Universität Stuttgart Biologisches Institut Pfaffenwaldring 57 D-70550 Stuttgart Tel. +49 (0)711-68565070 | holger.jeske@bio.uni-stuttgart.de | www.uni-stuttgart.de | Researchers at the University of Stuttgart, in cooperation with two academic groups led by Prof. Dr. Eduardo Rodríguez Bejarano, Universidad de Malaga, and Dr. Bruno Gronenborn, Institut des Sciences du Végétal, Paris along with the company Qiagen as industrial partner and specialist in diagnostic test methods, have been operating an international virus reference centre since 2007. The centre receives a total of 1.2 million euros in funding from the EU for a period of three years, of which 600,000 euros go towards the research carried out by the Stuttgart researchers. A major focus of the centre is the establishment of a gene bank to store and characterise viral DNA from across the globe. The Stuttgart scientists are specifically focusing on Gemini viruses with a two-component genome, the Spanish scientists are working on Gemini viruses with a one-component genome and the French scientists are researching nanoviruses. All these viruses are known to cause numerous plant diseases. | ||||||||
| IP-Innovatives Planen-GmbH | Biotech | Services, Medical Technology, Process Engineering | Clean-room planning | Neckartenzlingen | Christian Hage (Managing Director) | 1992 | Robert-Bosch-Strasse 15 72654 Neckartenzlingen Germany Tel.: +49 (0)7127-9370-3 Fax: +49 (0)7127-9370-55 | info@ip-planung.de | www.ip-planung.de | IP-Innovatives Planen-GmbH specialises in the planning of clean-room plants and technical equipment for buildings, from design to start-up. The company integrates modern ventilation concepts and innovative energy solutions into clean-room environments. | 15 | ||||||
| JatroSolutions GmbH | Biotech | Services, Development, Ecology/Environment | Development of concepts for the integrated production of biofuels and animal feed on waste land | Stuttgart | Prof. Dr. Klaus Becker (Managing Director) Dr. George Francis (Director of Research and Business Development) | Wollgrasweg 49 70599 Stuttgart-Hohenheim Tel.: +49 (0)711-451071420 Fax: +49 (0)711-451071421 | www.jatrosolutions.com | The company’s key focus area is Jatropha curcas, an oil seed plant that is indigenous to almost all tropical countries and that grows on poor soils in extreme climatic conditions. Due to its versatility, the plant is well suited to the production of biofuels, the recultivation of waste land, CO2 sequestration as well as to the creation of local jobs and income. JaotroaSolutions develops concepts for sustainable development in the tropics and subtropics as well as offering comprehensive process-oriented consulting and supporting the development of international trade relationships. | |||||||||
| JOLINE GmbH & Co. KG | Medtech | Development, Medical Technology | Production of catheters for use in dialysis | Hechingen | Wilfried Hermes, Head of Sales & Marketing Karl-Heinz Klotz, Head of Development Dr. Anselm Steegers, Head of Quality Management Thomas Müller, Head of Production | 1999 | Neue Rottenburger Strasse 50 72379 Hechingen Germany Tel.: +49 (0)7471-98810 Fax: +49 (0)7471-9881111 | info@joline.net | www.joline.de | The company, founded in 1999 by Lars Sunnanväder, specialises in the production of various catheters for use in dialysis and sells its products worldwide. Single-lumen, double-lumen and triple-lumen catheters are manufactured for use in acute dialysis. For chronic dialysis, the company produces single- and double-lumen silicon catheters in order to ensure maximum biocompatibility. | CE mark, ISO certification | ||||||
| Joma-Polytec Kunststofftechnik GmbH | Medtech | Medical Technology | Development and production of technical plastics parts | Bodelshausen | Alexander Maute Dr. Hans-Ernst Maute Katherina Maute | 1958 | Robert-Bosch-Str. 4 D-72411 Bodelshausen Tel.: +49 7471 706-0 Fax: +49 7471 726-61 | info@joma-polytec.de | www.joma-polytec.de | The company Joma-Polytec GmbH was established in 1958 as Joma-Plastik GmbH; it was later renamed Joma-Polytec Kunststofftechnik GmbH. The company offers a broad range of technical plastics parts and solutions in the field of toolmaking and plastics processing. Joma-Polytec has core competences in the automotive industry, the medical technology sector and the construction industry as well as in process and control technology. Joma-Polytec is ISO 9001, ISO 14001, ISO/TS 16949 and ISO 13485 certified. It owns numerous national and international patents, in particular in the automotive sector. | 334 (12/2007) | ||||||
| JOTEC GmbH | Medtech | Development, Medicine, Medical Technology, Process Engineering | Development and production of vessel prostheses and stenting systems | Hechingen | Thomas Bogenschütz, CEO | 2000 | Lotzenäcker 23 72379 Hechingen Germany Tel.: +49 (0)7471-9220 Fax: +49 (0)7471-922100 | info@jotec.net | www.jotec.net | Since 2000, the medical technology firm has been developing and producing various systems that can be used to treat vascular diseases. Its portfolio of products includes vessel prostheses made from ePTFE and polyester. Coating technologies involving collagen and heparin reduce the risk of thrombosis. The firm also supplies stents, stent prostheses and various insertion systems that are designed based on its experience of nitinol and catheter technologies. In the field of tissue engineering, JOTEC offers a patch made from a micro-porous collagen matrix and collagen membrane (Matricart) that helps in the creation of autologous cartilage implants. | 125 | In vivo endothelialisation of vessel prostheses through coating with DNA aptameres as catcher molecules for endothelial progenitor cells (EPC). | |||||
| Kas. Haiss KG | Medtech | Medical Technology | Production and distribution of blood pressure monitors and other medical devices | Jungingen | 1919 | Postfach 7 Hochmeisterstrasse 17 72417 Jungingen Germany Phone: +49 (0)7477-1023 Fax: +49 (0)7477-1758 | The company, which was founded in 1919, produces and distributes a variety of blood pressure monitors, as well as compression devices for ischemia, dynamometers, salpingographs, lumbar puncture devices, pressure sleeves and stethoscopes. It also produces customized pressure gauges and valves for a wide range of applications. | ||||||||||
| Käthe Kollwitz School | Service | Services | Education of schoolchildren | Esslingen | Thomas Fischle Roland Conradt | Steinbeisstr. 17 73730 Esslingen Tel.: +49(0)711-3607400 Fax: +49(0)711-3607444 | kks-es@web.de | www.kks.es.schule-bw.de | The Käthe Kollwitz School in Esslingen has around 800 pupils. The school brings together a large number of types of schooling under one roof, including a biotechnological grammar school, a grammar school focusing on nutrition, a vocational school focusing on nutrition and housekeeping, a dual vocational school focusing on social affairs (part-time) and two-year vocational schools (nutrition, gastronomy, nutrition and housekeeping, health and patient care, laboratory technology) as well as a vocational school focusing on housekeeping and social pedagogy. In the 2001/2002 school year, Baden-Württemberg was the first German state to take account of the growing importance of biotechnology at grammar schools, which led to the establishment of “biotechnological grammar schools.” The new course, as offered by the Käthe Kollwitz School in Esslingen, is designed to strengthen the profile of the natural sciences and to boost young people’s interest in biotechnology, a sector which looks to have a promising future. Biotechnology grammar schools offer a six-hour biotechnology profile course, which is complemented by bioinformatics, chemistry and special biosciences areas and practical courses. | ||||||||
| KaWe Germany - KIRCHNER & WILHELM GmbH & Co. KG | Medtech | Medical Technology | Production and distribution of medical products | Asperg | Regina Kirchner (Managing Director) | 1890 | Eberhardtstrasse 56 71679 Asperg Germany Phone: +49 (0)7141-68188-0 Fax: +49 (0)7141-68188-11 | info@kawemed.com | www.kawemed.com | Founded by Gustav Kirchner and Hugo Wilhelm in 1890 in Stuttgart, the company has been certified to DIN EN 9001 and 13485 since 1997. For over a century, the company’s philosophy has been based around innovation, the highest quality standards and attractive, state-of-the-art products that offer the optimal price-performance ratio. Its product portfolio includes otoscopes, diagnostic sets, laryngoscopes, sphygmometers, iontophoresis devices, stethoscopes, reflex hammers, tuning forks, infusion stands and examination lamps. | |||||||
| KISTERS AG | Biotech | Ecology/Environment, Information Technology | Software solutions for resource management, environmental protection and safety; software-based quality-assurance documentation for the life sciences and health care sectors. | Tübingen | Klaus Kisters (Chairman, CEO) Hanns Kisters (COO) | 1963 as Ingenieurbüro Kisters | Biesinger Strasse 10 D-72070 Tübingen Tel.: +49 (0)7071 40711-0 Fax: +49 (0)7071 40711-90 Company headquarters Charlottenburger Allee 5 52068 Aachen | info@klisters.de | www.kisters.de | As a company that began by specialising in environmental information technology, KISTERS AG develops and sells software solutions for resource management, environmental protection and safety. The company has several branches throughout Germany, as well as in France, Spain, Australia, China and the U.S. The takeover of the Tübingen-based energie & concept GmbH in July 2007 has opened up new opportunities for KISTERS in the life sciences and health care sectors. In the past, energie & concept has primarily addressed the growing demands associated with documentation regulations and clinical quality assurance. Haematology/oncology and stem cell transplantation are key focal points, with clinics throughout Europe required to obtain JACIE accreditation for their quality standards. The KISTERS branch in Tübingen therefore focuses on end-to-end, software-based, quality-assured documentation, diagnosis, and treatment and care planning associated with in- and out-patient care in clinics. It also aims to strengthen its position in other areas related to life sciences and health care. | 250 at 10 sites worldwide (as of 2007) | ||||||
| Kopp Verpackungssysteme - Inh. Ludwig P. Goller | Medtech | Medical Technology | Production and distribution of packaging machinery/equipment | Reichenbach an der Fils | Ludwig P. Goller, Götz Goller (Managing Directors) | Ulmer Strasse 51 - 53 73262 Reichenbach / Fils Germany Phone: +49(0)7153-9510-0 Fax: +49(0)7153-9510-100 | info@kopp-online.de | www.kopp-online.de | The company’s extensive product portfolio includes a wide variety of foil welding machines, heat sealing machines, shrink wrapping units, vacuum packaging machines, automatic and semi-automatic packaging machinery and suitable consumables such as bags and foils. KOPP also offers foil-welding equipment with check functions for validating e.g. sterilized goods packaging to ISO 11607 and EN 868. Developed specifically for use in laboratories, the ‘Labormaster 3000’ enables sealing seam strength testing (hot-tack and cold-tack) in research, development and quality control. KOPP has developed the SGPE 3000 laboratory sealing machine for seals with precise parameters. | ||||||||
| LAZ Prof. Dr. H. Hamacher - Laboratorium für Arzneimittelprüfung und Zulassungsberatung | Biotech | Services, Development | Quality testing of pharmaceutical source materials, finished products and packaging materials. Development and validation of testing methods. Stability analyses. | Tübingen | 1984 | Dischinger Weg 15 72070 Tübingen Germany Tel.: +49 (0)7071-791163 Fax: +49 (0)7071-791598 | LAZ-Prof.Hamacher@t-online.de | www.laz-labor.de | With over 20 years of experience, the Laboratory for Testing Medicinal Products and Registration Advice (LAZ) is a pioneer in the area of pharmaco-analytical services and has built up exceptional specialist and advisory know-how in the development and registration of medical products. Its portfolio of analytical services includes the development and validation of testing methods, the implementation of quality control measures, compatibility and stability studies for medical products, the determination of residues, the characterization/structural analysis of impurities, microbiology and bioanalytics. All services are provided in strict accordance with current national and international regulatory requirements and under GMP-compliant conditions. The consultancy services of the LAZ cover all aspects of quality assurance related to the development and registration of medical products, the creation and appraisal of documentation and the management of regulatory procedures. | 11 | |||||||
| LBBW Venture Capital GmbH | Service | Services | Provision of capital for start-up companies and expanding companies | Stuttgart | Harald Fuchs (CEO) | Königstraße 10 C D-70173 Stuttgart Tel.: +49(0)711-30589200 (switchboard) | Zukunft@lbbw-venture.de | www.lbbw-venture.de | LBBW Venture Capital GmbH is an investment company providing innovative companies with the economic framework for the growth of ideas and business models with a promising future. The company invests primarily in the fields of information technologies, innovative services, industrial technologies and life sciences. The geographic investment hotspot is southern Germany. The company provides financial support in the start-up, expansion and pre-IPO phases. The LBBW Venture Capital GmbH network includes specialised VC partners as well as specialist solicitors, auditors, and experts from a broad range of disciplines. | ||||||||
| LEHNER GmbH SENSOR-SYSTEME | Biotech | Development, Ecology/Environment, Information Technology, Process Engineering | Development of specific sensor systems | Kirchheim unter Teck | Rolf-Peter Lehner (Managing Director) | 1990 | Kruichling 31 73230 Kirchheim/Teck Germany Tel.: +49 (0)7021-97013-0 Fax. +49 (0)7021-97013-33 | info@lehner-gmbh.com | www.lehner-gmbh.com | Lehner GmbH Sensor-Systeme was founded in 1990 by Rolf-Peter Lehner. Its traditional focus is on printing processes in the graphic arts industry, but the company now also develops specific sensor systems geared to the requirements and challenges of other customer sectors, including biotech research institutes. For example, the company has joined forces with scientists from the Institute for Biology II at the University of Freiburg and other partners to develop and produce a modular measuring instrument for the continuous cultivation and analysis of biological material. | |||||||
| Life Science Center Hohenheim (LSC) | Institute | Services, Development, Genomics | Life sciences research with a special focus on the food chain – from production to consumer behaviour, as well as biological signals. | Stuttgart | Prof. Dr. Andreas Schaller (Director) Dr. Caroline Liepert (Managing Director) Prof. Dr. Andreas Kuhn (Spokesperson Division 1) Prof. Dr. Herbert Schmidt (Spokesperson Division 2) Prof. Dr. Thilo Streck (Spokesperson Division 3) | Fruwirthstraße 12 D-70599 Stuttgart Tel.: +49 (0)711-45924026 | lsc@uni-hohenheim.de | www.lsc.uni-hohenheim.de | The Life Science Centre (LSC) is a research centre attached to the University of Hohenheim that is directly assigned to the University’s rectorate. It offers life science-oriented disciplines a central platform for research projects and scientific developments. The LSC has a special focus on the food chain and hopes to advance its work through inter- and transdisciplinary approaches. In addition, the Centre also supports bordering basic-research oriented sciences, in particular in the field of biological signals. In analogy to the thematic research priorities of the Centre, the LSC has three scientific divisions: Division 1: Biomolecular signals and genomics Division 2: Quality and biofunctionality of food Division 3: Ecosystems and resource management The LSC has a central service unit that uses state-of-the-art methods and devices for genome and proteome analysis. | ||||||||
| M+W Process Industries GmbH | Biotech | Services, Medical Technology, Chemistry, Trade/Distribution, Laboratory Techniques | Planners and systems engineers specialising in the life sciences industry | Stuttgart | Hermann Schwarzkopf (Managing Director) Dr. Tobias Lücke (Managing Director) | 1995 | Lotterbergstrasse 30 70499 Stuttgart Germany Tel.: +49 (0)711-8804-1800 Fax: +49 (0)711-8804-1888 | www.mwgroup.net | Stuttgart-based M+W Process Industries GmbH -formerly LSMW GmbH- is a planner and systems engineer which specializes in the requirements of the life sciences industry. It offers solutions for large, medium-sized and start-up companies in the pharmaceuticals, biotechnology, fine chemicals, chemical, medical products, foodstuffs and cosmetics industries. The company’s range of services comprises consulting, planning, implementation, qualification/validation and technical facility management for the construction of new or conversion of existing buildings. | 344 (as of Jan. 2007) | |||||||
| Malvern Instruments | Biotech | Trade/Distribution, Laboratory Techniques | Malvern Instruments is a global company that develops, manufactures and markets advanced analytical systems used in characterizing a wide variety of materials, from bulk powders to the latest nanomaterials and delicate macromolecules. | Herrenberg | Dr. Mark Wingfield | Year of Foundation in Germany 1994 | Rigipsstr. 19 71083 Herrenberg Germany Tel.: +49 (0)7032 97770 Fax: +49 (0)7032 77854 | sales@malvern.de | www.malvern.de | The key role of particulate materials throughout the biotech and pharmaceutical industry drives Malvern Instruments' close involvement in drug discovery, development and manufacture. As suppliers to the industry, we seek to work alongside our pharmaceutical partners and customers. In this way, we can understand and anticipate concerns and be aware of emerging trends. Measurement of particle size and particle charge (zeta potential) are two important diagnostic techniques that can give the scientist useful information about the conformation of their macromolecules. Innovative technologies and powerful software produce systems that deliver industrially relevant data enabling customers to make the connection between micro (eg particle size) and macro (bulk) material properties (rheology) and chemical composition (chemical imaging). Malvern laboratory, on-line and in-line solutions are proven in sectors from cement to pharmaceuticals and support the understanding, improvement and optimization of many industrial processes. Headquartered in Malvern, UK, the company has subsidiary organizations in all major European markets, North America, China, Korea and Japan, key partnerships in India, a global distributor network and a number of applications laboratories around the world. Malvern Instruments is a subsidiary of Spectris plc, the precision instrumentation and controls company. | |||||||
| Manz Automation Tübingen GmbH | Biotech | Automation Solutions | Automation solutions for the life science sector | Tübingen | Albrecht Werner (Managing Director) | Manz Automation Tübingen GmbH: 2008 | Jopestrasse 14 D-72072 Tübingen Tel.: +49 (0) 7071-948 170 Fax: +49 (0) 7071-948 103 | lab@manz-automation.com | www.manz-automation.com | Manz Automation Tübingen GmbH, through its business division ‘systems.lab’, offers innovative automation solutions to the life science sector. By integrating industry standards, the company guarantees reliability and operational safety of the systems developed. In addition, individual, modular concepts enable the realisation of client-specific solutions in small and medium quantities. As part of an asset deal in 2008, software, patents and know-how of CyBio Robotics GmbH – formerly accelab GmbH – were integrated into the division, thereby enabling systems.lab to combine construction, software development, mechanical production, assembly and service under one roof. | Dr. Berend Oberdorfer (Product Manager systems.lab) | 125 | |||||
| MAQUET Cardiopulmonary AG | Medtech | Medical Technology | Equipment for operating rooms and intensive care units | Hirrlingen | Josef Bogenschütz (CEO) Gerhard Mayer (CFO) Manfred Engler | 1982 as Jostra | Hechinger Strasse 38 72145 Hirrlingen Germany Tel.: +49 (0)7478-921-0 Fax: +49 (0)7478-921-100 | info@maquet-cp.com | www.maquet.com | Jostra was founded in 1982 and the Jostra Group was taken over by Swedish company Getinge AB in 2003. MAQUET belongs to Getinge AB and specialises in providing equipment for operating theatres and intensive care units. Listed on the Swedish stock exchange, Getinge AB offers products for surgical medicine, intensive care, care of the elderly and the pharmaceuticals industry worldwide. MAQUET is made up of three divisions: The Cardiopulmonary division develops, manufactures and markets heart-lung machines, artificial lungs and disposable products for open heart surgery. The company maintains its focus on heart surgery and the extracorporeal circulation required during these operations with products from "Jostra" and "Polystan". MAQUET Cardiopulmonary is headquartered in Hirrlingen and has production facilities in Hechingen, Germany. MAQUET Cardiopulmonary began life as Jostra, a company founded by Lars Sunnanväder in 1982 and taken over by Getinge in 2003. Surgical Workplaces provides equipment such as operating tables, operating lamps, ceiling-mounted equipment and prefabricated construction systems for operating theatres. The product portfolio of the Critical Care division ranges from anaesthetic and ventilation systems for the operating theatre and intensive care, including software, and essential disposable products right through to monitoring systems. | |||||||
| Mathilde-Weber School | Service | Services | Education in the fields of biotechnology, nutrition, floristics, health, social affairs, social pedagogy | Tübingen | Bernhard Kandler (Head of the school) | Primus-Truber-Strasse 39 D-72072 Tübingen Tel.: +49(0)7071-565160 | poststelle@mws.tue.schule.bwl.de | www.mws.tue.bw.schule.de | The Mathilde Weber School in Tübingen offers a broad range of schooling, including the possibility of obtaining a secondary general school certificate (Hauptschulabschluss), a secondary school certificate (Realschulabschluss) as well as an advanced technical college entrance qualification and the Abitur (university entrance diploma). In addition, the school also offers courses for accreditation as an educator or florist. Vocational training to obtain a bachelor’s degree in social work organisation and leadership and the acquisition of additional qualifications at the MWS vocational school is also offered. The MWS has two grammar schools, one focusing on nutrition and the other focusing on biotechnology. The nutrition-oriented grammar school teaches general education subjects along with nutrition and chemistry (6-hour profile course), data processing and economics. The biotechnology-oriented grammar school teaches general education subjects along with biotechnology (6-hour profile course), chemistry and special areas in the biosciences and bioinformatics. | ||||||||
| Max Planck Institute for Biological Cybernetics | Institute | Development | Clarification of cognitive processes | Tübingen | Prof. Dr. Bernhard Schölkopf (Managing Director) | Spemannstraße 38 D-72076 Tübingen Mailing Adress: Postfach 21 69 D-72012 Tübingen Tel.: +49(0)7071-601510 Fax: +49(0)7071-601520 | www.kyb.mpg.de | The Max Planck Institute for Biological Cybernetics in Tübingen works on the clarification of cognitive processes on the experimental, theoretical and methodological level. The "Cognitive Human Psychophysics" (Director: Prof. Dr. Heinrich Bülthoff; formed in 1993) and "Physiology of Cognitive Processes" departments (Director: Prof. Dr. Nikos Logothetis; founded in 1997) employ complementary methodological approaches for the systems analysis of complex processes in the brain of primates. The "Empirical Inference for Machine Learning and Perception" department (Director: Prof. Dr. Bernhard Schölkopf; founded in 2001) works in the field of statistical learning theory and its application in various fields - ranging from computer vision to bioinformatics. The "High-Field Magnetic Resonance Centre" (Acting Director: Prof. Dr. Bernhard Schölkopf; founded in 2003) works on the development of new contrast agents as well as the methodical enhancement and application of imaging techniques (major focus: magnetic resonance). | |||||||||
| Max Planck Institute for Developmental Biology | Institute | Development, Genomics | Basic research in the fields of biochemistry, molecular biology and genetics as well as cell and evolutionary biology | Tübingen | Prof. Dr. Detlef Weigel (Managing Director) Directors: Prof. Dr. Andrei Lupas Dr. Elisa Izaurralde Prof. Dr. Christiane Nüsslein-Volhard Prof. Dr. Ralf Sommer Prof. Dr. Gerd Jürgens Prof. Dr. Detlef Weigel | Spemannstraße 35 D-72076 Tübingen Tel.: +49(0)7071-601350 Fax: +49(0)7071-601300 | mpi.entwicklungsbiologie@tuebingen.mpg.de | www.eb.mpg.de | The Max Planck Institute for Developmental Biology carries out basic research in the fields of biochemistry, molecular biology and genetics as well as cell and evolutionary biology. It has a staff of around 325 and is located on the Max Planck campus in Tübingen. The MPI for Developmental Biology is one of 80 institutes and research institutes belonging to the Max Planck Society for the Promotion of Science. The institute was established in 1937 as a working group of the Unit for Virus Research attached to the Kaiser Wilhelm Institutes of Biochemistry and Biology in Berlin-Dahlem, which was renamed MPI for Developmental Biology when it relocated to Tübingen 40 years later. The working groups run by the institute directors focus on the evolutionary history of proteins and protein systematics (Lupas), the genetics of embryonic development in Drosophila melanogaster and zebrafish (Nüsslein-Volhard), the evolution of developmental processes (Sommer), the integration of environmental and genetic factors during the development of Arabidopsis thaliana (Weigel), the post-transcriptional mechanisms of gene expression (Izaurralde) and the embryonic development of Arabidopsis thaliana (Jürgens). | ||||||||
| Max Planck Institute for Metals Research | Institute | Development | Basic materials research | Stuttgart | Prof. Dr. Joachim Spatz (Acting Director) | Heisenbergstr. 3 70569 Stuttgart Tel.: +49 (0)711-6890 Fax +49 (0)711-6891010 | www.mf.mpg.de | The Max Planck Institute for Metals Research was founded in 1921 as one of the first Kaiser Wilhelm Institutes and has been a leading research institution in this field ever since. Since its relocation to Stuttgart in the 1930s, the Institute has been closely connected with the University of Stuttgart. Nowadays, the Institute’s main research areas are the basic functions and applications of nano-biosystems. Its close connections with the traditional disciplines of physics, chemistry and the life sciences enable the Institute to work with exciting, basic issues in an interdisciplinary way and at the border of the aforementioned disciplines. Up to 400 scientists, including around 150 foreign scientists, focus on research, with the support of technicians and other staff members. The scientists are spread around eight departments, each one managed by a director and scientific member of the Max Planck Society (Prof. Dr. Siegfried Dietrich, Prof. Dr. Manfred Rühle, Prof. Dr. Ir. Eric Mittemeijer, Prof. Dr. Gisela Schütz, Prof. Dr. Joachim Spatz –three departments do not currently have a director in place). Five junior research groups have recently been established at the MPI-MF. The junior research groups run for a period of five years and are led by excellent junior researchers (Dr. Dagmar Goll, Dr. Frauke Gräter, Dr. Raquel Martin, Dr. Ralf Richter, Dr. Sylvie Roke). In addition, Prof. Dr. Clemens Becher, Head of the Institute of Physics II at the University of Stuttgart, was appointed Max Planck Fellow in 2007. The Institute has a world-class reputation in the analysis of materials, including methods of X-ray diffraction and absorption, neutron scattering, electron and X-ray microscopy, surface analytics as well as calorimetric, magnetic and mechanic measurement techniques. This broad range of methods enables the Stuttgart researchers to gain detailed insights into complex material phenomena. “From model systems to implementation of model systems up to materials with real microstructures and application potential” – this is the development chain at the MPI-MF. Although the chain is mainly basic research-based, this type of research nevertheless often enables the Institute to cross over to application-oriented research. The Institute makes major contributions to the development of materials for practical applications for use in energy, transport, information technology and the life sciences. This basis for technical innovations is based on active and successful collaborations with industrial companies. | |||||||||
| Mediagnost GmbH | Biotech | Development, Medicine, Nutrigenomics, Diagnostics | Testing systems for numerous applications in the field of infection diagnosis, endocrinology and food analysis; the production of antibodies, proteins and viruses | Reutlingen | Dr. Angelika Haage (Managing Director) | 1985 | Aspenhaustrasse 25 72770 Reutlingen Germany Tel.: +49 (0)7121-51484-0 Fax: +49 (0)7121-51484-10 | info@mediagnost.de | www.mediagnost.de | Mediagnost GmbH was founded in 1985 in Tübingen and is now based in the Tübingen-Reutlingen technology park. Mediagnost produces antibodies, proteins and viruses in accordance with GMT guidelines. The testing systems focus on infectious diseases such as hepatitis A/C, enteroviruses, HIV and the diagnosis of Pseudomonas aeruginosa. The firm’s portfolio also includes testing systems for the qualitative demonstration of genetically-modified foods and contamination of food, along with immunoassays used in endocrinology. | Dr. Angelika Haage | Production in accordance with GLP and GMP guidelines as decreed by the German Drug Law (AMG) and the Act on Medical Devices (MPG). Quality management system certified according to ISO 9001:2000. | AgeQuant – development of a multi-dimensional testing system for the quantitative determination of parameters relevant to regenerative biology in ageing humans. | ||||
| Medical Valley Hechingen Competence Network | Service | Services | Strengthening medical technology companies | Hechingen | Hans Marquart (City of Hechingen Business Development) | Kompetenznetzwerk Medical Valley Hechingen c/o Büro des Bürgermeisters Marktplatz 1 72379 Hechingen Tel.: +49 (0)7471-940127 | buero.bm@hechingen.de | www.medical-valley-hechingen.de | The “Medical Valley Hechingen” competence network was launched by the mayor of Hechingen in 2002 as a joint initiative involving medical technology companies in Hechingen, Hirrlingen, Jungingen and Rangendingen. The network’s objective is to strengthen the power of innovation and the services and products offered by the region’s medical technology companies. The medical technology focus will in future be located in the “Naßwasen” (Hechingen North business park) industrial estate. At present, around 2,700 employees work in the medical technology companies in the Hechingen area. The companies employ a total of over 4,000 people worldwide. The competence network initiative was established with the support of the Neckar-Alb Regional Association (Regionalverband Neckar-Alb) and the ISW of the Steinbeis Foundation (Stuttgart). BioRegio STERN supports the competence network by promoting networking within the region and in particular cooperative projects with the biotech industry. Key medical technology products include medical instruments and devices for diagnosis and therapy, as well as disposable therapeutic products. All products are the result of intensive development work. The Medical Valley not only welcomes life sciences specialists. Outstanding software and electronics companies, equipment manufacturers and automation specialists are all major prerequisites for quick and efficient development and production. | ||||||||
| medigroba GmbH | Medtech | Medical Technology | Medical supplies wholesaler founded in 1975 in Balingen | Balingen | Gerold Allgayer (Managing Director) Stefan Allgayer (Managing Director) | 1975 | Spessartstrasse 4 72336 Balingen Germany Phone: +49 (0)7433-9896-70 Fax: +49 (0)7433-9896-94 | info@medigroba.de | www.medigroba.de | Since its foundation in 1975, medigroba has established itself as a leading partner for the clinical practice, medical care and operative surgery sectors in Baden-Württemberg. The company’s customer markets include all types of specialist clinics, outpatient operation centres, clinics in the field of aesthetic plastic surgery, residential homes for the elderly, nursing homes, alternative practitioners, patients in intensive care and private customers. The company’s special focus is on home care – above all support for intensive care patients in their own homes, medical care and care for diabetes patients. | 17 | DIN EN ISO 13485:2003 | |||||
| medimod pharmacology services GmbH | Biotech | Contract research institute for preclinical pharmacology in animal models | Dr. Andrea Heyne (CEO) Urte Dahm (CEO) | Aspenhaustrasse 25 72770 Reutlingen Germany Tel.: + 49 (0)7121-93938–0 Fax: + 49 (0)7121-93938-10 | contact@medimod.com | www.medimod.com | medimod, whose name is a contraction of "mental disorder models", utilises animal models for behavioural-pharmacological analysis of the effect that certain substances have on the central nervous system. The company's service portfolio includes drug development, optimisation and safety and phenotyping. | ||||||||||
| Metec AG - Ingenieur-Aktiengesellschaft | Medtech | Medical Technology | Manufacturer of Braille cells and provider of products and services for the blind and visually impaired. | Stuttgart | Eugen Schäfer (Chairman) | 1974 | Gutenbergstrasse 65a 70176 Stuttgart Germany Phone: +49 (0)711-666030 Fax: +49 (0)711-6660333 | contact@metec-ag.de | www.metec-ag.de | Metec Ingenieur GmbH was founded in 1974. In 1975, Metec launched the first lot of pocket calculators with a readout in Braille. Today, the company supplies a variety of Braille displays with piezo-electric actuators to customers worldwide. In 1998, Metec became a public limited company. | |||||||
| M-fold Biotech GmbH | Biotech | Services, Development, Proteomics | Structural analyses, in vitro bonding and functional testing of membrane proteins, production of antibodies | Tübingen | Dr. Hans Kiefer, Scientific Director Dr. Wolfgang Vogt, Managing Director | 1999 | Vor dem Kreuzberg 17 72070 Tübingen Germany Tel.: +49 (0)7071-7945-0 Fax: +49 (0)7071-7945-11 | contact@m-phasys.com | www.m-phasys.com | M-fold Biotech was founded in 1999 as m-phasys by Dr. Hans Kiefer, Dr. Wolfgang Vogt, Marc Lohrmann and i.con. innovation GmbH. Membrane proteins are the most commercially-interesting target proteins for medications and represent M-fold Biotech GmbH’s core area of expertise yet they are also the most difficult to work with. The key to the firm’s success was the use of the patented M-FOLD technology, which was used to manufacture membrane protein antigens. Using two very different methods (immunisation and “phage display” selection), the firm succeeded in manufacturing antibodies with the required binding properties and biological activity and selectivity. In addition to structural analysis, m-phasys has recently established a new area of business, namely the manufacture of antibodies that act against membrane proteins and can themselves act as medications. M-fold Biotech's customers include major pharmaceutical companies who commission the structural analyses in order to develop medications. | 12 | Structural explanations of therapeutically-relevant potassium channels | Associated project: Joint project into the generation of antibodies against frizzled receptors (GPCRs) for the isolation and characterisation of stem cells. | ||||
| micro-biolytics GmbH | Biotech | Development, Trade/Distribution, Laboratory Techniques | Services for the pharmaceutical industries | Esslingen | Andreas Wolf (CEO) Ralf Masuch (CSO) | 2001 in Freiburg | Schelztorstraße 54 D-73728 Esslingen am Neckar Tel.: +49 711 901-211-230 Fax: +49 711 901-211-900 | www.micro-biolytics.com | The major focus of micro-biolytics GmbH is the provision of services for the pharmaceutical industry. The current spectrum of services offered ranges from the development of individual applications to service measurements in combination with statistical and mathematical data analysis to the integration of the patented AquaSpec technology into the production process of the pharmaceutical industry. micro-biolytics GmbH’s AquaSpec technology, which these days is marketed around the globe, is considerably more efficient than previous methods in the analysis of potential pharmaceutically active substances. The AquaSpec method is based on infrared spectroscopy in the medium infrared range; it is a sensitive and specific spectroscopic method for the analysis of aqueous or organic samples. micro-biolytics GmbH has further developed the method, making it fit for industrial application. Based on its patented AquaSpec technology, the company offers fully automated analysis systems for use in pharmaceutical drug development, process control and medical diagnostics. | ||||||||
| Mikropack GmbH | Medtech | Medical Technology | Research, development, manufacture and distribution of light optic devices | Ostfildern | Gerald Nitsch (Managing Director) Dieter Steck (Managing Director) Keith Roy (Managing Director) | 1995 | Maybachstrasse 11 73760 Ostfildern Germany Phone: +49 (0)711-341696-0 Fax: +49 (0)711-341696-85 | info@mikropack.de | www.mikropack.de | Optical fibres are the name of the game at Mikropack, founded in 1995 by Gerald Nitsch and Dieter Steck, and Ocean Optics. The multimode fibres or fibre bundles are used in general spectroscopy, colorimetric technology, fibre optic sensors for oxygen or pH measurement technology. The products are used in many sectors, ranging from UV-VIS to NIR, and enable applications to be performed easily in the fields of analytics and process measurement technology. Mikropack develops, produces and distributes a wide range of miniature spectrometers, light sources, software and accessories to enable these applications. Ten years ago, Mikropack merged its innovative products with the globally successful spectroscopy product line from Ocean Optics Inc., Florida. The Ocean Optics spectrometer was the perfect accompaniment for Mikropack’s fibre-optic light sources, Ulbricht spheres, multiplexers, mapping tables and wide range of other accessories. Mikropack is rapidly being expanded into a central European base for the Photonics Group. Mikropack is directly responsible for the distribution of all products for Germany, Austria and Switzerland. Another core area of Mikropack’s operations is the development, manufacture and distribution of measuring systems in the thin film metrology sector. | 20 | ||||||
| Morcher GmbH | Medtech | Medical Technology | Production and development of IOLs (intraocular lenses) | Stuttgart | Olaf Morcher (Managing Director) (gl@morcher.com) | 1948 | Kapuzinerweg 12 70374 Stuttgart Germany Phone: +49 (0)711-95320-0 Fax: +49 (0)711-95320-80 | info@morcher.com | www.morcher.com | The company was founded in 1948 by Kurt A. Morcher and specializes in the production of intraocular lenses (IOL), which are used to replace human lenses in the event of cataracts. The company developed the first Binkhorst 4-loop lens (named after the Dutch doctor who first implanted this lens) and is now one of the leading international manufacturers of IOLs. | 47 | ||||||
| Multi Channel Systems MCS GmbH | Biotech | Development, Laboratory Techniques | Electrophysiology, automation | Reutlingen | Karl-Heinz Boven (Managing Director) Andreas Möller (Managing Director) | 1996 | Aspenhaustrasse 21 72770 Reutlingen Germany Tel: +49 (0)7121-909250 Fax: +49 (0)7121-9092511 | info@multichannelsystems.com | www.multichannelsystems.com | Multi Channel Systems MCS GmbH was founded in 1996 and is based in the Reutlingen/Tübingen Science and Technology Park. Its focus lies on the development of measuring instruments and technical accessories in the context of electrophysiology for university-based research and the pharmaceutical industry. MCS products automate laborious measuring methods and analyses. Three product lines demonstrate Multi Channel Systems’ core areas of expertise: in vitro and in vivo systems for the derivation of extracellular activities of excitable cells; the Robocyte, a fully-automatic “two-electrode voltage clamp (TEVC)” system for oocytes of the African clawed frog Xenopus laevis and its latest development, the QT Screen – an automated system for tests on the potential extension of the QT interval. This is a key instrument for safety pharmacology applications in the development of new medications. The goal is always to develop intelligent and convenient solutions that combine maximum functionality with ease of use. | Karl-Heinz Boven | 16 | Development of a biotechnology platform for electrophysiological tissue assays for the investigation of active agents in conditions that are as similar as possible to in vivo | ||||
| MULTIMED Wicker GmbH | Biotech | Medical Technology, Trade/Distribution, Laboratory Techniques | Specialist dealer in laboratory and medical technology | Kirchheim unter Teck | Rolf W. Wicker, Managing Director (Rolf.Wicker@multimed.de) | 1982 | Tannenbergstrasse 47 73230 Kirchheim unter Teck Germany Tel: +49 (0)7021-9407-0 Fax: +49 (0)7021-9407-10 | info@multimed.de | www.multimed.de | Wicker GmbH primarily supplies consumables and laboratory equipment for use in university-based and industrial research institutions. Its portfolio also includes materials and products for use in laboratory-based medicine, along with environmental analysis and food monitoring. Its product range primarily serves the field of molecular biology (PCR laboratories) and cell and tissue culture. | Rolf W.Wicker | 8 | |||||
| Nascatec GmbH | Biotech | Development, Laboratory Techniques | Development and production of high-tech solutions in microsystems technology and nanoanalysis | Stuttgart | Wolfgang Barth (CEO) | Wankelstraße 14 70563 Stuttgart Tel.: +49 (0)711-686894-90 Fax: +49 (0)711-686894-99 | info@nascatec.com | Nascatec GmbH, a world market leader in high-resolution optical near-field microscopy, develops and produces high-tech solutions in the microsystems technology and nanoanalysis sectors. Nascatec products are deployed in all fields of nano- and microtechnology. The company has developed not only the first piezoresistive AFM sensors but also the world’s first SNOM sensor based on cantilever technology, which analyses surfaces using optical measurement. For example, Nascatec has equipped both the ESA’s Rosetta mission and NASA’s Stardust mission with Nascatec sensors. The company’s core business focuses on the development, prototype production and manufacture of SPM/AFM sensors, SNOM sensors and micro-nanomanipulators for applications in research and development, surface characterisation, process controls and biotechnology. Now, the product portfolio is to be expanded, with the aim of exploiting the potential of nanomodules for the life science sector. | |||||||||
| Nexxor GmbH | Biotech | Services, Development, Information Technology | Knowledge-oriented information systems for the life sciences, pharmaceutical and biotechnology sectors | Stuttgart | Dr. Gerhard Weber Ralf Eilbracht Stefan Kesberg | 2008 | Vollmoellerstr. 11 70563 Stuttgart Tel.: +49 (0)711-91260466 Fax: +49 (0)711-91260468 | info@nexxor.de | www.nexxor.de | Nexxor GmbH develops so-called “knowledge-oriented information systems” using its proprietary topicWorks technology, which is based on a family of semantic ISO standards. The company, which was established in 2008 by two bioinformaticians and an ecologist, designs software solutions specifically aimed at clients in the life sciences, pharmaceutical and biotechnology sectors. The software systems developed by Nexxor do not just focus on data and documents, but are also able to represent the meaning and context of database content in a flexible and meaningful way, thus making the knowledge of individual members of a cooperative project accessible to all. In addition, the software systems enable independent data sources to be linked. The technology can for example be used for the administration of a broad range of project data generated by medical, pharmacological, agricultural or ecological studies, but also for substance collections or drug information systems, as well as a broad range of biological, biochemical or physiological relationships. In many areas that use rigidly structured databases for the management of information, the new technology will greatly benefit users thanks to its high degree of flexibility and the large number of access paths that confer meanings. | |||||||
| NMI Natural and Medical Sciences Institute | Institute | Services | Transfer of research results to industry, Transfer of research findings to the business sector | Reutlingen | Prof. Dr. Hugo Hämmerle (Managing Director) Dr. Alfred Stett (Deputy Managing Director), Prof. Dr. Hugo Hämmerle (Director) Dr. Alfons Stett (Deputy Director) | 1985 | Markwiesenstr. 55 D-72770 Reutlingen Tel.: +49 (0)7121-515300 Fax: +49 (0)7121-5153016 , Markwiesenstrasse 55 72770 Reutlingen Germany Tel.: +49 (0)7121-515300 Fax: +49 (0)7121-5153016 | info@nmi.de, info@nmi.de | www.nmi.de, www.nmi.de | The NMI was founded in 1985 as a non-profit foundation under civil law. The foundation comprises 12 mostly small- to medium-sized companies as well as the city of Reutlingen. A board of trustees, which is made up of representatives from research and industry, the Ministry of Economic Affairs and the Ministry of Science, Research and the Arts (Baden-Württemberg), oversees the institution. The NMI’s objective is the successful transfer of research findings to the world of business. The NMI covers the following core areas of activity: pharmaceutical and biotechnology research, biomedical technology and surface technology. The scientists who work within the NMI’s 16 research groups are among the pioneers of groundbreaking technologies and are internationally renowned for their innovations and patents. It was here, for example, that micro-electrode arrays (MEAs) were developed. These arrays are used to determine the effects of substances on cardiac muscle and nerve cells. The system was further developed by MCS Multi Channel Systems in Reutlingen and is now marketed worldwide. In conjunction with industrial partners and publicly-funded research institutions, the NMI is also involved in the development of tests based on protein or peptide arrays. In future, these systems will play an important role in diagnostics. By miniaturising and parallelising test systems (microarray technology), numerous parameters can be determined simultaneously in the smallest sample volumes. The use of protein arrays increases the speed of tests and results in a dramatic reduction in the cost of diagnostics, as it is possible to analyse several hundred parameters in a single experiment. Working with other companies, the NMI also initiates projects for the optimisation and further development of implants and surgical instruments. These consortia enable small- and medium-sized companies to take part in research projects under the Institute’s guidance, without having to provide the necessary equipment or scientific expertise themselves. They can access the NMI’s technologies, systems and services, including equipment such as the “Focused Ion Beam”, which enables material samples in the nanometer range to be mapped and prepared. With this latest advancement of the scanning ion microscope, companies from the fields of medical technology and the automotive industry are investigating functional flaws in semiconductor chips, the failure of coatings or instances of corrosion damage. The NMI also operates a comprehensive database (www.biochipnet.com) that is available for biotechnology companies, research institutions and service providers free of charge., NMI was founded in 1985 as a non-profit-making foundation under civil law. The foundation includes 12 mostly small to medium-sized companies and the City of Reutlingen. A board of trustees, which is made up of representatives from research and industry, the Ministry of Economic Affairs and the Ministry of Science and Research (Baden-Württemberg), oversees the institution. The NMI’s objective is to successfully transfer research findings to the world of business. The NMI is an established figure in its core areas of activity, namely: pharmaceuticals and biotechnology, biomedical technology and surface technology. The scientists, who work within the NMI in 13 working groups, are among the pioneers of groundbreaking technologies and are renowned internationally for their innovations and patents. It was here, for example, that micro-electrode arrays (MEAs) were developed. These are used to determine the effects of substances on cardiac muscle and nerve cells. The system was developed further by MCS Multi Channel Systems in Reutlingen and is marketed worldwide. In conjunction with industrial partners and publicly-funded research institutions, the NMI is also involved in the development of tests based on protein or peptide arrays. These systems will in future play an important role in diagnostics. By miniaturising and parallelising testing systems (micro-array technology), a range of measuring parameters can be determined simultaneously in even the smallest sample volumes. The use of protein arrays increases the speed of tests and results in a dramatic reduction in costs for diagnostics, since several hundred measuring parameters can be captured in a single experiment. Working with other companies, NMI also initiates projects for the optimisation and further development of implants and surgical instruments. These consortia enable small and medium-sized companies, under the Institute’s guidance, to take part in research projects without having to come up with the necessary equipment or scientific expertise themselves. They can access the NMI’s technologies, systems and services, such as the “Focused Ion Beam”, which enables material samples in the nanometer range to be mapped and prepared. With this latest further development of the scanning ion microscope, companies from the fields of medical technology and the automotive industry are investigating functional flaws in semiconductor chips, the failure of coatings or instances of corrosion damage. The firm also operates a comprehensive and freely-accessible BioChip database (www.biochipnet.com) for biotechnology companies, research institutions and service providers. | Dr. Nadja Gugeler – Public Relations (gugeler@nmi.de), Dr. Nadja Gugeler - Marketing (gugeler@nmi.de) | ca. 130, Approx. 100 | Postgenomic Screening Platform – modular technology platform for complex biological assays – in conjunction with EDI and accelab GmbH | Joint research project: Bio-reabsorbable collagen fibres for nerve regeneration. Joint research project: Bio-artificial surface substitute for the treatment of degenerative cartilage diseases; subproject 3 | |||
| Novalung GmbH | Medtech | Services, Medical Technology, Regenerative Biology, Process Engineering | Development of therapies for acute and chronic lung failure | Talheim | Dr. Georg Matheis (CEO) Hannes Wetscher | 2002 | Egerten 3 74388 Talheim Tel.: +49 (0)7133-90110 Fax: +49 (0)7133-09011299 | info@novalung.com | www.novalung.com | "Solutions for Lung Failure" - this is Novalung’s philosophy. Novalung GmbH started in 2003 as the world's first company to market an artificial lung, the iLA Membrane Ventilator®, which is perfused by the heart like a natural organ. Through this reliable extrapulmonary ventilation, i.e. the removal of carbon dioxide of the lungs, signifies the patients' lung is given “Time to Heal"®. This enables a paradigm shift in the treatment of respiratory failure: from prioritization of pulmonary gas exchange to true of lung protection. In the meantime this procedures has been established and the portfolio of products for the so-called "ultra-protective" ventilation is constantly growing. Although Novalung operates on an international level, "Made in Germany" applies hundred percent to the iLA Membrane Ventilator®. The complete value chain, research and development, production site as well as marketing is situated exclusively in Germany. | |||||||
| novineon Healthcare Technology Partners GmbH | Biotech | Services, Development, Nutrigenomics | Consulting and research in the field of healthcare technology | Tübingen | Prof. Marc O. Schurr (Managing Director) | 2001 | Dorfackerstrasse 26 72074 Tübingen Germany Tel.: +49 (0)7071-7704514 Fax: +49 (0)7071-763574 | info@novineon.com | www.novineon.com | novineon operates in all sectors of the healthcare industry. The consulting firm, with its international network, supports manufacturers and users of medical products and services in all aspects of development, trials and marketing. Its research activities – including both its own and commissioned research – focus on the development, trial and validation of new technologies in medicine and ranges from the development of concepts and prototyping to the medical trials of prototypes and validation of the new product. The company also holds shares in newcomers to the industry and supports them as they turn their technologies into marketable products. | Joint research project: Tissue engineering with entodermal stem cells and the development of endoscopic technologies for the removal of such cells from the colon | ||||||
| npi electronic GmbH | Biotech | Development, Drug Development, Medicine, Laboratory Techniques, Process Engineering | Electronic measuring instruments for the life sciences sector, drug-screening systems | Tamm | Hannelore Polder Hans Reiner Polder (M.Sc.EE) | 1989 | Hauptstrasse 96 71732 Tamm Germany Tel.: +49(0)7141-9730230 Fax: +49(0)7141-9730240 | sales@npielectronic.com | www.npielectronic.com | Hans Reiner Polder founded npi in 1989 based on the method he developed to improve the measurement of intracellular signals. Using this newly-developed enhancement system, it was possible to improve the resolution capabilities of existing measuring systems. npi currently has a wide portfolio of products for recording bio-electrical signals. npi develops and sells numerous systems for use in fundamental medical, biological and drug research, such as voltage and patch clamp amplifiers, intra- and extracellular amplifiers, micromanipulators etc. The firm also offers products for drug screening and laboratory automation. npi electronic is a member of the Electrophysiology Innovation Partnership network. | Hans Reiner Polder | 5 | |||||
| Nürtingen-Geislingen University | Institute | Education | University with a Department of Agriculture and one of the largest Departments of Economics in Baden-Württemberg | Nürtingen | Prof. Dr. Werner Ziegler | Neckarsteige 6-10 D-72622 Nürtingen Tel. +49(0)7022-2010 Fax +49(0)7022-201303 | info@hfwu.de | www.hfwu.de | Nürtingen-Geislingen University was founded on 15th November 1949 as a “College of Agricultural Engineering”. The director at the time was Professor Dr. Johannes Knecht. Originally focusing strongly on agriculture, the college has since developed into a university that offers a wide range of courses. Today, besides the agricultural sciences, the HfWU has one of the biggest life science faculties in Baden-Württemberg. The Nürtingen-Geislingen University offers 12 bachelor’s and 12 master’s degree programmes at its campuses in Nürtingen and Geislingen. The Geislingen campus offers courses in the automotive business, business law, real estate management, health and tourism management, and energy and recycling management. Geislingen has become an attractive study location offering places for around 1400 students. As part of the Bologna Process that aims at internationalising university degrees, all diploma degree courses have been converted into bachelor’s degree courses. Nürtingen-Geislingen University currently offers the following bachelor’s courses: * Agriculture (B.Sc., Nürtingen) * Automotive business (B.A., Geislingen) * Applied Economics (B.Sc., Nürtingen/Geislingen) * Energy and Resource Management (B.A., Geislingen) * Health and Tourism Management (B.A., Geislingen) * Real Estate Management (B.Sc., Geislingen) * International Financial Management (B.Sc., Nürtingen) * Landscape Architecture (B.Eng., Nürtingen) * Landscape Planning & Nature Protection (B.Eng., Nürtingen) * Horse Business (B.Sc, Nürtingen) from WS 2009/10 * Urban Planning (B.Eng., Nürtingen.) * Economics (B.Sc., Nürtingen) * Business Law (LL.B., Geislingen) The following master’s courses are available at Nürtingen-Geislingen University: * Accounting, Auditing & Taxation (M.A., Nürtingen) * Agriculture (M.Sc., Nürtingen) * Automotive Management (M.A., Geislingen) from WS 09 * International Finance (M.Sc., Nürtingen/Olten) * International Management (MBA, Nürtingen) * International Master of Landscape Architecture (M.Eng., Nürtingen/St. Gallen, Weihenstephan) * Law Enforcement, Reconstruction and Insolvency Management (LL.M., Geislingen) * Environmental Studies (M.Eng., Nürtingen/Esslingen/Reutlingen/Stuttgart) * Leadership (M.Sc., Geislingen) * Taxation, Auditing and Consulting (LL.M., Geislingen) Extra-occupational courses available at Nürtingen-Geislingen University: * Business Administration (B.A.) * Management and Finance as well as Management and Real Estate (MBA) * Traffic, Criminal and Insurance Law / Master of Laws (LL.M.) from Nov. 2009 * Process Management (M.Sc.) | ||||||||
| Ocuserv GmbH | Biotech | Services, Medicine | Opthamology services | Tübingen | Jasminweg 23 72076 Tübingen Germany Tel.: +49 (0)7071-650513 Fax: +49 (0)7071-650515 | office@ocuserv.de | www.ocuserv.de | The company offers a range of services based on its expertise in clinical and scientific opthamology. Its service portfolio ranges from organising courses and conferences, coordinating research projects, developing databases, preparing scientific reports and other documentation, researching and developing processes and equipment right through to ophthalmological diagnostics and treatment. | |||||||||
| oekoservice GmbH | Biotech | Services, Ecology/Environment | Development and construction of biological wastewater purification systems (B 2000, BioTop, BioTopp, sludge settling), biotechnological optimisation of the purification function of municipal wastewater treatment plants, plants for rainwater utilisation, and maintenance of small-scale wastewater treatment plants and separating plants. | Denkendorf | Gerlinde Zink, Managing Director Nicole Alderath-Zink, Assistant to the Managing Director Jürgen Zink, Technical Manager | 1984 | Köngener Strasse 14 73770 Denkendorf Germany Tel. +49 (0)711-934933-0 Fax: +49 (0)711-934933-21 | info@oekoservice.com | www.oekoservice.com | Ökoservice GmbH was founded in 1984. The company's core business includes plants for decentralised wastewater disposal (municipal wastewater treatment plants for 4 to 3000 residents), and industrial wastewater plants. A large number of plants based on the patented __B 2000__ system, the __BioTop__ system launched in 1997, and its improved successor the __BioTopp__ system are all successfully in service. The __BioTop__ and __BioTopp__ wastewater treatment plant systems are available in plastic or concrete configurations and in the form of a retrofit kit, which is also ideally suited for export. Ökoservice GmbH received a special recognition award at the "2005 Esslingen Innovation Prize" for its innovative combination comprising __BioTopp__ with no mechanical pre-treatment and a sludge settling system. The system does not process faecal sludge, which is relatively expensive when it comes to disposal, thereby ensuring full compliance with recycling management and waste disposal legislation. Rainwater utilisation plants are a further key area of environmental technology at Ökoservice. These can be adapted in the form of all-in-one systems to meet the requirements of private households and industry. The company's product portfolio also contains an extensive offering of separating plants for oil, petrol and fats. In addition to process development of wastewater purification systems, Ökoservice has performed maintenance on small-scale wastewater treatment plants for over 20 years and has a network of maintenance contracts across Germany. The company analyses wastewater samples in its own lab as evidence for the authorities. Furthermore, evaluations of analysis results are used to optimise the purification function. The maintenance programme also covers separating plant and pumping stations. | |||||||
| Ornamental Bioscience | Biotech | Development, Trade/Distribution | Development and marketing of transgenic ornamental plants | Stuttgart | Christian Klemm (Managing Director) | Hanfäcker 10 70378 Stuttgart Germany Phone: +49 (0)711-95325-88 Fax: +49 (0)711-95325-40 | info@ornamental-bioscience.com | www.ornamental-bioscience.com | Ornamental Bioscience is a new joint venture based in Stuttgart in which the German Selecta Group and the US company Mendel Biotechnology Inc. both have a stake. The company develops and markets transgenic ornamental plants. Ornamental Bioscience combines Mendel's technological know-how in the field of drought, cold, frost and pathogen resistance with Selecta's experience in the field of cultivation, production and sale of ornamental plants. Ornamental Bioscience has so far transformed and tested plant species from the Selecta product range such as petunias, poinsettias, New Guinea impatiens (Busy Lizzies) and geraniums. Now, further species are to be added through cooperation arrangements with other cultivators. Family business Selecta Klemm GmbH & Co. KG is one of the world’s leading cultivation and propagation companies for vegetatively reproducible ornamental plants. Selecta has acquired numerous patents and plant variety protection rights for cut flowers and bedding, balcony and pot plants over the past 40 years. The company has seven main sites worldwide with production, cultivation and sales facilities; the headquarters are in Stuttgart. Selecta has been active in biotechnology since 1996. Selecta Klemm was involved in the Australian company Florigene’s development of the blue carnation, which is as yet the only transgenic ornamental plant that has been approved for marketing in Europe | ||||||||
| Ovesco Endoscopy GmbH | Medtech | Medical Technology | Medical instruments for flexible endoscopy | Tübingen | Prof. Marc O. Schurr, Managing Director Dr. Andreas Kirschniak, Medical Affairs Chi-Nghia Ho, Research and Development Christine Fleisch, Quality Management | 2002 | Dorfackerstrasse 26 72074 Tübingen Germany Tel.: +49 (0)7071-7704514 Fax: +49 (0)7071-763574 | info@ovesco.com | www.ovesco.com | Ovesco Endoscopy GmbH develops, produces and sells medical instruments for investigation of the gastrointestinal tract. Ovesco’s majority partner is the firm novineon Healthcare Technology Partners GmbH, which also provides the management team. Ovesco collaborates with various medical and technical institutions such as the Institute of Anatomy at the University of Tübingen. The company produces clip systems and OTSC® (Over-The-Scope-Clip) application systems for the treatment of bleeding and lesions in the digestive tract. These feature an applicator cap mounted to the tip of the endoscope and a super-elastic nitinol clip. The working channel also serves as a conduit for a tool used for positioning the clip correctly. During flexible endoscopy, use of the instrument allows more tissue to be compressed than previously, thereby facilitating the treatment of perforations and severe bleeding. | Prof. Marc O. Schurr | 3 | EN ISO 13485:2003 and EN ISO 9001:2000 certification | ||||
| OWISAN - Biotechnische Entwicklungen und Vertrieb OHG | Biotech | Ecology/Environment, Trade/Distribution | Biotech developments for foodstuffs | Tübingen | Dr. M. K. Otto (CEO) Dr. W. Wiesner (CEO) | Innovationszentrum Mömpelgarder Weg 10 72072 Tübingen Germany Tel.: +49 (0)7071-365 604 Fax: +49 (0)7071-364 804 | www.owisan.de | In conjunction with the Fraunhofer Gesellschaft (Fraunhofer Society), OWISAN has developed a germination process that, using a germinator developed in cooperation with Berghof – Elektronik und Umwelttechnik, produces growth-active seeds (Goldkeimlinge®) from wheat, rye, spelt and other grains. | |||||||||
| PANATecs GmbH | Biotech | Services, Development, Medicine, Nutrigenomics, Diagnostics | Provision of bioanalytical services, particularly mass spectrometry-based, for the pharmaceutical, foodstuffs and animal feed industries. Manufacture and sale of bioanalytical substances for research (e.g. peptides, antibodies, marker reagents etc.). | Tübingen | Dr. Thomas Flad, Pharmacist (CSO) Alexander Cansier (COO) | 2004 | Ob dem Himmelreich 7 72074 Tübingen Germany Tel.: +49 (0)7071-29720-93, -94 and -95 Fax: + 49 (0)7071-294445 | info@panatecs.com | www.panatecs.com | PANATecs GmbH was founded in 2004 as a spin-off of the University of Tübingen. Its founding partners are Prof. Claudia Müller (Transplantation Immunology and Immunohaematology Section, “Medizinische Klinik und Poliklinik”, Dept. II), Prof. Gerhard A. Müller (Nephrology & Rheumatology Department, Centre for Internal Medicine, Georg August University, Göttingen), Dr. Hubert Kalbacher (University of Tübingen, Physiological Chemistry Institute (PCI), Medical and Scientific Research Centre, University of Tübingen) and the two Managing Directors Dr. Thomas Flad and Alexander Cansier. In addition to the production of bioanalytical products and the conducting of specialist analyses, PANATecs GmbH also carries out its own research projects. In collaboration with major partners, the firm handles projects from the field of clinical mass spectrometry. The aim of these research activities is to develop new, mass spectrometry-based diagnostic methods for the early detection of autoimmune and cancer-related diseases. | Alexander Cansier | 12 | Development of new tests for the molecular diagnosis of rheumatoid arthritis | ||||
| Patent Information Centre | Service | Services | Services related to industrial property rights | Stuttgart | Regierungspräsidium Stuttgart Informationszentrum Patente Haus der Wirtschaft Willi-Bleicher-Str. 19 D-70174 Stuttgart Tel.: +49(0)711-1232558 | info@patente-stuttgart.de | www.patente-stuttgart.de | The spectrum of services offered by the Patent Information Centre ranges from the provision of comprehensive neutral information up to qualified consultation. Modern workstations with access to up-to-date property rights databases are available for visitors’ use. The centre’s staff offers support to users looking for patents, utility models, brands and industrial designs. These services are complemented by contract searches in chargeable databases and delivery services for property rights documents. In addition to initial consultation, the centre also offers short weekly consultations on all industrial property rights free of charge and in cooperation with patent attorneys from the region. Regular talks, patent research seminars and workshops and the “Tag der gewerblichen Schutzrechte” conference provide both first-time users and experts with useful information and training. On behalf of the German Patent Office, the centre accepts patent, utility model, brand and industrial design applications as well as European and international patent applications in due time. The centre is a useful point of contact in Baden-Württemberg for SMEs and scientific institutions that are new to industrial property rights or for start-up companies looking for a company name. | |||||||||
| Paul-Lechler Hospital and Clinic for Tropical Diseases | Institute | Medicine | Clinic for tropical medicine, geriatrics and pain treatment | Tübingen | Dr. Gisela Schneider (Director) | Paul-Lechler-Str. 24 72076 Tübingen Tel.: +49 (0)7071-2060 | info@tropenklinik.de | www.tropenklinik.de | The Paul-Lechler Hospital and Clinic for Tropical Diseases specialises in tropical and travel medicine, microbiology and the epidemiology of infections. The tropical disease department treats around 2500 patients annually. Over the last few years, the Hospital has also established General Internal Medicine, Palliative Medicine and Diabetology departments. The most frequent reason for visiting the hospital is for the treatment of internal diseases. The Paul-Lechler Hospital and Clinic for Tropical Diseases is part of the Centre of Geriatrics at the University of Tübingen. For many years, pain therapy has been another major treatment priority at the Hospital. In cooperation with the Tübingen project “Häusliche Betreuung Schwerkranker” (Home care of critically ill people), the Hospital’s palliative medicine department is a role model for treatment centres of its kind in the region. The Hospital was established in 1916 and was initially a medical treatment and convalescent centre for sick missionaries. | ||||||||
| Pegasus Fachgesellschaft Arbeitsmedizin mbH | Medtech | Medical Technology | Preventive healthcare services and analysis services | Hechingen | Dr. Michael Wagner (Managing Director) Dr. Bernd Kasper (Managing Director) | 1993 | Lotzenäcker 7 72379 Hechingen Germany Phone:+49-(0)7471/13022 Fax: +49-(0)7471/13023 | servicezentrum@pegasus-online.de | www.pegasus-online.de | Founded by Dr. Michael Wagner MD and Dr. Bernd Kasper MD in 1993, Pegasus Fachgesellschaft Arbeitsmedizin mbH offers comprehensive healthcare services and technical analysis services primarily for large-scale businesses and administrative departments. The company's portfolio is rounded off by workplace health promotion and a full range of occupational safety services including risk analyses. Focusing on southern Germany, healthcare and prevention centres have also been set up offering preventive medical checks, health check-ups, expert opinions and advice relating to hygiene inspections, clean-room inspections and inspections to check compliance with bio-material and genetic-engineering safety regulations. The prevention centre in Hechingen has been the competence centre for special prevention schemes for managers (manager check-ups) for 10 years. Pegasus is a partner in the Medical Valley Hechingen competence network. | |||||||
| Philips Medizin Systeme Böblingen GmbH | Medtech | Medical Technology | Patient monitoring – sensor technology, physiological metrology, patient monitors and monitoring system solutions, clinical information systems | Böblingen | Michael Dreher (Managing Director) Dr. Werner Haas (Managing Director) | 1864 (Philips Medizin Systeme came into being in 1987 when the Hamburg-based company CHF Müller was renamed (acquired by Philips | Hewlett-Packard-Strasse 2 71034 Böblingen Germany Phone: +49 (0)7031-463-0 Fax: +49 (0)7031-463-2202 | medizin.infoline@philips.com | www.philips.de | Philips is a global company focusing on healthcare, lifestyle and technology. Philips Medizin Systeme offers a broad spectrum of products and system solutions for diagnostics, treatment/treatment control and patient monitoring. The company's portfolio covers radiology, catheter laboratory solutions, magnetic resonance tomography, computer tomography, general and cardiovascular ultrasound imaging, nuclear medicine, positron emission tomography (PET), planning systems for radiotherapy, patient monitoring, defibrillation, electrocardiography and clinical information systems. Further services include system support, financing, consulting and training. Philips Medizin Systeme has around 30,000 employees worldwide, 3500 of whom are based in Germany with 650 in Böblingen. Böblingen is the headquarters for research, development, production and marketing of patient monitoring systems. The European marketing centre of the "Ultrasound & Monitoring" business unit is also based here, alongside molecular diagnostics and e-healthcare. | Approx. 30,000 worldwide | ||||||
| Polytec GmbH | Biotech | Imaging, Laboratory Techniques | Laser technology for industry and research | Waldbronn | Dr. Helmut Selbach Dr. Karl Spanner | 1967 | Polytec-Platz 1-7 76337 Waldbronn Germany Tel.: +49 (0)7243-6040 Fax: +49 (0)7243–69944 | info@polytec.de | www.polytec.de | The Waldbronn-based company Polytec was established in 1967 as a sales company for laser and electro-optical components. Today, the company employs over 200 people. Its major sales lines are electro-optical measurement systems, which are developed and manufactured in house. Business activity is divided into four product areas. Laser measurement systems division The laser measurement systems division specialises in non-contact measurement and visualisation using laser light. Polytec develops and manufactures high-quality measurement instruments for the analysis of vibrations, lengths, speeds and surface topographies. Applications range from micro-systems technology to heavy machine construction, and from automotive engineering and aerospace to medical technology, biosciences, etc. Spectral technologies division Polytec offers analytical measurement processes and holistic solutions for both laboratory applications and processing environments in industry and research. Photonics division This division supplies opto-electronical components and modules as well as complete measurement systems and special laser tools for a wide range of applications. Main areas of activity include automated image processing, optical telecommunications, optical radiation measurement technology and laser micro-machining. Products from innovative foreign high-tech companies are represented in this division. | DIN EN ISO 9001:2000 | ||||||
| Probios GmbH | Biotech | Medical & microbiological analyses. One particular speciality is the analysis of intestinal flora in human and veterinary medicine. | Angelika Bräunlein (Managing Director) | Reuchlinstr. 9a 70178 Stuttgart Germany Tel.: +49 (0)711-5053225 Fax: +49 (0)711–5053221 | info@probiosdiagnostik.com | www.probiosdiagnostik.com | Probios GmbH was founded in 2001 and carries out medical & microbiological laboratory analyses on the samples it is sent. One particular speciality is the analysis of intestinal flora in human and veterinary medicine, with a subsequent interpretation of findings and a recommended course of treatment. Probios GmbH also analyses water, feed and litter samples. | ||||||||||
| Proplanta – the information centre for the agricultural sector | Biotech | Information centre and online marketplace for the agricultural sector | Dr. Jörg Mehrtens (Managing Director) | IBH-Gebäude Wollgrasweg 49 70599 Stuttgart-Hohenheim Germany Phone: +49 (0)711-451017-610 Fax: + 49 (0)711-451017-615 | mail@proplanta.de | www.proplanta.de | On its agriculture portal www.proplanta.de the Proplanta team offers content from its highly diversified information network augmented by the team's own longstanding experience in the agricultural sector. Cooperation with major news agencies enables Proplanta to offer visitors to its site market-oriented agricultural reports, industry data and background information updated daily. The online portfolio also includes useful information on crops, cultivation and pest control alongside lexicons and dictionaries for quick searching of specialist knowledge and technical terms. Companies and institutions can also post a profile of themselves and their service spectrum online at Proplanta and list their products in catalogue form. This facilitates rapid searching of high-quality suppliers, products or specific training courses devoted to agricultural science. As well as an ads section, e.g. for tendering for cooperation partners, the site also features a jobs forum where advertisements can be placed for technical specialists and managers from the agricultural sector, placements can be advertised, and applications invited from persons wishing to write dissertations and doctorates. Further services from Proplanta include consultancy and coordination of projects and agricultural-science studies, data management and research, geostatic evaluations and support in writing technical articles. | ||||||||||
| Proplanta GmbH & Co. KG | Service | Services | Information services for the agricultural sector | Stuttgart | Dr. sc. agr. Jörg Mehrtens (Managing Director) | Wollgrasweg 49 D-70599 Stuttgart-Hohenheim Tel.: +49(0)711-451017610 Fax: +49(0)711-451017615 | mail@proplanta.de | www.proplanta.de | Proplanta GmbH & Co. KG is a media agency that acts as an independent information service provider for the agricultural sector, both in the print and online sector. The company’s services comprise, amongst other things, the preparation of agricultural papers, advice for agricultural monitoring studies, agricultural photo service (photo database: > 50,000 photos), planning and implementation of user-friendly IT solutions, search engine marketing, online geodatabase services, agricultural news service, agricultural ‘yellow pages’ and media data services. In addition, Proplanta also offers a job centre for the agricultural sector. | ||||||||
| PROTEC GmbH & Co. KG | Medtech | Medical Technology | Specialist in generating X-ray images | Oberstenfeld | Erhard Fichtner (Managing Director) Uwe Ridinger (Marketing and Sales) Bettina Witt (Finance) Frank Baisch (Technology) | 1984 | Lichtenberger Strasse 35 71720 Oberstenfeld Germany Phone: +49 (0)7062-9255-0 Fax: +49 (0)7062-22685 | protec@protec-med.com | www.protec-med.com | PROTEC is based in Oberstenfeld near Stuttgart and specialises in medical imaging. The company's portfolio includes both analogue and digital products, which are continuously being developed and enhanced. The analogue product range features various X-ray film development machines and corresponding equipment such as chemical mixers, x-ray cassettes and amplifier. The company also uses its new archiving systems, software for medical image processing and computer radiography systems (CR systems) to harness the new opportunities offered by digital technology. With its international dealer network, PROTEC operates in more than 100 countries worldwide, hence its high export share of approx. 95%. PROTEC runs its own joint sales venture in Hong Kong (PROTEC Asia) which exclusively serves the Chinese market. | |||||||
| raytest Isotopenmessgeräte GmbH | Medtech | Medical Technology, Imaging, Laboratory Techniques | Nuclear instruments and bio-imaging products | Straubenhardt | Günter Dietzel (CEO) | 1980 | Benzstrasse 4 75334 Straubenhardt Germany | info@raytest.com | www.raytest.com | Raytest was founded on 23 September 1980 in Straubenhardt, Germany, and now has the following branch offices: raytest Austria Ges.mbH, Vienna raytest BeNeLux B.V., Tilburg raytest France S.A. Paris raytest Iberica S.L. Barcelona raytest Italia, SRL. Milan raytest Nordic AB, Lund raytest Schweiz AG, Zurich raytest UK Ltd, Chesterfield raytest USA Inc. Wilmington NC and agencies in Japan, China, India, Australia, etc. raytest develops, manufactures, markets and provides customer service for the many and varied radioactivity measuring instruments for chromatography, quality control, nuclear medicine, and radiation and environmental protection in the fields of biological and medical research and development. Another product area, which has been just as significant for over 15 years, involves the measurement, recording and evaluation of images of luminescences and fluorescences in 1, 2 and 3 dimensional samples, in-vitro and in-vivo, in areas such as molecular-biological research with ultra-sensitive, ultra-high resolution CCD cameras and scanners. raytest works successfully with influential public research institutes and private companies in a number of funded development programmes. | Günter Dietzel (CEO) | 40 | ISO 9001 certification | ||||
| rent-a-lab Dr. Carsten Tober | Biotech | Services, Laboratory Techniques | CRO for radioactive bioassays: GPCR pharmacology, receptor binding studies, receptor mutation studies, in vivo-occupancy, enzyme assays, RIAs | Reutlingen | 2003 | Aspenhaustrasse 25 72770 Reutlingen Germany Tel.: +49 (0)7121-515367-0 Fax: +49 (0)7121-515367-9 | info@rent-a-lab.biz | www.rent-a-lab.biz | rent-a-lab is a contract research organisation (CRO) providing services mainly in the field of radioactive bioassays (isotopes: [3H], [125I], [14C], [35S], [33P] and [32P]). Services are customised to meet specific needs reaching from individual small scale solutions (e.g. execution of radioimmunoassays (RIAs) or enzyme assays) to assay development for new targets and medium-throughput screening (MTS) of test compounds. rent-a-lab is also able to generate transiently transfected cell lines (CHO, HEK) for receptor mutation studies. One main focus of rent-a-lab is the pharmacology of G-protein-coupled receptors (GPCRs), in this research area several functional assays are offered (e.g. [35S]GTPγS binding tests, adenylate cyclase assays, Gα-subtyp-specific assays). rent-a-lab produces and sells also membrane fragments (e.g. of pig brain). Currently rent-a-lab develops a method to produce pancreatic islets. | ||||||||
| Research Centre for Innovation and Service (FZID) | Institute | Services | Support and promotion of research at the University of Hohenheim | Stuttgart | Prof. Dr. Stefan Kirn (Chairman of the Board) Prof. Dr. Hans-Peter Burghof (Vice-Chairman of the Board) Dr. Frank Kupferschmidt (Managing Director) | Universität Hohenheim Fruwirthstraße 12 Räume 232 und 234 70599 Stuttgart Tel.: +49 (0)711-45922476 | fzid@uni-hohenheim.de | www.fzid.uni-hohenheim.de | The Research Centre for Innovation and Service (FZID), founded in 2005, is one of five scientific centres at the University of Hohenheim. The FZID brings together the interdisciplinary research competences of Hohenheim economic and social scientists. Its major focus is innovation and service research at the University of Hohenheim. Research at the FZID focuses on innovation and knowledge, innovation systems and communication technologies, corporate finance and risk management, healthcare management as well as communication management. The FZID is currently establishing research areas in marketing and management, economics and sustainability and ethics. | ||||||||
| Retina Implant AG | Medtech | Development, Medical Technology, Regenerative Biology, Information Technology | Development and marketing of a sub-retinal implant | Reutlingen | Walter-G. Wrobel (Chairman and CEO) Reinhard Rubow (CFO) | 2003 | Technologiepark Tübingen-Reutlingen Gerhard-Kindler-Strasse 8 72770 Reutlingen Germany Tel: +49 (0)7121-364030 Fax: +49 (0)7121-36403115 | www.retina-implant.de | Retina Implant AG is a medical technology start-up company founded in 2003 and built on the results of a research project that has been ongoing since 1996 and which involves numerous German university hospitals and research institutions, including the University Eye Hospital in Tübingen, the NMI Natural and Medical Institute in Reutlingen, the Institute of Microelectronics in Stuttgart, die University Eye Hospital and Ophthalmology Outpatients’ Department in Regensburg and the Institute of Physical Electronics at the University of Stuttgart. The company was converted into a corporation (AG=Aktiengesellschaft) in July 2007. Retina Implant’s scientists primarily focus on patients with retinitis pigmentosa, a hereditary condition that can lead to complete blindness in just a few years. Retina Implant is developing retinal implants that are intended to restore vision after blindness has occurred. The development work focuses on an active, sub-retinal silicon chip with tiny photo-sensors which control an electronic switch enabling the nerve cells of the retina to be supplied with more or less electrical stimulation, depending on the brightness. These send impulses via the optic nerve to the brain which can then generate a picture from these signals. Only recently, 2 blind patients were implanted the sub-retinal chip. Since undergoing surgery, both patients are able to make out shapes. In April 2006, as part of a capital increase, Mediplan GmbH took around a 25% share in Retina Implant AG by investing Euro 7.5 million in an initial tranche. Mediplan has also committed to investing a further Euro 7.5 million in the company once CE accreditation has been gained, which is required before a medical product can be marketed in Europe. The newly acquired funding will enable Retina Implant to finance clinical trials and the cost of approving the chip for market until it achieves break-even. Retina Implant AG is hoping to launch a fully functional chip in about two years' time. An important step towards reaching this goal is the recent ISO certification of the company. | Walter-G. Wrobel | 10 | Long-term compatibility of functional electrical retina stimulation to restore sight. Qualitative and quantitative analysis of retinal changes following electrical stimulation in an organo-typical retina culture. | |||||
| Reutlingen University | Institute | Education | University focusing on technology, economics and design | Reutlingen | Prof. Dr. Peter Nieß (President) Paula Mattes (Chancellor) | Alteburgstraße 150 D-72762 Reutlingen Tel.: +49(0)7121-2710 (switchboard) | info@reutlingen-university.de | www.reutlingen-university.de | Reutlingen University offers 22 bachelor’s and 14 master’s courses in the fields of technology, economics, informatics and design. Reutlingen University is very much focused on offering study programmes that comply with the best international standards, as it accepts students from all over the world. The course contents have a practical orientation at the same time as providing a solid scientific background, the programmes are designed to help build on students’ personal strengths, applicants are individually selected and there is the possibility of participating in research and development projects. Stays abroad and practical courses are an integral part of study at Reutlingen University. Close contacts with industry and science, with globally acting big companies and effective small- and medium-sized companies support the training and facilitate career entry after graduation. The Reutlingen University campus has 17 buildings with more than 30,000 square metres of usable space, including auditoriums, laboratories, pilot plants and duty rooms. Its textile training and pilot plant is unique worldwide. 7,700 square metres are dedicated to the laboratories of the cotton-spinning mill, combed yarn and woollen yarn spinning mills, weaving mill, manufacturing workshops and textile finishing. The big laboratories of the Faculties of Technology/Mechanical Engineering and Applied Chemistry are also housed here. | ||||||||
| Rottenburg University of Applied Forest Sciences | Institute | Education | University of Applied Forest Sciences | Rottenburg am Neckar | Prof. Dr. Bastian Kaiser (Rector) Prof. Dr. Matthias Scheuber (Prorector) Dieter Kienzle (Chancellor) | Schadenweilerhof D-72108 Rottenburg a.N. Tel.: +48 (0)7472-9510 | hfr@hs-rottenburg.de | www.hs-rottenburg.de | The Rottenburg University of Applied Forest Sciences is a modern university that adapts its teaching to the requirements of the continuously changing graduate career market and the potential jobs targeted by its graduates. The seven-semester forestry bachelor’s course includes practical education undertaken in the university’s own 25 ha forest where there are numerous test crops, a training hunt and fishing waters. Field trips in Germany and abroad ensure that students gain the broadest range of expert knowledge possible. The Sustainable Energy Competence (SENCE) master’s course that has been offered in association with the universities of Stuttgart and Hohenheim since the 2002/2003 winter semester, is a four-semester postgraduate course for 25 students leading to a master of science degree. The seven-semester BioEnergy bachelor’s course has been offered since the 2007/2008 winter semester and gives students the skills to plan and implement energy concepts in the area of biomass. The Resource Management Water bachelor’s course gives students comprehensive knowledge in the scientific basics that are important for successful water management, as well as dealing with sociological aspects related to the use of water as a resource. In 2006, the Rottenburg University of Applied Forest Sciences was awarded the “Official Project of the Decade of Education for Sustainable Development” by UNESCO for its commitment to sustainable education and its wide-ranging impact in the interest of sustainability. In 2008, the UNESCO committee awarded the same title to the University for 2008 and 2009. In December 2007, the University of Applied Forest Sciences Rottenburg came out top in the “Profile and Cooperation – Excellence Strategies for Small and Medium-sized Universities” competition organised by the Stifterverband für die Deutsche Wissenschaft and the Heinz Nixdorf Foundation. | ||||||||
| Rudolf Riester GmbH & Co.KG | Medtech | Medical Technology | Development, manufacture and sale of medical diagnostic instruments | Jungingen | Gerhard Glufke (Managing Director) | 1948 | Bruckstr. 31 72417 Jungingen Germany Phone: +49 (0)7477-9270-0 Fax: +49 (0)7477-9270-70 | info@riester.de | www.riester.de | Rudolf Riester GmbH & Co. KG based in Jungingen, south of Tübingen, specialises in medical diagnostic instruments. The company lays great store on the standard of quality assurance for its products which are sold in nearly 150 countries, while at the same time maintaining its commitment to ongoing development and enhancement. The product portfolio ranges from sphygmometers, stethoscopes and ENT and ophthalmology instruments to veterinary instruments. | 130 | ||||||
| Schärfe System GmbH | Biotech | Development, Diagnostics, Trade/Distribution, Laboratory Techniques | Development, production and marketing of cell analysers for cell culture control | Reutlingen | Karin B. Schärfe (CEO) | 1987 | Krämerstrasse 22 72764 Reutlingen Germany Tel.: +49 (0)7121-38786-0 Fax: +49 (0)7121-38786-99 | www.casy-technology.com | CASY®-Technology is the ideal solution for parallel determination of cell debris, vital cells, dead cells and cell aggregates, with applications ranging from cell number determination right through to the characterisation of cytotoxic investigations. The CASY®-Technology product portfolio includes tools such as cell counters, computerised cell analysers with integrated data processing capabilities and the accompanying consumables and accessories. The cell vitality techniques utilised in the field of cell culture control traditionally involve the use of a dye that often has a cytotoxic effect. However, Schärfe System GmbH offers an effective alternative with its Electrical Current Exclusion (ECETM) solution, which is an integral component of CASY®-Technology. | ||||||||
| SCHOBER medicare GmbH | Medtech | Development, Medical Technology | Development, production and sale of magnetic field therapy systems | Hechingen | Eberhard Schober (CEO) | Zu den Linden 3 72379 Hechingen Germany Tel.: +49 (0)7471-617611 Fax: +49 (0)7471-617612 | info@schober-medicare.de | www.schober-medicare.de | Schober’s equipment system for electromagnetic field therapy comprises a control unit and an applicator which generates a pulsing magnetic field. The applicators take the form of mats, cushions and/or cuffs, thereby facilitating local or full-body treatment. The numerous areas of application include inflammatory and degenerative complaints of the musculoskeletal system, oxygen enrichment of the lungs and metabolic disorders. The firm’s pulsing magnetic field resonance systems can be used in both human and veterinary medicine. | Certified in accordance with Appendix II, Section 3 of the Guideline 93/42 EEC; CE mark | |||||||
| science + computing ag | Biotech | Services, Information Technology | services in the field of IT systems | Tübingen | Dr. Ingrid Zech, Dr. Arno Steitz (Directors with representative authority) | Hagellocher Weg 73 72070 Tübingen Phone: +49 (0)7071-9457-0 Fax: +49 (0)7071-9457-211 | info@science-computing.de | www.science-computing.de | science + computing ag offers IT services and software for the efficient utilisation of computer systems in research and development and has 18 years’ experience on the technical computing market (CAD, CAE, CAT). science + computing ag ensure that IT infrastructures are efficient, cost-effective and fail-safe so that customers can concentrate fully on their core business. | ||||||||
| scienceDISPLAY | Service | Services | Professional representation of scientific topics | Tübingen | Dr. Bettina Danker | Dr. Bettina Danker Weizsäckerstr. 6 72074 Tübingen Tel.: +49 (0)7071-256335 | danker@science-display.com | www.science-display.com | scienceDISPLAY has extensive know-how in the professional representation of scientific topics and comprehensive experience in exact scientific illustrations. scienceDISPLAY creates virtual 3D models as well as graphics, animations, films and interactive presentations for advertising, fairs, Internet or educational purposes. Commercial homepages can be created using PHP and the MySQL database. Dr. Bettina Danker obtained her qualifications for research into scientific issues and their clear presentation as a scientist working in the fields of cell and developmental biology and molecular physiology. | ||||||||
| SensScreen Technologies GmbH | Biotech | Development, Laboratory Techniques, Proteomics | Development and production of magnetic particles for highly sensitive bioseparation | Stuttgart | Dr. Jochen F. Peter (Managing Director) | 2009 | Silberburgstrasse 144 D-70176 Stuttgart Mobil: +49 (0) 173-7069734 | jochen.peter@sensscreen.com | www.sensscreen.com | SensScreen Technologies GmbH develops and produces magnetic nano- and microparticles as well as new methods for the highly sensitive bioseparation of peptides and proteins from the secretome of cultivated cells or human fluids. SensScreen Technologies has developed an award-winning technology platform that enables the quick and gentle isolation of highly pure proteins from cell culture supernatants for example. Another major focus is the ultrasensitive detection of secreted peptides and proteins for the optimisation of cell culture methods. The technology can be used in research carried out at universities, research institutes and companies as well as in the industrial production of proteins and peptides. | |||||||
| SHS Gesellschaft für Beteiligungsmanagement mbH | Service | Services | Investment company | Tübingen | Dr. Bernhard Schirmers (Founder and Managing Director) Reinhilde Spatscheck (Founder and Managing Director) Hubertus Leonhardt (Partner and Managing Director) | 1993 | Bismarckstrasse 12 D-72072 Tübingen Tel.: +49(0)7071-91690 Fax: +49(0)7071-9169190 | tuebingen@shsvc.net | www.shsvc.net | SHS is an investment company providing venture capital to young technology companies. It also supports companies in the establishment and development phases. SHS invests in young, strong growth companies that are active in the life sciences/healthcare sectors (medical technology, diagnostics, biotechnology, pharma (not including drug development), platform and production technologies) in the German-speaking capital market. | 9 | ||||||
| Sieghard Schiller GmbH & Co. KG | Medtech | Medical Technology | Provider of automation systems | Sonnenbühl | Stefan Schiller (Managing Director) | 1978 | Pfullinger Strasse 58 72820 Sonnenbühl-Genkingen Germany Phone: +49 (0)7128-386-0 Fax: +49 (0)7128-386-199 | info@schilller-automation.com | www.schiller-automation.com | Sieghard Schiller GmbH & Co. KG is one of the world's leading providers of automation systems. The company was founded in 1978 and therefore has over 25 years' experience in the automation systems sector. Sieghard Schiller's 100th employee joined in 1993 and the first subsidiary was founded in Thüringen in the same year. In 1998, the first foreign branch was set up in the USA. This was followed by branches in Taiwan and China. The company's activities are divided into different market segments: automation and production systems for the microelectronics industry, the photovoltaics industry and the semiconductor industry. Of particular interest to the medical technology sector is the microelectronics aspect of the business and the company's considerable know-how in the field of clean-room automation. Sieghard Schiller GmbH has been certified according to DIN ISO 9001:2000 since 2003. | Approx. 200 | DIN ISO 9001:2000 | |||||
| SIMT Stuttgart Institute of Management and Technology | Service | Services | Business school for management and technology | Stuttgart | Prof. Dr. Dr. h.c. mult. Johann Löhn (Managing Director) President of the Steinbeis University in Berlin | Filderhauptstraße 142 70599 Stuttgart Tel.: +49 (0)711-4510010 | info@uni-simt.de | www.uni-simt.de | The Stuttgart Institute of Management and Technology (SIMT) is an international business school and advanced education institute of the Steinbeis University Berlin (SHB). In 1998, SIMT was founded on the initiative of a number of renowned global players headquartered in the Stuttgart area, among them Bosch, Daimler, Hewlett-Packard, Siemens and Trumpf. As an advanced education institute, SIMT offers postgraduate master’s programmes leading to MBA, MSc or MBE degrees. All SIMT master’s programmes focus on technology and innovation management as well as international management. All its degrees are recognised in Germany. The courses follow the concept of “Project Competence Projects”, which means the students work for a German or international company at the same time as pursuing their studies. | ||||||||
| SL-Medizintechnik | Medtech | Medical Technology | Production of pulsating magnetic field therapy systems | Murr | Gregor Schad (Managing Director) Armin Leuze (Managing Director) | 2001 | Vordere Str. 15 71642 Ludwigsburg From 1 Apr. 2007: Gottlieb-Daimler-Str. 7 71711 Murr Germany Phone: +49 (0)7144-85600 Fax: +49 (0)7144-856029 | info@magnetovital.de | www.magnetovital.de | SL-Medizintechnik specialises in the production of pulsating magnetic field therapy systems for humans and animals. Pulsating magnetic fields are reputed to improve the energy potential of the cells responsible for circulation and oxygen supply within the body. They can be used daily for therapeutic support, stimulation and prevention. Applications include arthritis, pain, osteoporosis, rheumatism, problems with circulation and metabolism, migraines and diabetes. The products are available in a wide range of versions for whole-body or local application, including complete systems with therapy mat, therapy rings, chairs, couches or cushions, cuffs and ear applicators with integrated coils. Mats, body covers and gaiters can be used for the treatment of animals. | 13 | ||||||
| SMP GmbH | Medtech | Services, Medical Technology | Service for medical products | Tübingen | Klaus Roth Dr. Ludger Schnieder | 2000 | Hechinger Strasse 262 72076 Tübingen Germany Tel. +49 (0)7071-857893-100 Fax +49 (0)7071-857893-200 | info@smpgmbh.com | www.smpgmbh.com | SMP GmbH was founded in 2000 from the PMP (Test Centre for Medical Products), however also became a new member of the PMP. Other members include the NMI Scientific and Medical Institute at the University of Tübingen in Reutlingen, the Section for Minimally Invasive Surgery and the Institute for Clinical Hygiene at the University Hospital Tübingen. SMP GmbH concentrates on applying the test methods developed at the PMP, in particular the radionuclide method, which can be used to validate the cleaning of medical products. SMP GmbH also specialises in the sterilisability of medical products with damp heat or hydrogen peroxide plasma (ASP Johnson & Johnson method) and services for evaluating prion decontamination on surgical instruments. In addition, SMP GmbH coordinates Cleantest, an EU-sponsored research project involving several European companies and institutes. The project aims to validate a cleaning process for minimally invasive surgical instruments and develop a monitoring system. | |||||||
| SNIKE Sport GmbH | Medtech | Medical Technology | Production of equipment for coordinative SNAIX training | Stuttgart | Engelbert Rolli (Managing Director) | Ludwigstrasse 57 70176 Stuttgart Germany Phone: +49 (0)711-256-9723 Fax: +49 (0)711-257-9145 | info@snaix.com, info@snike.com | www.snaix.com | Snike Sport GmbH with its SNAIX training equipment supplies completely new solutions for holistic medical motor activity and fitness training. What is special about this training equipment is the central hinge located between front and rear sections. In addition to the unique therapeutic benefits, this adds a fun element, thus providing motivation to use the equipment. Snike Sport GmbH supplies fitness bikes, walking bikes for children and gym training equipment that are proven to be particularly effective in the treatment and prevention of back pain. The special movement pattern resulting when using this equipment can also markedly improve coordination, balance, concentration and psychomotor performance. SNAIX training stabilises the back by strengthening the deep oblique muscles, densifies neural networks, intensifies the connection between the two hemispheres of the brain and is thus not only suitable for optimising coordination during sport, but also for therapy in patients with severe neurological problems. | ||||||||
| Society for the Promotion of Biotechnology Stuttgart/Tübingen/Neckar-Alb | Service | Services | Promotion of biotechnology in the Stuttgart/Tübingen/Neckar-Alb region | Tübingen | Prof. Dr. Claus D. Claussen (Chairman) | Paul-Ehrlich-Straße 15-17 72076 Tübingen Tel.: +49 (0)7071-689797 | info@biotechnologie-verein.de | www.biotechnologie-verein.de | The Verein zur Förderung der Biotechnologie Stuttgart/Tübingen/Neckar-Alb e.V. (Society for the Promotion of Biotechnology Stuttgart/Tübingen/Neckar-Alb) supports companies and research institutions in the STERN region in order to position the region as an outstanding biotechnology location in the long term. This involves the organisation of events such as the international BioStar Congress, which is held every two years in the STERN region, providing a forum for exchange and discussion for all key players and people interested in the field of regenerative biology. The Society is focused on linking up companies and institutions in the region. In order to promote networking activities, it organises regular meetings for its 90 members and all other people interested in biotechnology as well as numerous other events. It also publishes the “Biotech Regional” magazine several times a year. | Ursula Eising (eising@biotechnologie-verein.de) | |||||||
| Sohena GmbH | Biotech | Services, Chemistry, Laboratory Techniques | Contract synthesis, contract research, analytics and syntheses development consulting | Tübingen | Heike Sowinski Ulrich Heber Stefan Narr | Auf der Morgenstelle 18 72076 Tübingen Germany Tel.: +49 (0)7071-2976249 Fax: +49 (0)7071-295386 | kontakt@sohena.de | www.sohena.de | Sohena GmbH offers a range of contract synthesis, contract research and analytics services. The company's main areas of focus include substance classes such as isomer-pure components, aromatic and acyclic substance classes and carbohydrates and glycopeptides. In addition, the company develops analytical and test methods and stability and degradation studies. Building on these services, the company also offers a comprehensive consulting service for synthesis planning and development. | ||||||||
| SOURCON-PADENA GmbH & Co. KG | Biotech | Services, Development, Ecology/Environment, Trade/Distribution | Developing, manufacturing and marketing biological active agents to protect agricultural crops from pests. | Tübingen | Hilke Arndt (CEO and founder) | 2000 | Hechinger Strasse 262 72072 Tübingen Germany Tel.: +49 (0)7071-97552-0 Fax: +49 (0)7071-97552-50 | info@sourcon-padena.de | www.sourcon-padena.de | SOURCON-PADENA was founded in April 2000 as a joint-stock company (AG) from two private enterprises. The two original companies were spin-offs from the Universities of Stuttgart-Hohenheim and Tübingen. In May 2001, SOURCON-PADENA won Buck Chemie GmbH of Herrenberg, Germany, as a partner by acquiring a minority stake in the company. SOURCON-Padena's core expertise lies in the isolation, cultivation and extraction of micro-organisms as delivery media for active substances. Using quality control procedures in accordance with HPLC-MS, the company supplies high-quality extracts to search for active substances that are free from disrupting factors and are proven to contain new substances that were previously not accessible through conventional methods. The company also specialises in fermentation technologies and offers these at pilot-plant scale up to 200 litres (S1). The company's PRORADIX® plant strengthener, which effectively protects agricultural crops against pests in harmony with nature, is already marketed in the agricultural sector. The active agent is a natural soil bacterium that surrounds the roots of agricultural crops and can function from there without interfering with the ecosystem in the long term. | Associated project NAPRAS; Development of new agents against biofilm formation on regenerative and synthetic tissue implants; Subproject 1: Isolation and identification of the active agents | ||||||
| Southwest German Tumour Centre - Comprehensive Cancer Centre Tübingen | Institute | Medicine, Diagnostics | Diagnostics, therapy and cancer research | Tübingen | Prof. Dr. Diethelm Wallwiener (Director) | Herrenberger Str. 23 D-72070 Tübingen Tel.: +49 (0)7071-2985235 | tumorzentrum@med.uni-tuebingen.de | www.ccc-tuebingen.de, www.tumorzentrum-tuebingen.de | The mission of the Southwest German Tumour Centre - Comprehensive Cancer Centre Tübingen (CCC) is to focus on cancer research, promote multiprofessional cooperation and ensure optimal care for cancer patients. The Centre is well aware of the fact that the diagnosis and therapy of the 200 or more known tumours requires the cooperation of specialists of numerous disciplines. As one of five top oncology centres in Germany, the CCC has been funded by German Cancer Aid since March 2007. Cancer specialists from the University of Tübingen work in interdisciplinary tumour-specific centres within the CCC. Experienced diagnosticians, surgeons, internal medicine specialists and radiotherapists hold 16 tumour conferences per week with the aim of finding the best possible therapy for individual patients. The Tumour Centre stands out for its close integration of patient care and research, which enables the rapid transfer of research results into clinical practice. | ||||||||
| Spring Medical | Medtech | Medical Technology | Supplier of support and compression stockings and nursing products | Waldenbuch | Hans E. Ebbinghaus (Managing Director) | 1846 | Im Meissel 15 - 17 71111 Waldenbuch Germany Phone: +49 (0)7157-8837-0 Fax: +49 (0)7157-8837-88 | info@spring-medical.de | www.spring-medical.de | Founded in 1846 by Wilhelm Spring in Stuttgart, Spring Medical is now located in Waldenbuch between Stuttgart and Tübingen. This medium-sized family business has supplied compression stockings for over 150 years and, in 1988, added support stockings to its sales programme. The products help prevent varicose veins and venous disorders and can provide relief in existing cases of vein incompetence. However, in addition to the medical benefits, the company also places great emphasis on appearance, quality and comfort. Alongside models for allergy sufferers, antibacterial, antistatic and temperature-balancing stockings, Spring Medical also supplies a number of different walking aids and nursing products. | 30 | ||||||
| Steinbeis Beratungszentren GmbH | Service | Services | Consulting for the industrial, service, trade & consumer goods, financial services, healthcare and the public sectors | Stuttgart | Dipl.-Wirtsch.-Ing. August Musch (Managing Director) | 2005 | Steinbeis Beratungszentren GmbH Haus der Wirtschaft Willi-Bleicher-Str. 19 70174 Stuttgart Tel.: +49 (0)711-18395 | beratung@stw.de | www.stw-beratung.de | Steinbeis Beratungszentren GmbH (SBZ) comprises more than 60 consulting centres, offering a broad range of consulting for virtually all business sectors. Our consulting centres bring together experts and experienced consultants from all areas of knowledge and management. Our consulting centres offer a comprehensive service and consulting portfolio to companies in all industrial sectors as well as to public players. Through our holistic solutions and consulting adapted to the specific requirements of individual clients, the Steinbeis consultants contribute to the clients’ successful business development. The consulting services comprise the following fields: strategy & organisation, production and process optimisation, marketing & sales, finance & controlling, personnel development & management, mergers & acquisitions, reports & expertise as well as interim management and business development. SBZ is part of the Steinbeis Foundation. | |||||||
| Steinbeis-Europa-Zentrum (SEZ) | Service | Services | Advice to companies, research institutions, universities and regional funding agencies on questions related to European research programmes and technology cooperations. | Stuttgart | Prof. Dr. Norbert Höptner (Director Steinbeis-Europa-Zentrum and Commissioner for Europe of the Minister of Economic Affairs of Baden-Württemberg) Dr. Petra Püchner (Head of SEZ Stuttgart) Dr. Jonathan Loeffler (Head SEZ Karlsruhe) | Haus der Wirtschaft Willi-Bleicher-Str. 19 D-70174 Stuttgart Tel.: +49(0)711-1234010 | info@steinbeis-europa.de | www.steinbeis-europa.de | The Steinbeis-Europa-Zentrum (SEZ) was established in 1990 on the initiative of the then Commissioner for Europe of the Baden-Württemberg Minister of Economic Affairs. It offers support to small- and medium-sized companies, universities and research institutions in Baden-Württemberg relating to European research programmes and technology cooperations. With offices in Stuttgart and Karlsruhe, the SEZ provides support in the selection of funding programmes, the preparation of funding applications and the carrying out of cross-border projects including the search for suitable partners, project management, technology transfer and the development of regional innovation strategies. The Steinbeis-Europa-Zentrum is the national contact for small- and medium-sized companies in Baden-Württemberg and acts on behalf of the German Federal Ministry of Economics and Technology. It also acts as EU information centre for all Baden-Württemberg universities on behalf of the Ministry of Science, Research and the Arts. Since 2008, the SEZ has been a partner in the European Commission‘s Enterprise Europe Network that has a total of around 600 partners in around 40 countries. The objective of the Network is to support companies in all matters related to Europe, innovation, research and technology transfer as well as promoting the use of the results of European research. The SEZ is a partner in a Baden-Württemberg consortium that also comprises Handwerk International, the Baden-Württemberg Ministry of Economic Affairs and seven chambers of industry and commerce. From 1995 to 2008, the SEZ – in its role as the Innovation Relay Centre Stuttgart – Erfurt – Zurich - was a partner in the former innovation relay centre network. | ||||||||
| Stephan Merz Software & Medizintechnik | Medtech | Medical Technology | Audiological software and diagnostic systems for ENT, hearing aid acoustics, occupational medicine and pediatrics | Reutlingen | Stephan Merz Dr. Heike-Jana v. Raven | 2007 | Bei der Kirche 4 72768 Reutlingen Germany Tel.: +49 (0) 7121 - 284 654 -0 Fax: +49 (0) 7121 - 284 654 -44 | info@stephan-merz.de | www.stephan-merz.de | Stephan Merz Software & Medizintechnik develops and sells audiological software and diagnostic systems. For the first time, the evidENT2 software provides users with a cross-platform system for computer-controlled collection and documentation of audiological data and findings during various types of hearing tests. Our many years of experience with medical technology and diagnostics in this field enable us to provide and continually develop application-based solutions. Close cooperation with doctors and clinics plays a key role in this work. The company also sells medical technology for audiometry, tympanometry, OAE measuring systems, posturography, vestibular diagnostics, rhinomanometry and spirometry. | |||||||
| STRATEC Biomedical Systems AG | Biotech | Services, Development, Information Technology, Process Engineering | STRATEC Biomedical Systems AG plans, develops and produces fully-automatic analysis systems for partners from the field of clinical diagnostics and life sciences using its own, patent-protected technologies. | Birkenfeld | Hermann Leistner (Board Chairman) Marcus Wolfinger (CFO) Bernd M. Steidle (Director of Sales and Marketing) | 1979 | Gewerbestrasse 37 75217 Birkenfeld Germany Tel.: +49 (0)7082-79160 Fax: +49 (0)7082-7916999 | info@stratec-biomedical.de | www.stratec-biomedical.de | Founded in 1979 as STRATEC Elektronik GmbH, the company focused in 1994 on the core areas of OEM (Original Equipment Manufacturer) development and the production of integrated solutions for international manufacturers of diagnostic agents. STRATEC products have enjoyed success especially in the growth sectors of laboratory diagnostics and life sciences. Based on its existing product platforms, STRATEC develops innovative, customer-focused products with an effective cost structure and within a period of 18 to 36 months. STRATEC offers a first-rate full service and provides its entire range of instruments from a single source, drawing on a broadly-based pool of technologies including: liquid handling systems, software, robotics and detection modules, process validation, documentation services and approval services. New technologies are continuously being developed in the field of diagnostics and life sciences accompanied by changes in regulations so that processes must constantly be adapted to their specific environment. STRATEC meets all these challenges by supporting its customers’ instrumentation activities in the field of project management, hardware and software engineering, verification and production. With experience spanning over 25 years and an in-depth knowledge of technology and the regulations governing it, STRATEC offers its partners valuable support in all phases of the system life cycle. STRATEC’s development and production facilities are based on its own, patent-protected technologies and focus on integrated solutions. The company’s partners are skilled in market knowledge and specific reagent expertise while STRATEC provides expertise and application know-how in natural and engineering sciences as well as in automation and application software. | Bernd M. Steidle (b.steidle@stratec-biomedical.de) | 183 | DIN EN ISO 9001, DIN EN ISO 13485, FDA-registered , CSA/UL-registered | ||||
| Stuttgart University of Applied Sciences (HFT) | Institute | Education | University of applied sciences focusing on technology | Stuttgart | Prof. Rainer Franke (Rector) | Hochschule für Technik Stuttgart Schellingstr.24 70174 Stuttgart Tel.: +49 (0)711-89262660 | rektorat@hft-stuttgart.de | www.hft-stuttgart.de | The Stuttgart University of Applied Sciences offers numerous bachelor’s and master’s degree courses in a broad range of technical disciplines. Stuttgart University of Applied Sciences attaches great importance to studying and teaching in small groups, working closely with professors and clearly structured study contents. Students are given the opportunity to get acquainted with the professional world and are encouraged to make contact with potential future employers. Lecturers from industry and business as well as the advisory boards involved in course development provide the students with practical information. The Stuttgart University of Applied Sciences works in partnership with more than 50 universities in Germany and abroad and offers students the opportunity to do practical semesters abroad and gain valuable experience. The University has around 100 professors, 150 lecturers and approximately 2600 students. Research at the Stuttgart University of Applied Sciences is mainly focused on building physics, geoinformatics and technomathematics. Research activities are all housed in the Joseph von Egle Institute, which is one of the most renowned German institutes of applied research and development in the fields of building acoustics, thermal insulation, thermal building physics and the use of solar energy. In addition, the “Centre for Applied Research – Sustainable Energy Technology” (zafh.net) is part of the Stuttgart University of Applied Sciences, where five Baden-Württemberg universities of applied sciences combine their research skills in the development of “intelligent buildings”, with the aim of reducing the use of fossil fuels in heating and air-conditioning systems. The Centre for Building Physics is also part of the Stuttgart University of Applied Sciences, where a hall containing a broad range of measurement and test plants is among the most modern of its kind in Europe. | ||||||||
| Subitec GmbH | Biotech | Development, Ecology/Environment | Development and manufacture of sustainable bioproducts made from microalgae | Stuttgart | Dr. Peter Ripplinger (Managing Director) | 2000 | Nobelstrasse 12 70569 Stuttgart Germany Tel.: +49 (0)711-970-4210 Fax. +49 (0)711-970-4200 | www.subitec.com | SUBITEC was founded as a spin-off in 2000 by scientists from the Fraunhofer Institute for Interfacial Engineering and Biotechnology (IGB). The materials’ photosynthetic production takes place in closed bioreactors that must be kept sterile. These bioreactors are currently land-based, but will in future also be water-based. SUBITEC GmbH offers a flat panel airlift reactor (FPA) that satisfies the requirements on the commercial mass production of microalgae outdoors. The FPA reactor works on the principle of the airlift loop reactor and, thanks to a low layer density and targeted flow in the reactor over static mixers, achieves the ideal light supply to all algal cells. The types of algae used include: chlorella vulgaris, isochrysis aff. galbana (clone t. iso), haematococcus pluvialis and phaeodactylum triconutum. | Prof. Walter Trösch (walter.troesch@igb.fhg.de) | |||||||
| Synovo GmbH | Biotech | Services, Development, Drug Development, Medicine | Testing methods for choosing drug candidates | Tübingen | Dr. Michael Burnet (CEO) | Paul-Ehrlich-Strasse 15 72076 Tübingen Germany Tel.: +49 (0)7071-964325 Fax +49 (0)7071-964326 | contact@synovo.com | www.synovo.com | Synovo GmbH is a pharmaceutical research company that offers services in the fields of synthetic chemistry, pharmacology, cell engineering and peptide modification. The company’s focus lies in providing various testing methods and models – ideally using human cells, proteins or systems – for the selection of drug candidates with improved properties in terms of absorption, distribution, metabolism and elimination (ADME or DMPK). On behalf of customers from the pharmaceutical industry, Synovo is involved in projects investigating anti-inflammatory and immuno-suppressive drug optimisation and the improvement of existing technologies used for the development of new drugs from proteins and nucleic acids. This work is carried out in collaboration with public-sector laboratories. | Dr. Michael Burnet | 20 | ||||||
| T5 Interface GmbH | Service | Services | Human resource management | Böblingen | Peter Linde Klaus-Peter Kaas Andreas Schambert | Bunsenstr. 22 D-71032 Böblingen Tel.: +49(0)7031-285190 Fax: +49(0)7031-2851919 | info@t5-interface.de | www.t5-interface.de | T5 Interface GmbH, established in 2000, advises and supports companies in human resource management. The company’s core competence is personnel marketing, including consulting for the establishment of efficient and modern personnel recruitment concepts, as well as direct headhunting and selection of academic experts and executives. T5 Interface organises individual recruiting and image events for companies as well as pan-regional recruitment fairs. The “T5 Job Messen” fairs, with a special focus on healthcare, are the top recruitment fairs in Germany, based on reputation. The company has an Internet job portal where it publishes specific job offers for experts and executives in scientific and technical areas. The electronic company portal provides detailed profiles of potential employers, thereby offering companies an ideal platform for employer branding objectives. | ||||||||
| TANITA Europe GmbH | Medtech | Medical Technology | Production of scales and body analysis systems for various applications | Sindelfingen | Daisuke Tanida (Managing Director) Kanzo Tanida (Managing Director) Zentaro Yamazaki (Managing Director) | 1923 in Japan | Dresdener Strasse 25 71065 Sindelfingen Germany Phone: +49 (0)7031-6189-6 Fax: +49 (0)7031-6189-71 | info@tanita.de | www.tanita.de | The Tanita Corporation was founded in 1923 in Tokyo, Japan, and today has branch offices around the world, including in Germany. During its 80-year history, the company has developed a whole range of innovative products, which have been applied in health prevention, in the dietary advice field, the gym sector and professional sport. The company supplies a number of different scales, such as baby, pocket and bathroom scales, as well as body-fat analysis scales. The body-fat analysis scales use bio-impedance analysis which, after certain data is entered, provide detailed information on the quantity of excess fatty tissue, water and fat-free body mass. Another health innovation are the Inner Scan products, which are able to provide detailed information about a person’s muscle mass, bone mass, organ fat, metabolic rate and physique. | |||||||
| Technologieparks Tübingen-Reutlingen GmbH (TTR) | Service | Services | Operation and management of the Tübingen-Reutlingen Technology Parks | Reutlingen | Thomas Dephoff (Managing Director) | Gerhard-Kindler-Straße 8 D-72770 Reutlingen Tel.: +49(0)07121-9097990 | info@ttr-gmbh.de | www.ttr-gmbh.de | Technologieparks Tübingen-Reutlingen GmbH (TTR) is a wholly-owned subsidiary of L-Bank. The goal of TTR GmbH is to create an environment that makes it simpler and quicker to transfer ideas and introduce new products to the market. The TTR management team provides advice and looks after its clients from the word go. It also looks after the smooth operation of the park and associated buildings. TTR is represented at two sites, Tübingen and Reutlingen. In Tübingen, the major focus is biotechnological research, in Reutlingen the focus is the development of high-technology products. Both locations have buildings and special properties that can be adapted to the different technological requirements of potential tenants. In Germany’s biggest biotechnology start-up centre, TTR offers large laboratory and office areas that also allow for future expansions. | ||||||||
| Technology Transfer Office at the University of Tübingen | Service | Services | Cooperation between industry and science | Tübingen | Dr. Rolf Hecker | University of Tübingen Zentrale Verwaltung Dez. VI.5 Technologietransfer Wilhelmstrasse 5 D-72074 Tübingen Tel.: +49(0)7071-2972639 | r.hecker@uni-tuebingen.de | The Technology Transfer Office at the University of Tübingen provides information, advice and support for all questions related to the collaboration between industry and science. The office arranges research contracts between the university and industry and licenses technologies developed at and property rights owned by the University of Tübingen. The University of Tübingen website gives an overview of its departments and institutes, the organisational structure of the faculties and its research priorities. | |||||||||
| TechnoStart GmbH | Service | Services | Consulting company for investment funds | Ludwigsburg | Michael Mayer (Managing Director) | Martin-Luther-Str. 59 71636 Ludwigsburg Tel.: +49 (0)7141-971590 | office@technostart.com | www.technostart.com | We invest in very small companies with big potential. TechnoStart is an independent venture capital organisation that has been operating since 1991. Its initial investments in any company are clearly focused on early stage investments in university spin-offs in the fields of applied physics, life sciences, chemistry and new materials. Our investment team consists of natural scientists; our background in the natural sciences and engineering enables us to assess your business idea competently and quickly. The cross-sectional technologies in which we are interested, serve as platforms for other technologies or products. They have the potential to sustainably change our client’s method of operation. Sometimes we invest in the completion of the scientific aspect of a project with the goal of accelerating the subsequent establishment of the technology platform and its commercialisation through products. If your ”idea” fits into this framework, then you could benefit from our active management activities and know-how. If we invest in your company, we will assist you in the entire process associated with the establishment of your company. | ||||||||
| TETEC® AG | Biotech | Development, Medicine, Medical Technology, Regenerative Biology | Development of new methods for the treatment of complex damage to and disease of the human skeletal and locomotor system. | Reutlingen | Dr. med. Karl-Christoph Gaissmaier Dr. Stephan Rapp | 2000 | Tissue Engineering Technologies - Aktiengesellschaft zur Entwicklung und Herstellung von biologischem Gewebeersatz Aspenhaustrasse 25 72770 Reutlingen Germany Tel.: +49 (0)7121-514-8760 Fax: +49 (0)7121-514-8761 | info@tetec-ag.de | www.tetec-ag.de | TETEC was initially founded as a limited liability company (GmbH). In 2003, TETEC® was converted into a joint-stock company (AG). “TE” stands for tissue engineering and “TEC” for innovative technologies. TETEC AG holds a manufacturing permit in accordance with §13 Para.1 German Drug Law (AMG) for its autologous cartilage cell products NOVOCART, NOVOCART 3D and NOVOCART Disc. NOVOCART is an autologous chondrocyte preparation while NOVOCARD 3D is a combination of autologous cartilage cells and a bi-phasic, three-dimensional, collagen-based matrix. NOVOCART 3D is ideal for the biological reconstruction of articular cartilage defects. NOVOCART Disc is a high-quality, autologous cell preparation for the biological reconstruction of partially-damaged intervertebral discs following a slipped disc. ADCT (Autologous Disc Cell Transplantation; the transplantation of in chondrocytes from autologous disc tissue that have been cultured in vitro) is the only method that facilitates the biological reconstruction of partially-damaged disc tissue before widespread degeneration occurs. The cultured cartilage cells, isolated from the biopsy material, induce the desired biological reconstruction. | Dr. Stephan Rapp | 20 | The company operates in accordance with GMP standards | Therapeutic use of adult mesenchymal stem cells (MSC) for the replacement of cartilage/bone. Joint research project: Gelatin-based, smart biomaterials for cartilage regeneration | |||
| The Microarray Facility | Biotech | Services, Medicine, Diagnostics | Analyses with DNA chips | Tübingen | Dr. Michael Bonin (CEO) | 2001 | Medizinische Genetik Calwerstrasse 7 72076 Tübingen Germany Tel.: +49 (0)7071-2972295 Fax: +49 (0)7071-295172 | michael.bonin@microarray-facility.com | www.microarray-facility.com | The Microarray Facility at the University of Tübingen specialises most notably in providing services based on Affymetrix GeneChip® technology. Microarrays have a versatile range of diagnostic uses. The Microarray Facility diagnostic tools include the Roche AmpliChip which has been approved by the US FDA as a tool for in vitro diagnosis to examine 33 different alleles of the cytochrome P450 enzymes 2D6 and 2C19. Doctors can then use the result to adjust the individual dose of drugs where the two enzymes are involved. The Affymetrix CustomSeq® resequencing array, which enables analysis of the CFTR gene, can be used to help diagnose cystic fibrosis, a commonly autosomal recessive hereditary disorder. Oligonucleotide arrays have a number of applications, including genetic coupling or association studies and the detection of chromosomal defects. | |||||||
| Tosoh Bioscience GmbH | Biotech | Services, Chemistry, Laboratory Techniques | Media and pre-packed columns for chromatography | Stuttgart | Hiroyuki Uchida (Managing Director, Tosoh Corporation) Hiroyuki Suzuki (President, Tosoh Bioscience GmbH) Yoichi Yasuda (General Manager, Bioscience Division, Tosoh Corporation) Masayuki Yamada (President, Tosoh Bioscience Limited, Tosoh Bioscience Incorporated) | 1987 | Zettachring 6 70567 Stuttgart Germany Tel.: +49 (0)711-13257-0 Fax: +49 (0)711-13257-89 | info.sep.eu@tosoh.com | www.tosohbioscience.de | Tosoh Bioscience is an internationally-acknowledged supplier in the field of bio-separation technology. Earning its reputation under the name TosoHaas, the firm was founded in 1987 from a joint venture between the chemical group Rohm & Haas, USA and the Tosoh Corporation (founded in 1935) from Japan. In 2001, the company was renamed Tosoh Biosep. At the start of 2003, all areas of Tosoh’s Scientific Instrument Division (Separation and Diagnostics) were combined under the umbrella name Tosoh Bioscience. Tosoh Bioscience is part of the Scientific Instruments Division of the Japanese Tosoh Corporation which was founded in 1935. Tosoh Bioscience offers a wide range of media and pre-packed columns (based on silicon or polymer materials) for all common chromatography methods. These products are based on the brand products TSK-GEL®, Toyopearl® and ToyoScreen®. Tosoh Bioscience also offers modified media for customer-specific separations and technical service such as applications for research and analysis, method development and scale-up plus assistance and consulting for the packaging of large columns on site. Production facilities in Japan supply the company’s subsidiaries in the USA and Europe. | Dr. Regina Holzhauser | ||||||
| Transgenic Facility Tübingen, IZKF Service Transgenic Animals | Institute | Services, Genomics | Service facility for the generation of transgenic animal models | Tübingen | Dr. Thomas Ott (Director) | Forschungsverfügungsgebäude der Medizinischen Fakultät Universitätsklinikum Tübingen Otfried-Müller-Str. 27 D-72076 Tübingen Tel.: +49 (0)7071-2972280 and 2972300 | thomas.ott@uni-tuebingen.de | www.medizin.uni-tuebingen.de | The Tübingen Transgenic Facility focuses on the generation of transgenic animal models with the aim of gaining insights into human hereditary diseases. Transgenic rats and mice are produced by injecting DNA into the pronucleus of zygotes and by the specific manipulation of genes in embryonic stem cells. The service laboratory also provides a service that generates knock-out and knock-in mice through the injection of embryonic stem cells into blastocysts. The facility’s services are complemented by planning advice and support for the production of genetically modified embryonic stem cell lines (knock-out and knock-in embryonic stem cell lines) as well in the planning of projects, including the preparation of applications for use with experimental animals. | ||||||||
| Translumina GmbH | Medtech | Development, Medicine, Medical Technology, Process Engineering | International company for medical technology focussing on drug-eluting stent systems | Hechingen | Lars Sunnanväder (Managing Director) | 2000 | Marketing & Sales Steinsdorfstraße 8 80538 München Germany Tel.: +49 (0)89-210289-0 Fax: +49 (0)89-210289-29 Production Neue Rottenburger Straße 50 72379 Hechingen Germany Tel.: +49 (0)7471-9894-0 Fax: +49 (0)7471-9894-380 | info@translumina.de | www.translumina.de | Translumina GmbH was established in 2000 and since then has developed into a leading company in the production and development of innovative and biocompatible stent coatings. Translumina has developed a coating system (YUKON®DES Drug Eluting Stent) and the Stent Coating Machine (SCM) for cardiac stents (vessel wall supports), which allow doctors to apply a customised medication coating to a stent, which is then inserted into the coronary vessels. The coating prevents occlusion and restenosis of the vessel. The active substance can be applied to the stent without the need for additional polymers. | 40 | ||||||
| TRUMPF Werkzeugmaschinen GmbH + Co. KG | Medtech | Medical Technology | Production of machine tools for sheet metal production, industrial laser technology, high-performance electronics and medical technology | Ditzingen | Dr. phil. Nicola Leibinger-Kammüller Dipl.-Ing. Peter Leibinger Dr.-Ing. Mathias Kammüller Dipl.-Ing. Friedrich Kilian Dr. rer. soc. Gerhard Rübling Dipl.-Ök. Harald Völker | 1923 | Johann-Maus-Strasse 2 71254 Ditzingen Germany Phone: +49 (0)7156-303-0 Fax +49 (0)7156-303-309 | info@de.trumpf.com | www.trumpf.com | The TRUMPF Group, founded in 1923 by Christian Trumpf in Stuttgart, is one of the world's leading companies in the production engineering sector. Trumpf has 45 subsidiaries and operates around the globe. In the market for machine tools for sheet metal processing, the company is a leading manufacturer of machines for laser processing, punching, forming and bending, automated production solutions, and software and services. It also supplies power tools for separating, joining or shaping. The company’s laser systems include CO2 lasers, lamp- and diode-pumped solid-state lasers, marking lasers and multi-axis laser systems. In the fields of electronics and medical technology, Trumpf provides system solutions such as operating tables, ceiling-mounted workstations and operating lamps | 6049 worldwide | ||||||
| Tuebingen Scientific Medical GmbH | Medtech | Medical Technology | Development of innovative instrument systems for minimally invasive surgery | Tübingen | Professor Marc O. Schurr (CEO) Marcus Braun (CEO) | Dorfackerstrasse 26 72074 Tübingen Germany Tel.: +49 (0)7071-7704518 Fax: +49 (0)7071-763574 | info@tuebingen-scientific.de | www.tuebingen-scientific.de | The company was founded in 1999 by a research team at the University of Tübingen and develops innovative instrument systems for minimally invasive surgery, including optimised guide systems, controllable instruments and manipulators. The company's product portfolio also includes complete workstation units for endoscopic operations. The systems developed by Tuebingen Scientific offer high mobility and feature an ergonomic handle and modular/multifunctional design. The company's Radius Surgical System offers the surgeon greater freedom through stepless inclination, the ability to freely turn the tip of the instrument round 360 degrees and the option to rotate the effector at any angle. | ||||||||
| University Hospital of Tübingen | Institute | Medicine, Education | Centre for healthcare, science and education | Tübingen | Prof. Dr. med. Michael Bamberg, Managing Medical Director and Chairman of the Executive Board of Directors Rüdiger Strehl, Commercial Director and Deputy Chairman of the Executive Board of Directors Gabriele Sonntag, Commercial Director and Deputy Chairwoman of the Executive Board of Directors Prof. Dr. med. Karl-Ulrich Bartz-Schmidt, Deputy Managing Medical Director Prof. Dr. med. Ingo B. Autenrieth, Dean of the Medical Faculty Günther Brenzel, Director of Nursing | 1805 | Geissweg 3 D-72076 Tübingen Tel. +49 (0)7071 - 290 Fax +49 (0)7071 - 29-39 66 | vorstand@med.uni-tuebingen.de | www.medizin.uni-tuebingen.de | The University Hospital of Tübingen has established itself as a leading centre of German university medicine. The German Science Council has attested the Hospital and the Medical School’s outstanding achievements in research, education and healthcare as well as its role as a pacemaker for university medicine in Germany. As a hospital offering maximum medical care and with a catchment area extending from the Mittlerer Neckar metropolitan region to Lake Constance, Tübingen University Hospital is known beyond its regional borders and functions as a district hospital for the city and district of Tübingen. Since January 1998, the Hospital has been a public-law institution with a board of directors and a supervisory board. | ca. 8500 | ||||||
| University of Hohenheim | Institute | Education | Research and education | Stuttgart | Prof. Dr. Dr. h.c. Hans-Peter Liebig (Rector) | Rector’s Office Castle of Hohenheim D-70599 Stuttgart Tel.: +49(0)711-4590 | post@uni-hohenheim.de | www.uni-hohenheim.de | The University of Hohenheim currently offers 12 bachelor courses, including B.Sc. courses in the life sciences, agricultural sciences, economics and social sciences, as well as state exam courses in biology and food chemistry. The number of master courses in the natural sciences, agricultural sciences, economics and social sciences is continually being expanded. The University of Hohenheim focuses on applied research and education. It strives for excellence in education and research by bringing together different competences and skills, evaluation and quality management. The University of Hohenheim’s objective is to integrate its teaching and research activities with regional and international partners. It also offers numerous further training courses for lifelong education. The largest faculty is the Faculty of Economics and Social Sciences, which comprises around fifty percent of all students enrolled at Hohenheim University. Approximately 30 percent of students are enrolled at the Faculty of Agricultural Sciences, and around 20 percent at the Life Sciences Faculty. The University of Hohenheim has a unique selling point due to its particular profile that covers the entire chain of the development of natural and economic values through finishing processes, economic utilisation and sustainable return into the ecosystem. The University’s profile topics are the nutrition sciences as part of the food chain, the contribution of agriculture to energy and raw material supply, biological signals as well as innovation and services. In 2004, Hohenheim became, and remains today, the first university in Baden-Württemberg to be certified as a family-friendly university. The “Studium schnupperale” specifically targets children and adolescents with the aim of awakening their interest in the natural sciences. | ||||||||
| University of Stuttgart | Institute | Education | Research and education | Stuttgart | Prof. Dr.-Ing. Wolfram Ressel (Rector) | Keplerstraße 7 70174 Stuttgart Tel.: +49 (0)711-6850 | poststelle@uni-stuttgart.de | www.uni-stuttgart.de | The University of Stuttgart is a research-intensive university with an interdisciplinary profile and a particular focus on the natural and engineering sciences. It offers a broad range of courses in the engineering sciences, natural sciences, mathematics, languages and cultural sciences, as well as in economics and social sciences. The University of Stuttgart works in close cooperation with Baden-Württemberg universities, including the Universities of Hohenheim, Ulm and Tübingen, as well as with highly renowned research institutions such as the Max Planck and Fraunhofer Societies, the German Aerospace Centre and with numerous other research institutions and industrial companies. The core competence of the University of Stuttgart is the interdisciplinary integration of its research activities. This is confirmed by the University’s leading position in many areas: it has a cluster of excellence and a graduate school that receive funding through the German government’s Excellence Initiative, collaborative research centres, priority programmes and research training schools as well as integrated and international courses of study. The research activities of the University of Stuttgart are focused on the following eight interdisciplinary priorities: * Modelling and simulation technologies * New materials * Complex systems and communication * Technology concepts and technology assessment * Sustainable energy supply and environment * Mobility * Integrated product and production design * The development and technology of sustainable living spaces. The overall vision behind all the research activities is the comprehensive exploration of the entire product development and product life cycle. The “Simulation Technology” cluster of excellence and the “Graduate School for Advanced Manufacturing Engineering” at the University of Stuttgart receive funding through the German government’s Excellence Initiative. | ||||||||
| Virex GmbH | Medtech | Medical Technology | Development of the Virex medical device for fast pasteurisation of breast milk | Tübingen | Klaus Lauf Werner Rühl | 2004 | Reutlinger Str. 2 72072 Tübingen Germany Phone: +49 (0)7071-368540 Fax: +49 (0)7071-551011 | info@virex.eu.com | www.virex.eu.com | In cooperation with the Institute for Medical Virology of the University Hospital Tübingen and the Neonatology Department of the University Children's Hospital Tübingen, Klaus Lauf (Klaus Lauf Medizintechnik und Sonderbau), precision engineering expert by profession, succeeded in developing a device which kills all herpes viruses (HCMV) in breast milk within 90 seconds. The HCM virus, which is transmitted through breast milk, poses a particularly serious risk for premature babies (< 30th week of pregnancy and < 1000 grams). A patent specification has been submitted for Virex and this has already been confirmed for Europe (European Patent 00 935 139.6-2114). | |||||||
| WEGASOFT Software-Entwicklungs GmbH | Medtech | Medical Technology | Specialisation in PPC/ERP system solutions | Balingen | Josef Kudlacek (Managing Director) | Hölzlestr. 44/1 72336 Balingen Germany Phone: +49 (0)7433-9072140 | info@wegasoft.de | www.wegasoft.de | In cooperation with users and partners, WEGASOFT - Software-Entwicklungs GmbH has been developing and servicing the CAMplus industry software solution – a professional, high-performance PPC/ERP solution for small and medium-sized manufacturing companies – for over 15 years. CAMplus solutions are available for handling all business processes – from order processing to materials management and production planning – for the metal working, medical technology, automotive, electrical engineering and basic functionality sectors. | 10 | |||||||
| Welch Allyn GmbH & Co. KG | Medtech | Medical Technology | Manufacturer of medical equipment and solutions for clinical practices, hospitals, emergency medical services, military medical services and veterinary medicine. The company has its own service engineers worldwide. | Jungingen | Dr. Walter F. Müller (Sales + Marketing) Jörg Ringwald (Admin., Technical + Production) | 1915 | Zollerstrasse 2-4 72417 Jungingen Germany Phone: +49 (0)7477-9271-0 Fax: +49 (0)7477-9271-90 | info@welchallyn.de | www.welchallyn.de | Welch Allyn was founded in 1915 and is now a leading manufacturer of innovative medical equipment for diagnostics and treatment, defibrillators, ECG data management systems, patient monitoring systems, W-LAN patient monitoring systems and miniature precision light sources. The company headquarters is in Skaneateles Falls, New York State, USA. Welch Allyn was voted one of the "100 best companies to work for" by Forbes magazine in 2003. The company has received innovation awards for numerous products including the DuraShock™ sphygmometer, the PanOptic™ ophthalmoscope, the Propaq LT™ transport monitor and the Acuity Flexnet© patient monitoring system. Welch Allyn has more than 2,300 employees and numerous production sites and sales offices worldwide. | Over 2300 worldwid |
